response to heat (GO:0009408),5,5,0.98,+,5.12,3.31E-03
cholesterol biosynthetic process (GO:0006695),5,5,0.98,+,5.12,3.31E-03
cellular response to heat (GO:0034605),5,5,0.98,+,5.12,3.31E-03
secondary alcohol biosynthetic process (GO:1902653),5,5,0.98,+,5.12,3.31E-03
cellular component macromolecule biosynthetic process (GO:0070589),1,1,0.2,+,5.12,1.77E-01
nucleolar large rRNA transcription by RNA polymerase I (GO:0042790),2,2,0.39,+,5.12,5.90E-02
cell wall organization or biogenesis (GO:0071554),1,1,0.2,+,5.12,1.77E-01
phytosteroid metabolic process (GO:0016128),1,1,0.2,+,5.12,1.77E-01
cellular alcohol metabolic process (GO:0044107),1,1,0.2,+,5.12,1.77E-01
multi-organism cellular process (GO:0044764),1,1,0.2,+,5.12,1.77E-01
cell wall biogenesis (GO:0042546),1,1,0.2,+,5.12,1.77E-01
cell wall macromolecule biosynthetic process (GO:0044038),1,1,0.2,+,5.12,1.77E-01
cell wall macromolecule metabolic process (GO:0044036),1,1,0.2,+,5.12,1.77E-01
erythrocyte differentiation (GO:0030218),5,4,0.98,+,4.1,1.76E-02
proteasome assembly (GO:0043248),7,5,1.37,+,3.66,1.30E-02
regulation of circadian rhythm (GO:0042752),7,5,1.37,+,3.66,1.30E-02
pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),7,5,1.37,+,3.66,1.30E-02
pyrimidine nucleotide biosynthetic process (GO:0006221),7,5,1.37,+,3.66,1.30E-02
sterol biosynthetic process (GO:0016126),13,9,2.54,+,3.54,1.26E-03
pyrimidine nucleotide metabolic process (GO:0006220),9,6,1.76,+,3.41,9.30E-03
tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),3,2,0.59,+,3.41,1.17E-01
purine nucleobase biosynthetic process (GO:0009113),6,4,1.17,+,3.41,3.13E-02
"nucleotide-excision repair, DNA incision (GO:0033683)",6,4,1.17,+,3.41,3.13E-02
triglyceride homeostasis (GO:0070328),6,4,1.17,+,3.41,3.13E-02
regulation of mitochondrial membrane permeability (GO:0046902),3,2,0.59,+,3.41,1.17E-01
regulation of reactive oxygen species metabolic process (GO:2000377),3,2,0.59,+,3.41,1.17E-01
intra-S DNA damage checkpoint (GO:0031573),8,5,1.56,+,3.2,2.16E-02
circadian regulation of gene expression (GO:0032922),16,10,3.12,+,3.2,1.47E-03
folic acid-containing compound metabolic process (GO:0006760),13,8,2.54,+,3.15,4.63E-03
GPI anchor metabolic process (GO:0006505),18,11,3.52,+,3.13,1.05E-03
lysosomal microautophagy (GO:0016237),5,3,0.98,+,3.07,7.60E-02
piecemeal microautophagy of the nucleus (GO:0034727),5,3,0.98,+,3.07,7.60E-02
regulation of epithelial cell differentiation (GO:0030856),5,3,0.98,+,3.07,7.60E-02
circadian rhythm (GO:0007623),22,13,4.3,+,3.03,5.25E-04
GPI anchor biosynthetic process (GO:0006506),17,10,3.32,+,3.01,2.28E-03
regulation of lipid biosynthetic process (GO:0046890),14,8,2.73,+,2.93,7.09E-03
purine ribonucleotide catabolic process (GO:0009154),7,4,1.37,+,2.93,5.00E-02
nucleoside monophosphate metabolic process (GO:0009123),14,8,2.73,+,2.93,7.09E-03
mitochondrial respiratory chain complex I assembly (GO:0032981),7,4,1.37,+,2.93,5.00E-02
ubiquinone biosynthetic process (GO:0006744),7,4,1.37,+,2.93,5.00E-02
establishment of mitotic spindle orientation (GO:0000132),7,4,1.37,+,2.93,5.00E-02
iron ion transmembrane transport (GO:0034755),7,4,1.37,+,2.93,5.00E-02
intraciliary retrograde transport (GO:0035721),7,4,1.37,+,2.93,5.00E-02
nucleobase metabolic process (GO:0009112),23,13,4.49,+,2.89,7.85E-04
pteridine-containing compound metabolic process (GO:0042558),16,9,3.12,+,2.88,4.90E-03
establishment of spindle orientation (GO:0051294),9,5,1.76,+,2.84,3.34E-02
DNA unwinding involved in DNA replication (GO:0006268),9,5,1.76,+,2.84,3.34E-02
protein localization to cytoskeleton (GO:0044380),9,5,1.76,+,2.84,3.34E-02
pyrimidine-containing compound metabolic process (GO:0072527),20,11,3.91,+,2.82,2.36E-03
ribonucleoside monophosphate metabolic process (GO:0009161),11,6,2.15,+,2.79,2.25E-02
rhythmic process (GO:0048511),24,13,4.69,+,2.77,1.14E-03
endocytic recycling (GO:0032456),15,8,2.93,+,2.73,1.04E-02
cholesterol metabolic process (GO:0008203),17,9,3.32,+,2.71,7.14E-03
cellular carbohydrate catabolic process (GO:0044275),10,5,1.95,+,2.56,4.85E-02
response to temperature stimulus (GO:0009266),10,5,1.95,+,2.56,4.85E-02
pyrimidine nucleobase metabolic process (GO:0006206),10,5,1.95,+,2.56,4.85E-02
Golgi to vacuole transport (GO:0006896),10,5,1.95,+,2.56,4.85E-02
fat cell differentiation (GO:0045444),4,2,0.78,+,2.56,1.84E-01
mitochondrial respiratory chain complex II assembly (GO:0034553),2,1,0.39,+,2.56,3.23E-01
mitochondrial respiratory chain complex III assembly (GO:0034551),4,2,0.78,+,2.56,1.84E-01
endosome to lysosome transport (GO:0008333),6,3,1.17,+,2.56,1.14E-01
intracellular sterol transport (GO:0032366),2,1,0.39,+,2.56,3.23E-01
neuron apoptotic process (GO:0051402),12,6,2.34,+,2.56,3.23E-02
basic amino acid transmembrane transport (GO:1990822),2,1,0.39,+,2.56,3.23E-01
carbohydrate transport (GO:0008643),4,2,0.78,+,2.56,1.84E-01
folic acid-containing compound biosynthetic process (GO:0009396),4,2,0.78,+,2.56,1.84E-01
sterol metabolic process (GO:0016125),30,15,5.86,+,2.56,1.10E-03
oligosaccharide biosynthetic process (GO:0009312),2,1,0.39,+,2.56,3.23E-01
centrosome localization (GO:0051642),6,3,1.17,+,2.56,1.14E-01
lipid homeostasis (GO:0055088),34,17,6.64,+,2.56,5.36E-04
mitochondrial outer membrane translocase complex assembly (GO:0070096),2,1,0.39,+,2.56,3.23E-01
regulation of membrane permeability (GO:0090559),4,2,0.78,+,2.56,1.84E-01
vacuolar protein processing (GO:0006624),4,2,0.78,+,2.56,1.84E-01
regulation of exit from mitosis (GO:0007096),2,1,0.39,+,2.56,3.23E-01
vitamin transmembrane transport (GO:0035461),2,1,0.39,+,2.56,3.23E-01
peptidyl-arginine methylation (GO:0018216),2,1,0.39,+,2.56,3.23E-01
establishment of mitotic spindle localization (GO:0040001),8,4,1.56,+,2.56,7.37E-02
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),2,1,0.39,+,2.56,3.23E-01
mitochondrial protein processing (GO:0034982),8,4,1.56,+,2.56,7.37E-02
choline transport (GO:0015871),4,2,0.78,+,2.56,1.84E-01
Golgi to endosome transport (GO:0006895),2,1,0.39,+,2.56,3.23E-01
steroid biosynthetic process (GO:0006694),23,11,4.49,+,2.45,6.55E-03
microtubule polymerization (GO:0046785),19,9,3.71,+,2.43,1.39E-02
phospholipid biosynthetic process (GO:0008654),55,26,10.74,+,2.42,5.46E-05
cleavage involved in rRNA processing (GO:0000469),15,7,2.93,+,2.39,3.00E-02
regulation of lipid metabolic process (GO:0019216),28,13,5.47,+,2.38,4.22E-03
cell cycle DNA replication (GO:0044786),13,6,2.54,+,2.36,4.46E-02
nuclear DNA replication (GO:0033260),13,6,2.54,+,2.36,4.46E-02
nucleus organization (GO:0006997),24,11,4.69,+,2.35,8.81E-03
double-strand break repair via break-induced replication (GO:0000727),11,5,2.15,+,2.33,6.70E-02
cholesterol homeostasis (GO:0042632),11,5,2.15,+,2.33,6.70E-02
neuron migration (GO:0001764),11,5,2.15,+,2.33,6.70E-02
negative regulation of neuron death (GO:1901215),11,5,2.15,+,2.33,6.70E-02
cellular response to insulin stimulus (GO:0032869),31,14,6.05,+,2.31,3.89E-03
membrane lipid metabolic process (GO:0006643),71,32,13.87,+,2.31,2.05E-05
mitochondrial respiratory chain complex assembly (GO:0033108),20,9,3.91,+,2.3,1.86E-02
mitochondrial membrane organization (GO:0007006),20,9,3.91,+,2.3,1.86E-02
purine ribonucleoside monophosphate metabolic process (GO:0009167),9,4,1.76,+,2.28,1.02E-01
purine nucleoside monophosphate metabolic process (GO:0009126),9,4,1.76,+,2.28,1.02E-01
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),9,4,1.76,+,2.28,1.02E-01
intracellular pH reduction (GO:0051452),9,4,1.76,+,2.28,1.02E-01
heme biosynthetic process (GO:0006783),9,4,1.76,+,2.28,1.02E-01
pigment biosynthetic process (GO:0046148),18,8,3.52,+,2.28,2.73E-02
membrane lipid biosynthetic process (GO:0046467),54,24,10.55,+,2.28,2.52E-04
negative regulation of autophagy (GO:0010507),9,4,1.76,+,2.28,1.02E-01
establishment of cell polarity (GO:0030010),18,8,3.52,+,2.28,2.73E-02
regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),9,4,1.76,+,2.28,1.02E-01
very long-chain fatty acid metabolic process (GO:0000038),18,8,3.52,+,2.28,2.73E-02
pH reduction (GO:0045851),9,4,1.76,+,2.28,1.02E-01
vacuolar acidification (GO:0007035),9,4,1.76,+,2.28,1.02E-01
nucleotide-excision repair (GO:0006289),27,12,5.27,+,2.28,8.05E-03
energy reserve metabolic process (GO:0006112),16,7,3.12,+,2.24,4.01E-02
glycogen metabolic process (GO:0005977),16,7,3.12,+,2.24,4.01E-02
cellular glucan metabolic process (GO:0006073),16,7,3.12,+,2.24,4.01E-02
response to insulin (GO:0032868),32,14,6.25,+,2.24,5.09E-03
glucan metabolic process (GO:0044042),16,7,3.12,+,2.24,4.01E-02
phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),7,3,1.37,+,2.19,1.59E-01
cristae formation (GO:0042407),7,3,1.37,+,2.19,1.59E-01
N-terminal protein amino acid acetylation (GO:0006474),7,3,1.37,+,2.19,1.59E-01
alcohol biosynthetic process (GO:0046165),35,15,6.84,+,2.19,4.60E-03
glutathione metabolic process (GO:0006749),28,12,5.47,+,2.19,1.05E-02
rRNA base methylation (GO:0070475),7,3,1.37,+,2.19,1.59E-01
peptidyl-lysine trimethylation (GO:0018023),7,3,1.37,+,2.19,1.59E-01
type I interferon signaling pathway (GO:0060337),7,3,1.37,+,2.19,1.59E-01
cognition (GO:0050890),7,3,1.37,+,2.19,1.59E-01
phosphatidylinositol biosynthetic process (GO:0006661),28,12,5.47,+,2.19,1.05E-02
epidermal cell differentiation (GO:0009913),7,3,1.37,+,2.19,1.59E-01
protein localization to cell surface (GO:0034394),7,3,1.37,+,2.19,1.59E-01
response to type I interferon (GO:0034340),7,3,1.37,+,2.19,1.59E-01
melanosome organization (GO:0032438),7,3,1.37,+,2.19,1.59E-01
pyrimidine nucleobase catabolic process (GO:0006208),7,3,1.37,+,2.19,1.59E-01
phospholipid dephosphorylation (GO:0046839),26,11,5.08,+,2.17,1.51E-02
glycerophospholipid biosynthetic process (GO:0046474),38,16,7.42,+,2.16,4.14E-03
glycolipid metabolic process (GO:0006664),38,16,7.42,+,2.16,4.14E-03
nucleoside phosphate catabolic process (GO:1901292),19,8,3.71,+,2.16,3.57E-02
sphingolipid catabolic process (GO:0030149),12,5,2.34,+,2.13,8.89E-02
cellular response to misfolded protein (GO:0071218),12,5,2.34,+,2.13,8.89E-02
glycogen biosynthetic process (GO:0005978),12,5,2.34,+,2.13,8.89E-02
response to ionizing radiation (GO:0010212),12,5,2.34,+,2.13,8.89E-02
pigmentation (GO:0043473),12,5,2.34,+,2.13,8.89E-02
nuclear envelope organization (GO:0006998),12,5,2.34,+,2.13,8.89E-02
DNA replication checkpoint (GO:0000076),12,5,2.34,+,2.13,8.89E-02
glucan biosynthetic process (GO:0009250),12,5,2.34,+,2.13,8.89E-02
protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),12,5,2.34,+,2.13,8.89E-02
glycerolipid biosynthetic process (GO:0045017),53,22,10.35,+,2.13,1.06E-03
fatty acid biosynthetic process (GO:0006633),41,17,8.01,+,2.12,3.71E-03
'de novo' protein folding (GO:0006458),17,7,3.32,+,2.11,5.22E-02
sphingolipid metabolic process (GO:0006665),51,21,9.96,+,2.11,1.49E-03
liposaccharide metabolic process (GO:1903509),39,16,7.62,+,2.1,5.26E-03
cellular response to peptide (GO:1901653),44,18,8.59,+,2.09,3.31E-03
secondary alcohol metabolic process (GO:1902652),22,9,4.3,+,2.09,3.15E-02
cellular response to peptide hormone stimulus (GO:0071375),44,18,8.59,+,2.09,3.31E-03
ATP-dependent chromatin remodeling (GO:0043044),27,11,5.27,+,2.09,1.93E-02
lipid biosynthetic process (GO:0008610),167,68,32.61,+,2.08,3.54E-08
monocarboxylic acid biosynthetic process (GO:0072330),47,19,9.18,+,2.07,2.95E-03
nucleoside triphosphate catabolic process (GO:0009143),5,2,0.98,+,2.05,2.56E-01
skin development (GO:0043588),5,2,0.98,+,2.05,2.56E-01
negative regulation of DNA repair (GO:0045738),5,2,0.98,+,2.05,2.56E-01
C-terminal protein amino acid modification (GO:0018410),5,2,0.98,+,2.05,2.56E-01
carbohydrate derivative catabolic process (GO:1901136),45,18,8.79,+,2.05,4.16E-03
sphingolipid biosynthetic process (GO:0030148),35,14,6.84,+,2.05,1.06E-02
mRNA export from nucleus (GO:0006406),30,12,5.86,+,2.05,1.70E-02
mitochondrion distribution (GO:0048311),5,2,0.98,+,2.05,2.56E-01
aspartate family amino acid biosynthetic process (GO:0009067),10,4,1.95,+,2.05,1.34E-01
snRNA processing (GO:0016180),15,6,2.93,+,2.05,7.69E-02
"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",10,4,1.95,+,2.05,1.34E-01
triglyceride biosynthetic process (GO:0019432),15,6,2.93,+,2.05,7.69E-02
snRNA 3'-end processing (GO:0034472),15,6,2.93,+,2.05,7.69E-02
nucleobase-containing small molecule biosynthetic process (GO:0034404),25,10,4.88,+,2.05,2.77E-02
quaternary ammonium group transport (GO:0015697),5,2,0.98,+,2.05,2.56E-01
chromatin silencing at telomere (GO:0006348),5,2,0.98,+,2.05,2.56E-01
DNA duplex unwinding (GO:0032508),15,6,2.93,+,2.05,7.69E-02
IMP metabolic process (GO:0046040),5,2,0.98,+,2.05,2.56E-01
protein processing involved in protein targeting to mitochondrion (GO:0006627),5,2,0.98,+,2.05,2.56E-01
interstrand cross-link repair (GO:0036297),10,4,1.95,+,2.05,1.34E-01
organic hydroxy compound biosynthetic process (GO:1901617),50,20,9.76,+,2.05,2.63E-03
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),30,12,5.86,+,2.05,1.70E-02
negative regulation of double-strand break repair (GO:2000780),5,2,0.98,+,2.05,2.56E-01
positive regulation of immunoglobulin mediated immune response (GO:0002891),5,2,0.98,+,2.05,2.56E-01
protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),5,2,0.98,+,2.05,2.56E-01
establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),15,6,2.93,+,2.05,7.69E-02
basic amino acid transport (GO:0015802),5,2,0.98,+,2.05,2.56E-01
iron ion transport (GO:0006826),20,8,3.91,+,2.05,4.56E-02
glycolipid biosynthetic process (GO:0009247),28,11,5.47,+,2.01,2.43E-02
neutral amino acid transport (GO:0015804),23,9,4.49,+,2,3.98E-02
cellular amino acid biosynthetic process (GO:0008652),36,14,7.03,+,1.99,1.32E-02
acyl-CoA metabolic process (GO:0006637),36,14,7.03,+,1.99,1.32E-02
snRNA metabolic process (GO:0016073),18,7,3.52,+,1.99,6.64E-02
mRNA transport (GO:0051028),31,12,6.05,+,1.98,2.12E-02
regulation of protein dephosphorylation (GO:0035304),13,5,2.54,+,1.97,1.14E-01
spindle localization (GO:0051653),13,5,2.54,+,1.97,1.14E-01
vesicle transport along microtubule (GO:0047496),13,5,2.54,+,1.97,1.14E-01
establishment of spindle localization (GO:0051293),13,5,2.54,+,1.97,1.14E-01
ceramide metabolic process (GO:0006672),34,13,6.64,+,1.96,1.86E-02
pigment metabolic process (GO:0042440),21,8,4.1,+,1.95,5.73E-02
chaperone-mediated protein folding (GO:0061077),21,8,4.1,+,1.95,5.73E-02
phosphatidylinositol metabolic process (GO:0046488),74,28,14.45,+,1.94,9.85E-04
establishment or maintenance of bipolar cell polarity (GO:0061245),16,6,3.12,+,1.92,9.69E-02
endothelial cell differentiation (GO:0045446),8,3,1.56,+,1.92,2.07E-01
DNA geometric change (GO:0032392),16,6,3.12,+,1.92,9.69E-02
DNA synthesis involved in DNA repair (GO:0000731),8,3,1.56,+,1.92,2.07E-01
negative regulation of cell motility (GO:2000146),16,6,3.12,+,1.92,9.69E-02
endosome organization (GO:0007032),8,3,1.56,+,1.92,2.07E-01
establishment or maintenance of apical/basal cell polarity (GO:0035088),16,6,3.12,+,1.92,9.69E-02
negative regulation of Ras protein signal transduction (GO:0046580),8,3,1.56,+,1.92,2.07E-01
protein localization to extracellular region (GO:0071692),35,13,6.84,+,1.9,2.28E-02
cellular modified amino acid metabolic process (GO:0006575),62,23,12.11,+,1.9,3.33E-03
protein localization to nucleus (GO:0034504),54,20,10.55,+,1.9,5.98E-03
small molecule biosynthetic process (GO:0044283),176,65,34.37,+,1.89,1.83E-06
organelle transport along microtubule (GO:0072384),19,7,3.71,+,1.89,8.26E-02
posttranscriptional gene silencing (GO:0016441),19,7,3.71,+,1.89,8.26E-02
phospholipid metabolic process (GO:0006644),133,49,25.97,+,1.89,3.35E-05
post-transcriptional gene silencing by RNA (GO:0035194),19,7,3.71,+,1.89,8.26E-02
neuron death (GO:0070997),19,7,3.71,+,1.89,8.26E-02
gene silencing by RNA (GO:0031047),19,7,3.71,+,1.89,8.26E-02
ceramide biosynthetic process (GO:0046513),22,8,4.3,+,1.86,7.07E-02
cytochrome complex assembly (GO:0017004),11,4,2.15,+,1.86,1.71E-01
protein demethylation (GO:0006482),11,4,2.15,+,1.86,1.71E-01
"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",11,4,2.15,+,1.86,1.71E-01
response to peptide hormone (GO:0043434),55,20,10.74,+,1.86,7.22E-03
transcription by RNA polymerase III (GO:0006383),11,4,2.15,+,1.86,1.71E-01
regulation of cyclin-dependent protein kinase activity (GO:1904029),25,9,4.88,+,1.84,6.06E-02
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),25,9,4.88,+,1.84,6.06E-02
fatty acid metabolic process (GO:0006631),134,48,26.17,+,1.83,7.71E-05
rRNA methylation (GO:0031167),14,5,2.73,+,1.83,1.42E-01
response to peptide (GO:1901652),56,20,10.94,+,1.83,8.67E-03
regulation of neuron death (GO:1901214),14,5,2.73,+,1.83,1.42E-01
sulfur compound metabolic process (GO:0006790),115,41,22.46,+,1.83,2.68E-04
glycerophospholipid metabolic process (GO:0006650),101,36,19.72,+,1.83,6.10E-04
macroautophagy (GO:0016236),62,22,12.11,+,1.82,6.60E-03
triglyceride metabolic process (GO:0006641),31,11,6.05,+,1.82,4.48E-02
carboxylic acid biosynthetic process (GO:0046394),96,34,18.75,+,1.81,9.41E-04
organic acid biosynthetic process (GO:0016053),96,34,18.75,+,1.81,9.41E-04
tRNA methylation (GO:0030488),17,6,3.32,+,1.81,1.19E-01
establishment of protein localization to extracellular region (GO:0035592),34,12,6.64,+,1.81,3.86E-02
protein secretion (GO:0009306),34,12,6.64,+,1.81,3.86E-02
steroid metabolic process (GO:0008202),54,19,10.55,+,1.8,1.19E-02
RNA methylation (GO:0001510),37,13,7.23,+,1.8,3.33E-02
rRNA modification (GO:0000154),20,7,3.91,+,1.79,1.01E-01
myeloid cell differentiation (GO:0030099),20,7,3.91,+,1.79,1.01E-01
glycerolipid metabolic process (GO:0046486),140,49,27.34,+,1.79,1.12E-04
DNA damage checkpoint (GO:0000077),23,8,4.49,+,1.78,8.58E-02
glycerolipid catabolic process (GO:0046503),26,9,5.08,+,1.77,7.31E-02
organophosphate biosynthetic process (GO:0090407),183,63,35.74,+,1.76,2.13E-05
developmental cell growth (GO:0048588),32,11,6.25,+,1.76,5.36E-02
response to radiation (GO:0009314),35,12,6.84,+,1.76,4.61E-02
peptide secretion (GO:0002790),38,13,7.42,+,1.75,3.97E-02
organelle disassembly (GO:1903008),38,13,7.42,+,1.75,3.97E-02
cellular amino acid metabolic process (GO:0006520),129,44,25.19,+,1.75,4.09E-04
alcohol metabolic process (GO:0006066),88,30,17.19,+,1.75,3.10E-03
carbohydrate catabolic process (GO:0016052),44,15,8.59,+,1.75,2.96E-02
cellular lipid metabolic process (GO:0044255),362,123,70.7,+,1.74,7.51E-09
monocarboxylic acid metabolic process (GO:0032787),183,62,35.74,+,1.73,3.85E-05
tRNA metabolic process (GO:0006399),92,31,17.97,+,1.73,3.17E-03
mRNA polyadenylation (GO:0006378),21,7,4.1,+,1.71,1.21E-01
autophagosome assembly (GO:0000045),42,14,8.2,+,1.71,4.04E-02
autophagosome organization (GO:1905037),42,14,8.2,+,1.71,4.04E-02
"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",27,9,5.27,+,1.71,8.72E-02
nucleotide catabolic process (GO:0009166),15,5,2.93,+,1.71,1.73E-01
mitochondrial fusion (GO:0008053),9,3,1.76,+,1.71,2.58E-01
nucleoside diphosphate metabolic process (GO:0009132),33,11,6.44,+,1.71,6.36E-02
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),9,3,1.76,+,1.71,2.58E-01
dendritic spine organization (GO:0097061),9,3,1.76,+,1.71,2.58E-01
axon extension (GO:0048675),27,9,5.27,+,1.71,8.72E-02
acylglycerol catabolic process (GO:0046464),15,5,2.93,+,1.71,1.73E-01
neutral lipid catabolic process (GO:0046461),15,5,2.93,+,1.71,1.73E-01
negative regulation of small GTPase mediated signal transduction (GO:0051058),9,3,1.76,+,1.71,2.58E-01
stress fiber assembly (GO:0043149),9,3,1.76,+,1.71,2.58E-01
neuron projection extension (GO:1990138),30,10,5.86,+,1.71,7.44E-02
"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",9,3,1.76,+,1.71,2.58E-01
endonucleolytic cleavage involved in rRNA processing (GO:0000478),9,3,1.76,+,1.71,2.58E-01
insulin receptor signaling pathway (GO:0008286),18,6,3.52,+,1.71,1.44E-01
establishment or maintenance of cell polarity (GO:0007163),54,18,10.55,+,1.71,2.25E-02
epidermis development (GO:0008544),9,3,1.76,+,1.71,2.58E-01
transcription initiation from RNA polymerase II promoter (GO:0006367),27,9,5.27,+,1.71,8.72E-02
transcription by RNA polymerase I (GO:0006360),9,3,1.76,+,1.71,2.58E-01
contractile actin filament bundle assembly (GO:0030038),9,3,1.76,+,1.71,2.58E-01
organic cation transport (GO:0015695),15,5,2.93,+,1.71,1.73E-01
mitochondrial translation (GO:0032543),18,6,3.52,+,1.71,1.44E-01
mitotic recombination (GO:0006312),9,3,1.76,+,1.71,2.58E-01
late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),15,5,2.93,+,1.71,1.73E-01
negative regulation of cell migration (GO:0030336),15,5,2.93,+,1.71,1.73E-01
positive regulation of cell growth (GO:0030307),9,3,1.76,+,1.71,2.58E-01
regulation of muscle contraction (GO:0006937),9,3,1.76,+,1.71,2.58E-01
negative regulation of cellular component movement (GO:0051271),36,12,7.03,+,1.71,5.46E-02
hexose metabolic process (GO:0019318),36,12,7.03,+,1.71,5.46E-02
developmental growth involved in morphogenesis (GO:0060560),33,11,6.44,+,1.71,6.36E-02
mitotic DNA damage checkpoint (GO:0044773),15,5,2.93,+,1.71,1.73E-01
protein K11-linked ubiquitination (GO:0070979),9,3,1.76,+,1.71,2.58E-01
regulation of phosphoprotein phosphatase activity (GO:0043666),9,3,1.76,+,1.71,2.58E-01
negative regulation of locomotion (GO:0040013),36,12,7.03,+,1.71,5.46E-02
COPII-coated vesicle budding (GO:0090114),15,5,2.93,+,1.71,1.73E-01
intermediate filament cytoskeleton organization (GO:0045104),12,4,2.34,+,1.71,2.10E-01
heme metabolic process (GO:0042168),12,4,2.34,+,1.71,2.10E-01
transcription preinitiation complex assembly (GO:0070897),12,4,2.34,+,1.71,2.10E-01
negative regulation of NF-kappaB transcription factor activity (GO:0032088),6,2,1.17,+,1.71,3.27E-01
positive regulation of DNA replication (GO:0045740),3,1,0.59,+,1.71,4.43E-01
negative regulation of protein dephosphorylation (GO:0035308),3,1,0.59,+,1.71,4.43E-01
carbohydrate transmembrane transport (GO:0034219),3,1,0.59,+,1.71,4.43E-01
positive regulation of cell division (GO:0051781),3,1,0.59,+,1.71,4.43E-01
response to UV (GO:0009411),6,2,1.17,+,1.71,3.27E-01
digestion (GO:0007586),6,2,1.17,+,1.71,3.27E-01
regulation of glucose metabolic process (GO:0010906),12,4,2.34,+,1.71,2.10E-01
"mitochondrial electron transport, succinate to ubiquinone (GO:0006121)",3,1,0.59,+,1.71,4.43E-01
negative regulation of response to DNA damage stimulus (GO:2001021),6,2,1.17,+,1.71,3.27E-01
protein insertion into mitochondrial inner membrane (GO:0045039),3,1,0.59,+,1.71,4.43E-01
regulation of double-strand break repair via homologous recombination (GO:0010569),3,1,0.59,+,1.71,4.43E-01
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),6,2,1.17,+,1.71,3.27E-01
toll-like receptor 4 signaling pathway (GO:0034142),3,1,0.59,+,1.71,4.43E-01
intracellular mRNA localization (GO:0008298),3,1,0.59,+,1.71,4.43E-01
positive regulation of immunoglobulin production (GO:0002639),3,1,0.59,+,1.71,4.43E-01
liver development (GO:0001889),3,1,0.59,+,1.71,4.43E-01
positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),3,1,0.59,+,1.71,4.43E-01
insulin secretion (GO:0030073),6,2,1.17,+,1.71,3.27E-01
positive regulation of cell-substrate adhesion (GO:0010811),6,2,1.17,+,1.71,3.27E-01
somatic recombination of immunoglobulin gene segments (GO:0016447),3,1,0.59,+,1.71,4.43E-01
prostaglandin metabolic process (GO:0006693),12,4,2.34,+,1.71,2.10E-01
mitochondrial cytochrome c oxidase assembly (GO:0033617),6,2,1.17,+,1.71,3.27E-01
protein stabilization (GO:0050821),12,4,2.34,+,1.71,2.10E-01
AMP metabolic process (GO:0046033),6,2,1.17,+,1.71,3.27E-01
melanocyte differentiation (GO:0030318),3,1,0.59,+,1.71,4.43E-01
protein targeting to vacuole (GO:0006623),24,8,4.69,+,1.71,1.03E-01
sterol transport (GO:0015918),12,4,2.34,+,1.71,2.10E-01
plasma membrane phospholipid scrambling (GO:0017121),12,4,2.34,+,1.71,2.10E-01
translesion synthesis (GO:0019985),6,2,1.17,+,1.71,3.27E-01
inner mitochondrial membrane organization (GO:0007007),12,4,2.34,+,1.71,2.10E-01
positive regulation of cytokinesis (GO:0032467),3,1,0.59,+,1.71,4.43E-01
execution phase of apoptosis (GO:0097194),12,4,2.34,+,1.71,2.10E-01
negative regulation of double-strand break repair via homologous recombination (GO:2000042),3,1,0.59,+,1.71,4.43E-01
mitochondrial calcium ion transmembrane transport (GO:0006851),3,1,0.59,+,1.71,4.43E-01
negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),6,2,1.17,+,1.71,3.27E-01
dicarboxylic acid transport (GO:0006835),6,2,1.17,+,1.71,3.27E-01
organophosphate metabolic process (GO:0019637),358,119,69.92,+,1.7,4.11E-08
organic hydroxy compound metabolic process (GO:1901615),121,40,23.63,+,1.69,1.27E-03
nucleoside phosphate metabolic process (GO:0006753),189,62,36.91,+,1.68,9.26E-05
import into nucleus (GO:0051170),49,16,9.57,+,1.67,3.51E-02
organophosphate catabolic process (GO:0046434),49,16,9.57,+,1.67,3.51E-02
protein import into nucleus (GO:0006606),49,16,9.57,+,1.67,3.51E-02
carboxylic acid metabolic process (GO:0019752),340,111,66.4,+,1.67,2.71E-07
nucleobase-containing small molecule metabolic process (GO:0055086),224,73,43.75,+,1.67,2.91E-05
internal protein amino acid acetylation (GO:0006475),43,14,8.4,+,1.67,4.73E-02
monocarboxylic acid catabolic process (GO:0072329),43,14,8.4,+,1.67,4.73E-02
peptidyl-lysine acetylation (GO:0018394),43,14,8.4,+,1.67,4.73E-02
internal peptidyl-lysine acetylation (GO:0018393),43,14,8.4,+,1.67,4.73E-02
ribonucleoprotein complex localization (GO:0071166),43,14,8.4,+,1.67,4.73E-02
ribonucleoprotein complex export from nucleus (GO:0071426),43,14,8.4,+,1.67,4.73E-02
cytosolic transport (GO:0016482),40,13,7.81,+,1.66,5.50E-02
cell growth (GO:0016049),37,12,7.23,+,1.66,6.40E-02
energy derivation by oxidation of organic compounds (GO:0015980),68,22,13.28,+,1.66,1.72E-02
lipid metabolic process (GO:0006629),434,140,84.76,+,1.65,1.60E-08
mitochondrial transport (GO:0006839),62,20,12.11,+,1.65,2.29E-02
nucleotide metabolic process (GO:0009117),183,59,35.74,+,1.65,2.08E-04
alpha-amino acid metabolic process (GO:1901605),87,28,16.99,+,1.65,8.62E-03
autophagy of mitochondrion (GO:0000422),28,9,5.47,+,1.65,1.03E-01
double-strand break repair via homologous recombination (GO:0000724),53,17,10.35,+,1.64,3.53E-02
positive regulation of proteasomal protein catabolic process (GO:1901800),25,8,4.88,+,1.64,1.21E-01
peroxisome organization (GO:0007031),25,8,4.88,+,1.64,1.21E-01
epithelial cell differentiation (GO:0030855),25,8,4.88,+,1.64,1.21E-01
response to light stimulus (GO:0009416),22,7,4.3,+,1.63,1.44E-01
cellular carbohydrate metabolic process (GO:0044262),66,21,12.89,+,1.63,2.29E-02
gene silencing (GO:0016458),44,14,8.59,+,1.63,5.49E-02
developmental growth (GO:0048589),44,14,8.59,+,1.63,5.49E-02
monosaccharide metabolic process (GO:0005996),41,13,8.01,+,1.62,6.39E-02
cellular lipid catabolic process (GO:0044242),82,26,16.01,+,1.62,1.31E-02
fatty acid catabolic process (GO:0009062),38,12,7.42,+,1.62,7.45E-02
dendrite morphogenesis (GO:0048813),19,6,3.71,+,1.62,1.71E-01
small molecule metabolic process (GO:0044281),650,205,126.94,+,1.61,4.90E-11
recombinational repair (GO:0000725),54,17,10.55,+,1.61,4.07E-02
autophagy (GO:0006914),105,33,20.51,+,1.61,6.56E-03
process utilizing autophagic mechanism (GO:0061919),105,33,20.51,+,1.61,6.56E-03
positive regulation of cell migration (GO:0030335),51,16,9.96,+,1.61,4.71E-02
oxoacid metabolic process (GO:0043436),358,112,69.92,+,1.6,1.70E-06
regulation of cell growth (GO:0001558),32,10,6.25,+,1.6,1.02E-01
mRNA 3'-end processing (GO:0031124),32,10,6.25,+,1.6,1.02E-01
gene silencing by miRNA (GO:0035195),16,5,3.12,+,1.6,2.06E-01
RNA modification (GO:0009451),77,24,15.04,+,1.6,1.97E-02
regulation of establishment of protein localization (GO:0070201),29,9,5.66,+,1.59,1.20E-01
glucose metabolic process (GO:0006006),29,9,5.66,+,1.59,1.20E-01
regulation of protein transport (GO:0051223),29,9,5.66,+,1.59,1.20E-01
histone acetylation (GO:0016573),42,13,8.2,+,1.58,7.38E-02
cellular amide metabolic process (GO:0043603),367,113,71.67,+,1.58,3.10E-06
positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),26,8,5.08,+,1.58,1.41E-01
positive regulation of cellular protein catabolic process (GO:1903364),26,8,5.08,+,1.58,1.41E-01
protein acetylation (GO:0006473),52,16,10.16,+,1.58,5.41E-02
porphyrin-containing compound metabolic process (GO:0006778),13,4,2.54,+,1.58,2.51E-01
bile acid and bile salt transport (GO:0015721),13,4,2.54,+,1.58,2.51E-01
establishment of protein localization to peroxisome (GO:0072663),13,4,2.54,+,1.58,2.51E-01
protein localization to peroxisome (GO:0072662),13,4,2.54,+,1.58,2.51E-01
mRNA splice site selection (GO:0006376),13,4,2.54,+,1.58,2.51E-01
protein targeting to peroxisome (GO:0006625),13,4,2.54,+,1.58,2.51E-01
regulation of dendrite morphogenesis (GO:0048814),13,4,2.54,+,1.58,2.51E-01
"regulation of DNA-templated transcription, elongation (GO:0032784)",13,4,2.54,+,1.58,2.51E-01
behavior (GO:0007610),13,4,2.54,+,1.58,2.51E-01
regulation of protein stability (GO:0031647),13,4,2.54,+,1.58,2.51E-01
membrane protein ectodomain proteolysis (GO:0006509),13,4,2.54,+,1.58,2.51E-01
lipoprotein metabolic process (GO:0042157),65,20,12.69,+,1.58,3.47E-02
"DNA-templated transcription, initiation (GO:0006352)",39,12,7.62,+,1.58,8.60E-02
endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),78,24,15.23,+,1.58,2.25E-02
small molecule catabolic process (GO:0044282),124,38,24.22,+,1.57,5.58E-03
ribonucleotide metabolic process (GO:0009259),144,44,28.12,+,1.56,3.23E-03
"mRNA cis splicing, via spliceosome (GO:0045292)",23,7,4.49,+,1.56,1.68E-01
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),23,7,4.49,+,1.56,1.68E-01
intra-Golgi vesicle-mediated transport (GO:0006891),23,7,4.49,+,1.56,1.68E-01
organic acid metabolic process (GO:0006082),388,118,75.77,+,1.56,3.31E-06
regulation of peptide transport (GO:0090087),33,10,6.44,+,1.55,1.18E-01
ribose phosphate metabolic process (GO:0019693),152,46,29.68,+,1.55,3.16E-03
microtubule polymerization or depolymerization (GO:0031109),43,13,8.4,+,1.55,8.46E-02
double-strand break repair (GO:0006302),86,26,16.8,+,1.55,2.20E-02
RNA 3'-end processing (GO:0031123),53,16,10.35,+,1.55,6.17E-02
vacuolar transport (GO:0007034),63,19,12.3,+,1.54,4.55E-02
negative regulation of protein catabolic process (GO:0042177),10,3,1.95,+,1.54,3.11E-01
regulation of dephosphorylation (GO:0035303),20,6,3.91,+,1.54,2.00E-01
protein import into peroxisome matrix (GO:0016558),10,3,1.95,+,1.54,3.11E-01
cellular response to amino acid starvation (GO:0034198),10,3,1.95,+,1.54,3.11E-01
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),10,3,1.95,+,1.54,3.11E-01
protein autophosphorylation (GO:0046777),40,12,7.81,+,1.54,9.86E-02
receptor clustering (GO:0043113),10,3,1.95,+,1.54,3.11E-01
negative regulation of DNA-binding transcription factor activity (GO:0043433),10,3,1.95,+,1.54,3.11E-01
peptide hormone secretion (GO:0030072),10,3,1.95,+,1.54,3.11E-01
L-alpha-amino acid transmembrane transport (GO:1902475),10,3,1.95,+,1.54,3.11E-01
endosome transport via multivesicular body sorting pathway (GO:0032509),20,6,3.91,+,1.54,2.00E-01
clathrin-dependent endocytosis (GO:0072583),20,6,3.91,+,1.54,2.00E-01
cholesterol transport (GO:0030301),10,3,1.95,+,1.54,3.11E-01
cell cycle arrest (GO:0007050),10,3,1.95,+,1.54,3.11E-01
release of sequestered calcium ion into cytosol (GO:0051209),10,3,1.95,+,1.54,3.11E-01
protein catabolic process in the vacuole (GO:0007039),10,3,1.95,+,1.54,3.11E-01
Golgi vesicle budding (GO:0048194),20,6,3.91,+,1.54,2.00E-01
histone lysine methylation (GO:0034968),20,6,3.91,+,1.54,2.00E-01
DNA integrity checkpoint (GO:0031570),30,9,5.86,+,1.54,1.38E-01
vesicle cytoskeletal trafficking (GO:0099518),30,9,5.86,+,1.54,1.38E-01
vacuole organization (GO:0007033),60,18,11.72,+,1.54,5.25E-02
activation of protein kinase activity (GO:0032147),50,15,9.76,+,1.54,7.15E-02
growth (GO:0040007),50,15,9.76,+,1.54,7.15E-02
mitochondrion organization (GO:0007005),137,41,26.76,+,1.53,6.06E-03
protein folding (GO:0006457),77,23,15.04,+,1.53,3.32E-02
nucleotide biosynthetic process (GO:0009165),104,31,20.31,+,1.53,1.60E-02
regulation of cell shape (GO:0008360),27,8,5.27,+,1.52,1.63E-01
nucleoside diphosphate phosphorylation (GO:0006165),27,8,5.27,+,1.52,1.63E-01
nucleotide phosphorylation (GO:0046939),27,8,5.27,+,1.52,1.63E-01
DNA-dependent DNA replication (GO:0006261),54,16,10.55,+,1.52,7.01E-02
DNA repair (GO:0006281),169,50,33,+,1.51,3.34E-03
cellular response to organonitrogen compound (GO:0071417),71,21,13.87,+,1.51,4.39E-02
lipid modification (GO:0030258),115,34,22.46,+,1.51,1.35E-02
amide biosynthetic process (GO:0043604),247,73,48.24,+,1.51,4.89E-04
acylglycerol metabolic process (GO:0006639),44,13,8.59,+,1.51,9.64E-02
neutral lipid metabolic process (GO:0006638),44,13,8.59,+,1.51,9.64E-02
"retrograde transport, endosome to Golgi (GO:0042147)",34,10,6.64,+,1.51,1.35E-01
regulation of macroautophagy (GO:0016241),17,5,3.32,+,1.51,2.41E-01
regulation of translational initiation (GO:0006446),17,5,3.32,+,1.51,2.41E-01
tricarboxylic acid cycle (GO:0006099),17,5,3.32,+,1.51,2.41E-01
"regulation of gene expression, epigenetic (GO:0040029)",51,15,9.96,+,1.51,8.11E-02
DNA replication initiation (GO:0006270),17,5,3.32,+,1.51,2.41E-01
DNA replication (GO:0006260),68,20,13.28,+,1.51,5.04E-02
negative regulation of BMP signaling pathway (GO:0030514),17,5,3.32,+,1.51,2.41E-01
purine-containing compound metabolic process (GO:0072521),170,50,33.2,+,1.51,3.73E-03
RNA splicing (GO:0008380),198,58,38.67,+,1.5,2.09E-03
nucleoside phosphate biosynthetic process (GO:1901293),106,31,20.7,+,1.5,2.01E-02
cellular response to hormone stimulus (GO:0032870),89,26,17.38,+,1.5,3.13E-02
ribonucleoside diphosphate metabolic process (GO:0009185),24,7,4.69,+,1.49,1.94E-01
purine ribonucleoside diphosphate metabolic process (GO:0009179),24,7,4.69,+,1.49,1.94E-01
purine nucleoside diphosphate metabolic process (GO:0009135),24,7,4.69,+,1.49,1.94E-01
histone methylation (GO:0016571),24,7,4.69,+,1.49,1.94E-01
ATP generation from ADP (GO:0006757),24,7,4.69,+,1.49,1.94E-01
glycolytic process (GO:0006096),24,7,4.69,+,1.49,1.94E-01
ADP metabolic process (GO:0046031),24,7,4.69,+,1.49,1.94E-01
fatty acid beta-oxidation (GO:0006635),24,7,4.69,+,1.49,1.94E-01
transition metal ion transport (GO:0000041),48,14,9.37,+,1.49,9.40E-02
positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),24,7,4.69,+,1.49,1.94E-01
cellular nitrogen compound catabolic process (GO:0044270),151,44,29.49,+,1.49,7.18E-03
positive regulation of cell motility (GO:2000147),55,16,10.74,+,1.49,7.91E-02
positive regulation of cellular component movement (GO:0051272),55,16,10.74,+,1.49,7.91E-02
response to abiotic stimulus (GO:0009628),86,25,16.8,+,1.49,3.58E-02
carbohydrate metabolic process (GO:0005975),131,38,25.58,+,1.49,1.25E-02
"mRNA splicing, via spliceosome (GO:0000398)",166,48,32.42,+,1.48,5.94E-03
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",166,48,32.42,+,1.48,5.94E-03
"RNA splicing, via transesterification reactions (GO:0000375)",166,48,32.42,+,1.48,5.94E-03
nuclear transport (GO:0051169),97,28,18.94,+,1.48,2.99E-02
nucleocytoplasmic transport (GO:0006913),97,28,18.94,+,1.48,2.99E-02
cellular respiration (GO:0045333),52,15,10.16,+,1.48,9.15E-02
purine nucleotide metabolic process (GO:0006163),156,45,30.47,+,1.48,7.82E-03
generation of precursor metabolites and energy (GO:0006091),111,32,21.68,+,1.48,2.20E-02
negative regulation of cell death (GO:0060548),66,19,12.89,+,1.47,6.52E-02
purine ribonucleotide metabolic process (GO:0009150),139,40,27.15,+,1.47,1.20E-02
heterocycle catabolic process (GO:0046700),153,44,29.88,+,1.47,8.87E-03
negative regulation of neuron differentiation (GO:0045665),21,6,4.1,+,1.46,2.31E-01
maturation of LSU-rRNA (GO:0000470),21,6,4.1,+,1.46,2.31E-01
regulation of calcium ion transport (GO:0051924),21,6,4.1,+,1.46,2.31E-01
respiratory electron transport chain (GO:0022904),28,8,5.47,+,1.46,1.86E-01
electron transport chain (GO:0022900),28,8,5.47,+,1.46,1.86E-01
platelet aggregation (GO:0070527),7,2,1.37,+,1.46,3.97E-01
regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),7,2,1.37,+,1.46,3.97E-01
negative regulation of TOR signaling (GO:0032007),14,4,2.73,+,1.46,2.93E-01
non-motile cilium assembly (GO:1905515),14,4,2.73,+,1.46,2.93E-01
regulation of phosphatase activity (GO:0010921),14,4,2.73,+,1.46,2.93E-01
response to hormone (GO:0009725),105,30,20.51,+,1.46,2.85E-02
extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),14,4,2.73,+,1.46,2.93E-01
translational termination (GO:0006415),7,2,1.37,+,1.46,3.97E-01
establishment of protein localization to vacuole (GO:0072666),35,10,6.84,+,1.46,1.53E-01
protein localization to vacuole (GO:0072665),35,10,6.84,+,1.46,1.53E-01
regulation of proteasomal protein catabolic process (GO:0061136),35,10,6.84,+,1.46,1.53E-01
regulation of autophagy (GO:0010506),49,14,9.57,+,1.46,1.06E-01
tetrapyrrole metabolic process (GO:0033013),14,4,2.73,+,1.46,2.93E-01
mitotic DNA replication checkpoint (GO:0033314),7,2,1.37,+,1.46,3.97E-01
autophagy of nucleus (GO:0044804),14,4,2.73,+,1.46,2.93E-01
chromatin remodeling (GO:0006338),56,16,10.94,+,1.46,8.89E-02
sarcomere organization (GO:0045214),7,2,1.37,+,1.46,3.97E-01
protein insertion into membrane (GO:0051205),14,4,2.73,+,1.46,2.93E-01
positive regulation of locomotion (GO:0040017),56,16,10.94,+,1.46,8.89E-02
negative regulation of catabolic process (GO:0009895),28,8,5.47,+,1.46,1.86E-01
catecholamine metabolic process (GO:0006584),7,2,1.37,+,1.46,3.97E-01
cytoplasmic translation (GO:0002181),49,14,9.57,+,1.46,1.06E-01
mitotic DNA replication (GO:1902969),7,2,1.37,+,1.46,3.97E-01
ncRNA metabolic process (GO:0034660),218,62,42.57,+,1.46,2.89E-03
mRNA processing (GO:0006397),211,60,41.21,+,1.46,3.34E-03
protein export from nucleus (GO:0006611),53,15,10.35,+,1.45,1.03E-01
organonitrogen compound biosynthetic process (GO:1901566),601,170,117.37,+,1.45,2.01E-06
carboxylic acid catabolic process (GO:0046395),92,26,17.97,+,1.45,4.34E-02
organic acid catabolic process (GO:0016054),92,26,17.97,+,1.45,4.34E-02
peptide biosynthetic process (GO:0043043),216,61,42.18,+,1.45,3.60E-03
translational initiation (GO:0006413),39,11,7.62,+,1.44,1.48E-01
translational elongation (GO:0006414),213,60,41.6,+,1.44,4.06E-03
translation (GO:0006412),213,60,41.6,+,1.44,4.06E-03
macromolecule methylation (GO:0043414),71,20,13.87,+,1.44,7.08E-02
methylation (GO:0032259),71,20,13.87,+,1.44,7.08E-02
RNA processing (GO:0006396),419,118,81.83,+,1.44,8.31E-05
polysaccharide metabolic process (GO:0005976),32,9,6.25,+,1.44,1.79E-01
cellular polysaccharide metabolic process (GO:0044264),32,9,6.25,+,1.44,1.79E-01
lipid oxidation (GO:0034440),32,9,6.25,+,1.44,1.79E-01
telomere maintenance (GO:0000723),32,9,6.25,+,1.44,1.79E-01
telomere organization (GO:0032200),32,9,6.25,+,1.44,1.79E-01
cellular carbohydrate biosynthetic process (GO:0034637),32,9,6.25,+,1.44,1.79E-01
carbohydrate derivative metabolic process (GO:1901135),406,114,79.29,+,1.44,1.21E-04
positive regulation of cellular catabolic process (GO:0031331),57,16,11.13,+,1.44,9.95E-02
peptidyl-lysine modification (GO:0018205),107,30,20.9,+,1.44,3.51E-02
multivesicular body sorting pathway (GO:0071985),25,7,4.88,+,1.43,2.21E-01
chromatin silencing (GO:0006342),25,7,4.88,+,1.43,2.21E-01
"negative regulation of gene expression, epigenetic (GO:0045814)",25,7,4.88,+,1.43,2.21E-01
protein import (GO:0017038),79,22,15.43,+,1.43,6.66E-02
regulation of cell morphogenesis (GO:0022604),79,22,15.43,+,1.43,6.66E-02
regulation of cell projection assembly (GO:0060491),18,5,3.52,+,1.42,2.77E-01
membrane protein proteolysis (GO:0033619),18,5,3.52,+,1.42,2.77E-01
negative regulation of programmed cell death (GO:0043069),54,15,10.55,+,1.42,1.15E-01
negative regulation of apoptotic process (GO:0043066),54,15,10.55,+,1.42,1.15E-01
maintenance of location (GO:0051235),54,15,10.55,+,1.42,1.15E-01
histone H3 acetylation (GO:0043966),18,5,3.52,+,1.42,2.77E-01
peptide metabolic process (GO:0006518),278,77,54.29,+,1.42,1.97E-03
endosomal transport (GO:0016197),94,26,18.36,+,1.42,5.32E-02
nucleobase-containing compound catabolic process (GO:0034655),127,35,24.8,+,1.41,3.03E-02
negative regulation of cell cycle (GO:0045786),80,22,15.62,+,1.41,7.37E-02
response to organonitrogen compound (GO:0010243),131,36,25.58,+,1.41,2.94E-02
phosphatidylinositol phosphorylation (GO:0046854),33,9,6.44,+,1.4,2.02E-01
RNA polymerase II preinitiation complex assembly (GO:0051123),11,3,2.15,+,1.4,3.63E-01
motor neuron axon guidance (GO:0008045),11,3,2.15,+,1.4,3.63E-01
response to hypoxia (GO:0001666),22,6,4.3,+,1.4,2.63E-01
endothelial cell migration (GO:0043542),11,3,2.15,+,1.4,3.63E-01
apoptotic mitochondrial changes (GO:0008637),11,3,2.15,+,1.4,3.63E-01
response to oxygen levels (GO:0070482),22,6,4.3,+,1.4,2.63E-01
protein kinase B signaling (GO:0043491),11,3,2.15,+,1.4,3.63E-01
regulation of dendritic spine development (GO:0060998),11,3,2.15,+,1.4,3.63E-01
positive regulation of growth (GO:0045927),11,3,2.15,+,1.4,3.63E-01
positive regulation of canonical Wnt signaling pathway (GO:0090263),22,6,4.3,+,1.4,2.63E-01
response to decreased oxygen levels (GO:0036293),22,6,4.3,+,1.4,2.63E-01
regulation of cellular pH (GO:0030641),22,6,4.3,+,1.4,2.63E-01
negative regulation of sequestering of calcium ion (GO:0051283),11,3,2.15,+,1.4,3.63E-01
regulation of sequestering of calcium ion (GO:0051282),11,3,2.15,+,1.4,3.63E-01
forebrain development (GO:0030900),11,3,2.15,+,1.4,3.63E-01
lysosomal transport (GO:0007041),22,6,4.3,+,1.4,2.63E-01
sequestering of calcium ion (GO:0051208),11,3,2.15,+,1.4,3.63E-01
histone H3-K4 methylation (GO:0051568),11,3,2.15,+,1.4,3.63E-01
positive regulation of cell development (GO:0010720),44,12,8.59,+,1.4,1.59E-01
regulation of histone modification (GO:0031056),11,3,2.15,+,1.4,3.63E-01
regulation of protein kinase B signaling (GO:0051896),11,3,2.15,+,1.4,3.63E-01
DNA strand elongation involved in DNA replication (GO:0006271),11,3,2.15,+,1.4,3.63E-01
"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",22,6,4.3,+,1.4,2.63E-01
regulation of pH (GO:0006885),22,6,4.3,+,1.4,2.63E-01
histone modification (GO:0016570),114,31,22.26,+,1.39,4.54E-02
RNA transport (GO:0050658),59,16,11.52,+,1.39,1.23E-01
nucleic acid transport (GO:0050657),59,16,11.52,+,1.39,1.23E-01
establishment of RNA localization (GO:0051236),59,16,11.52,+,1.39,1.23E-01
aromatic compound catabolic process (GO:0019439),155,42,30.27,+,1.39,2.45E-02
Golgi vesicle transport (GO:0048193),251,68,49.02,+,1.39,5.59E-03
ERAD pathway (GO:0036503),48,13,9.37,+,1.39,1.53E-01
regulation of axonogenesis (GO:0050770),48,13,9.37,+,1.39,1.53E-01
organic cyclic compound catabolic process (GO:1901361),170,46,33.2,+,1.39,1.98E-02
regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),37,10,7.23,+,1.38,1.93E-01
regulation of cellular protein catabolic process (GO:1903362),37,10,7.23,+,1.38,1.93E-01
amino acid transmembrane transport (GO:0003333),37,10,7.23,+,1.38,1.93E-01
regulation of growth (GO:0040008),37,10,7.23,+,1.38,1.93E-01
chromatin organization (GO:0006325),211,57,41.21,+,1.38,1.09E-02
covalent chromatin modification (GO:0016569),115,31,22.46,+,1.38,4.98E-02
mesenchyme development (GO:0060485),26,7,5.08,+,1.38,2.49E-01
cytosolic calcium ion transport (GO:0060401),26,7,5.08,+,1.38,2.49E-01
"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",26,7,5.08,+,1.38,2.49E-01
positive regulation of proteolysis (GO:0045862),52,14,10.16,+,1.38,1.47E-01
cortical cytoskeleton organization (GO:0030865),26,7,5.08,+,1.38,2.49E-01
modification-dependent macromolecule catabolic process (GO:0043632),287,77,56.05,+,1.37,4.26E-03
lipoprotein biosynthetic process (GO:0042158),56,15,10.94,+,1.37,1.41E-01
protein lipidation (GO:0006497),56,15,10.94,+,1.37,1.41E-01
RNA export from nucleus (GO:0006405),56,15,10.94,+,1.37,1.41E-01
DNA biosynthetic process (GO:0071897),86,23,16.8,+,1.37,8.62E-02
cellular response to nitrogen compound (GO:1901699),86,23,16.8,+,1.37,8.62E-02
apoptotic cell clearance (GO:0043277),15,4,2.93,+,1.37,3.37E-01
neuromuscular junction development (GO:0007528),15,4,2.93,+,1.37,3.37E-01
glycerophospholipid catabolic process (GO:0046475),15,4,2.93,+,1.37,3.37E-01
regulation of cell morphogenesis involved in differentiation (GO:0010769),60,16,11.72,+,1.37,1.36E-01
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),30,8,5.86,+,1.37,2.37E-01
protein-DNA complex assembly (GO:0065004),60,16,11.72,+,1.37,1.36E-01
negative regulation of inflammatory response (GO:0050728),15,4,2.93,+,1.37,3.37E-01
RNA localization (GO:0006403),64,17,12.5,+,1.36,1.30E-01
dephosphorylation (GO:0016311),128,34,25,+,1.36,4.91E-02
endoplasmic reticulum organization (GO:0007029),34,9,6.64,+,1.36,2.25E-01
cellular catabolic process (GO:0044248),794,210,155.06,+,1.35,1.00E-05
mRNA metabolic process (GO:0016071),280,74,54.68,+,1.35,6.98E-03
rRNA processing (GO:0006364),106,28,20.7,+,1.35,7.20E-02
lipid catabolic process (GO:0016042),106,28,20.7,+,1.35,7.20E-02
monocarboxylic acid transport (GO:0015718),38,10,7.42,+,1.35,2.14E-01
regulation of dendrite development (GO:0050773),19,5,3.71,+,1.35,3.15E-01
post-Golgi vesicle-mediated transport (GO:0006892),38,10,7.42,+,1.35,2.14E-01
modification-dependent protein catabolic process (GO:0019941),282,74,55.07,+,1.34,8.14E-03
organic substance catabolic process (GO:1901575),728,191,142.17,+,1.34,3.87E-05
regulation of plasma membrane bounded cell projection organization (GO:0120035),84,22,16.4,+,1.34,1.07E-01
rRNA metabolic process (GO:0016072),111,29,21.68,+,1.34,7.55E-02
organonitrogen compound catabolic process (GO:1901565),467,122,91.2,+,1.34,1.04E-03
positive regulation of peptidase activity (GO:0010952),23,6,4.49,+,1.34,2.96E-01
positive regulation of endopeptidase activity (GO:0010950),23,6,4.49,+,1.34,2.96E-01
RNA phosphodiester bond hydrolysis (GO:0090501),46,12,8.98,+,1.34,1.95E-01
protein localization (GO:0008104),736,192,143.74,+,1.34,5.01E-05
intracellular transport (GO:0046907),668,174,130.46,+,1.33,1.19E-04
protein-containing complex localization (GO:0031503),192,50,37.5,+,1.33,2.84E-02
amide transport (GO:0042886),569,148,111.12,+,1.33,3.93E-04
protein polymerization (GO:0051258),100,26,19.53,+,1.33,9.18E-02
polysaccharide biosynthetic process (GO:0000271),27,7,5.27,+,1.33,2.79E-01
mitochondrial gene expression (GO:0140053),27,7,5.27,+,1.33,2.79E-01
regulation of RNA splicing (GO:0043484),81,21,15.82,+,1.33,1.21E-01
cellular polysaccharide biosynthetic process (GO:0033692),27,7,5.27,+,1.33,2.79E-01
ubiquitin-dependent protein catabolic process (GO:0006511),274,71,53.51,+,1.33,1.21E-02
carbohydrate derivative biosynthetic process (GO:1901137),255,66,49.8,+,1.33,1.54E-02
macromolecule localization (GO:0033036),850,220,166,+,1.33,2.32E-05
regulation of cell projection organization (GO:0031344),85,22,16.6,+,1.33,1.17E-01
intracellular protein transport (GO:0006886),478,123,93.35,+,1.32,1.66E-03
aerobic respiration (GO:0009060),35,9,6.84,+,1.32,2.50E-01
ncRNA processing (GO:0034470),175,45,34.18,+,1.32,4.25E-02
nucleic acid phosphodiester bond hydrolysis (GO:0090305),74,19,14.45,+,1.31,1.44E-01
ubiquitin-dependent ERAD pathway (GO:0030433),39,10,7.62,+,1.31,2.37E-01
maintenance of location in cell (GO:0051651),39,10,7.62,+,1.31,2.37E-01
positive regulation of neurogenesis (GO:0050769),39,10,7.62,+,1.31,2.37E-01
protein-DNA complex subunit organization (GO:0071824),82,21,16.01,+,1.31,1.32E-01
endomembrane system organization (GO:0010256),125,32,24.41,+,1.31,7.93E-02
microtubule cytoskeleton organization involved in mitosis (GO:1902850),43,11,8.4,+,1.31,2.25E-01
positive regulation of nervous system development (GO:0051962),43,11,8.4,+,1.31,2.25E-01
catabolic process (GO:0009056),904,231,176.55,+,1.31,3.19E-05
proteolysis involved in cellular protein catabolic process (GO:0051603),321,82,62.69,+,1.31,1.04E-02
protein transport (GO:0015031),552,141,107.8,+,1.31,1.06E-03
oxidation-reduction process (GO:0055114),243,62,47.46,+,1.31,2.35E-02
peptide transport (GO:0015833),557,142,108.78,+,1.31,1.09E-03
cellular macromolecule localization (GO:0070727),659,168,128.7,+,1.31,4.08E-04
nucleoside triphosphate metabolic process (GO:0009141),51,13,9.96,+,1.31,2.04E-01
anatomical structure homeostasis (GO:0060249),51,13,9.96,+,1.31,2.04E-01
Golgi organization (GO:0007030),51,13,9.96,+,1.31,2.04E-01
cellular protein catabolic process (GO:0044257),322,82,62.88,+,1.3,1.11E-02
cellular protein localization (GO:0034613),657,167,128.31,+,1.3,4.81E-04
ATP metabolic process (GO:0046034),63,16,12.3,+,1.3,1.78E-01
chromosome organization (GO:0051276),335,85,65.42,+,1.3,1.08E-02
positive regulation of protein kinase activity (GO:0045860),71,18,13.87,+,1.3,1.63E-01
regulation of protein serine/threonine kinase activity (GO:0071900),87,22,16.99,+,1.29,1.37E-01
protein catabolic process (GO:0030163),348,88,67.96,+,1.29,1.04E-02
ribose phosphate biosynthetic process (GO:0046390),87,22,16.99,+,1.29,1.37E-01
lipid localization (GO:0010876),107,27,20.9,+,1.29,1.12E-01
nitrogen compound transport (GO:0071705),678,171,132.41,+,1.29,5.81E-04
cellular response to DNA damage stimulus (GO:0006974),226,57,44.14,+,1.29,3.45E-02
DNA metabolic process (GO:0006259),274,69,53.51,+,1.29,2.27E-02
secretion by cell (GO:0032940),147,37,28.71,+,1.29,7.63E-02
positive regulation of RNA metabolic process (GO:0051254),310,78,60.54,+,1.29,1.67E-02
establishment of protein localization (GO:0045184),562,141,109.75,+,1.28,2.02E-03
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),20,5,3.91,+,1.28,3.53E-01
spliceosomal complex assembly (GO:0000245),20,5,3.91,+,1.28,3.53E-01
regulation of cellular amide metabolic process (GO:0034248),80,20,15.62,+,1.28,1.62E-01
regulation of intracellular pH (GO:0051453),20,5,3.91,+,1.28,3.53E-01
positive regulation of GTPase activity (GO:0043547),80,20,15.62,+,1.28,1.62E-01
positive regulation of cysteine-type endopeptidase activity (GO:2001056),20,5,3.91,+,1.28,3.53E-01
positive regulation of autophagy (GO:0010508),20,5,3.91,+,1.28,3.53E-01
positive regulation of MAP kinase activity (GO:0043406),36,9,7.03,+,1.28,2.75E-01
mitotic DNA integrity checkpoint (GO:0044774),20,5,3.91,+,1.28,3.53E-01
amino acid transport (GO:0006865),52,13,10.16,+,1.28,2.23E-01
protein localization to mitochondrion (GO:0070585),32,8,6.25,+,1.28,2.91E-01
regulation of peptide secretion (GO:0002791),16,4,3.12,+,1.28,3.81E-01
negative regulation of dephosphorylation (GO:0035305),8,2,1.56,+,1.28,4.63E-01
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),12,3,2.34,+,1.28,4.15E-01
regulation of meiotic cell cycle (GO:0051445),12,3,2.34,+,1.28,4.15E-01
hormone biosynthetic process (GO:0042446),4,1,0.78,+,1.28,5.42E-01
developmental pigmentation (GO:0048066),4,1,0.78,+,1.28,5.42E-01
"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",4,1,0.78,+,1.28,5.42E-01
signal peptide processing (GO:0006465),8,2,1.56,+,1.28,4.63E-01
phosphatidylcholine metabolic process (GO:0046470),4,1,0.78,+,1.28,5.42E-01
steroid catabolic process (GO:0006706),4,1,0.78,+,1.28,5.42E-01
activation of MAPK activity (GO:0000187),28,7,5.47,+,1.28,3.09E-01
establishment of protein localization to mitochondrion (GO:0072655),32,8,6.25,+,1.28,2.91E-01
B cell activation involved in immune response (GO:0002312),4,1,0.78,+,1.28,5.42E-01
histone exchange (GO:0043486),8,2,1.56,+,1.28,4.63E-01
homotypic cell-cell adhesion (GO:0034109),8,2,1.56,+,1.28,4.63E-01
regulation of autophagosome maturation (GO:1901096),4,1,0.78,+,1.28,5.42E-01
pseudouridine synthesis (GO:0001522),12,3,2.34,+,1.28,4.15E-01
secondary metabolic process (GO:0019748),12,3,2.34,+,1.28,4.15E-01
regulation of centrosome duplication (GO:0010824),8,2,1.56,+,1.28,4.63E-01
positive regulation of transmembrane transport (GO:0034764),12,3,2.34,+,1.28,4.15E-01
"DNA catabolic process, endonucleolytic (GO:0000737)",8,2,1.56,+,1.28,4.63E-01
somatic cell DNA recombination (GO:0016444),4,1,0.78,+,1.28,5.42E-01
positive regulation of peptide hormone secretion (GO:0090277),4,1,0.78,+,1.28,5.42E-01
regulation of peptide hormone secretion (GO:0090276),8,2,1.56,+,1.28,4.63E-01
cytoplasmic microtubule organization (GO:0031122),32,8,6.25,+,1.28,2.91E-01
macrophage chemotaxis (GO:0048246),4,1,0.78,+,1.28,5.42E-01
DNA catabolic process (GO:0006308),12,3,2.34,+,1.28,4.15E-01
double-strand break repair via nonhomologous end joining (GO:0006303),12,3,2.34,+,1.28,4.15E-01
negative regulation of cell cycle G2/M phase transition (GO:1902750),12,3,2.34,+,1.28,4.15E-01
unsaturated fatty acid biosynthetic process (GO:0006636),8,2,1.56,+,1.28,4.63E-01
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),12,3,2.34,+,1.28,4.15E-01
nucleobase-containing compound transport (GO:0015931),68,17,13.28,+,1.28,1.85E-01
somatic diversification of immune receptors via germline recombination within a single locus (GO:0002562),4,1,0.78,+,1.28,5.42E-01
somatic diversification of immune receptors (GO:0002200),4,1,0.78,+,1.28,5.42E-01
regulation of autophagosome assembly (GO:2000785),8,2,1.56,+,1.28,4.63E-01
neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),8,2,1.56,+,1.28,4.63E-01
positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),4,1,0.78,+,1.28,5.42E-01
regulation of double-strand break repair (GO:2000779),8,2,1.56,+,1.28,4.63E-01
metaphase/anaphase transition of cell cycle (GO:0044784),16,4,3.12,+,1.28,3.81E-01
post-translational protein modification (GO:0043687),8,2,1.56,+,1.28,4.63E-01
glucose homeostasis (GO:0042593),16,4,3.12,+,1.28,3.81E-01
positive regulation of response to biotic stimulus (GO:0002833),12,3,2.34,+,1.28,4.15E-01
dendrite development (GO:0016358),32,8,6.25,+,1.28,2.91E-01
base-excision repair (GO:0006284),16,4,3.12,+,1.28,3.81E-01
regulation of insulin secretion (GO:0050796),4,1,0.78,+,1.28,5.42E-01
negative regulation of response to external stimulus (GO:0032102),44,11,8.59,+,1.28,2.47E-01
lipid storage (GO:0019915),12,3,2.34,+,1.28,4.15E-01
positive regulation of NIK/NF-kappaB signaling (GO:1901224),4,1,0.78,+,1.28,5.42E-01
regulation of cellular catabolic process (GO:0031329),120,30,23.44,+,1.28,1.07E-01
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),24,6,4.69,+,1.28,3.29E-01
regulation of protein secretion (GO:0050708),12,3,2.34,+,1.28,4.15E-01
regulation of ubiquitin-dependent protein catabolic process (GO:2000058),32,8,6.25,+,1.28,2.91E-01
L-amino acid transport (GO:0015807),16,4,3.12,+,1.28,3.81E-01
negative regulation of chromatin silencing (GO:0031936),8,2,1.56,+,1.28,4.63E-01
macromolecule catabolic process (GO:0009057),465,116,90.81,+,1.28,5.60E-03
cellular macromolecule catabolic process (GO:0044265),429,107,83.78,+,1.28,7.57E-03
positive regulation of nucleobase-containing compound metabolic process (GO:0045935),329,82,64.25,+,1.28,1.76E-02
establishment of protein localization to organelle (GO:0072594),161,40,31.44,+,1.27,7.83E-02
positive regulation of transcription by RNA polymerase II (GO:0045944),226,56,44.14,+,1.27,4.66E-02
regulation of anatomical structure morphogenesis (GO:0022603),109,27,21.29,+,1.27,1.30E-01
posttranscriptional regulation of gene expression (GO:0010608),105,26,20.51,+,1.27,1.36E-01
proteasomal protein catabolic process (GO:0010498),202,50,39.45,+,1.27,5.78E-02
lipid transport (GO:0006869),97,24,18.94,+,1.27,1.47E-01
DNA recombination (GO:0006310),89,22,17.38,+,1.27,1.60E-01
regulation of neuron differentiation (GO:0045664),81,20,15.82,+,1.26,1.75E-01
ribonucleotide biosynthetic process (GO:0009260),81,20,15.82,+,1.26,1.75E-01
ribosome biogenesis (GO:0042254),162,40,31.64,+,1.26,8.38E-02
mitotic cell cycle phase transition (GO:0044772),77,19,15.04,+,1.26,1.83E-01
cellular response to stress (GO:0033554),450,111,87.88,+,1.26,8.96E-03
regulation of transferase activity (GO:0051338),211,52,41.21,+,1.26,5.74E-02
establishment of localization in cell (GO:0051649),792,195,154.67,+,1.26,7.74E-04
nuclear export (GO:0051168),65,16,12.69,+,1.26,2.10E-01
"regulation of mRNA splicing, via spliceosome (GO:0048024)",61,15,11.91,+,1.26,2.20E-01
nuclear-transcribed mRNA catabolic process (GO:0000956),53,13,10.35,+,1.26,2.43E-01
positive regulation of hydrolase activity (GO:0051345),155,38,30.27,+,1.26,9.66E-02
organic substance transport (GO:0071702),813,199,158.77,+,1.25,8.99E-04
cellular response to topologically incorrect protein (GO:0035967),45,11,8.79,+,1.25,2.69E-01
response to topologically incorrect protein (GO:0035966),45,11,8.79,+,1.25,2.69E-01
positive regulation of transferase activity (GO:0051347),135,33,26.36,+,1.25,1.17E-01
purine-containing compound biosynthetic process (GO:0072522),86,21,16.8,+,1.25,1.80E-01
export from cell (GO:0140352),164,40,32.03,+,1.25,9.55E-02
cell cycle phase transition (GO:0044770),82,20,16.01,+,1.25,1.88E-01
cellular localization (GO:0051641),981,239,191.58,+,1.25,3.70E-04
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),189,46,36.91,+,1.25,8.11E-02
positive regulation of cell projection organization (GO:0031346),37,9,7.23,+,1.25,3.01E-01
regulation of neuron projection development (GO:0010975),70,17,13.67,+,1.24,2.16E-01
regulation of protein kinase activity (GO:0045859),140,34,27.34,+,1.24,1.20E-01
long-chain fatty acid metabolic process (GO:0001676),33,8,6.44,+,1.24,3.19E-01
protein N-linked glycosylation (GO:0006487),33,8,6.44,+,1.24,3.19E-01
positive regulation of neuron differentiation (GO:0045666),33,8,6.44,+,1.24,3.19E-01
cellular monovalent inorganic cation homeostasis (GO:0030004),33,8,6.44,+,1.24,3.19E-01
ribonucleoprotein complex biogenesis (GO:0022613),219,53,42.77,+,1.24,7.08E-02
organonitrogen compound metabolic process (GO:1901564),2438,590,476.13,+,1.24,2.94E-08
positive regulation of nucleic acid-templated transcription (GO:1903508),290,70,56.64,+,1.24,4.59E-02
"positive regulation of transcription, DNA-templated (GO:0045893)",290,70,56.64,+,1.24,4.59E-02
demethylation (GO:0070988),29,7,5.66,+,1.24,3.40E-01
positive regulation of RNA biosynthetic process (GO:1902680),290,70,56.64,+,1.24,4.59E-02
tRNA processing (GO:0008033),54,13,10.55,+,1.23,2.63E-01
phosphate-containing compound metabolic process (GO:0006796),1019,245,199,+,1.23,6.37E-04
regulation of metal ion transport (GO:0010959),50,12,9.76,+,1.23,2.77E-01
neural crest cell differentiation (GO:0014033),25,6,4.88,+,1.23,3.63E-01
neural crest cell development (GO:0014032),25,6,4.88,+,1.23,3.63E-01
positive regulation of catalytic activity (GO:0043085),300,72,58.59,+,1.23,4.79E-02
negative regulation of cellular catabolic process (GO:0031330),25,6,4.88,+,1.23,3.63E-01
mesenchymal cell differentiation (GO:0048762),25,6,4.88,+,1.23,3.63E-01
regulation of GTPase activity (GO:0043087),96,23,18.75,+,1.23,1.90E-01
carboxylic acid transport (GO:0046942),96,23,18.75,+,1.23,1.90E-01
organic acid transport (GO:0015849),96,23,18.75,+,1.23,1.90E-01
regulation of mRNA processing (GO:0050684),71,17,13.87,+,1.23,2.32E-01
nucleoside triphosphate biosynthetic process (GO:0009142),46,11,8.98,+,1.22,2.92E-01
regulation of cell cycle (GO:0051726),184,44,35.93,+,1.22,1.05E-01
cellular amino acid catabolic process (GO:0009063),46,11,8.98,+,1.22,2.92E-01
organic acid transmembrane transport (GO:1903825),46,11,8.98,+,1.22,2.92E-01
carboxylic acid transmembrane transport (GO:1905039),46,11,8.98,+,1.22,2.92E-01
regulation of kinase activity (GO:0043549),201,48,39.25,+,1.22,9.57E-02
protein-containing complex assembly (GO:0065003),377,90,73.63,+,1.22,3.38E-02
phosphorus metabolic process (GO:0006793),1032,246,201.54,+,1.22,9.70E-04
purine nucleotide biosynthetic process (GO:0006164),84,20,16.4,+,1.22,2.17E-01
late endosome to vacuole transport (GO:0045324),21,5,4.1,+,1.22,3.91E-01
"DNA-templated transcription, elongation (GO:0006354)",21,5,4.1,+,1.22,3.91E-01
calcium ion transmembrane import into cytosol (GO:0097553),21,5,4.1,+,1.22,3.91E-01
positive regulation of axonogenesis (GO:0050772),21,5,4.1,+,1.22,3.91E-01
cellular protein-containing complex assembly (GO:0034622),353,84,68.94,+,1.22,4.15E-02
regulation of catabolic process (GO:0009894),143,34,27.93,+,1.22,1.45E-01
regulation of cell migration (GO:0030334),101,24,19.72,+,1.22,1.94E-01
negative regulation of multicellular organismal process (GO:0051241),59,14,11.52,+,1.22,2.69E-01
regulation of translation (GO:0006417),76,18,14.84,+,1.21,2.38E-01
tRNA modification (GO:0006400),38,9,7.42,+,1.21,3.27E-01
regulation of mRNA metabolic process (GO:1903311),93,22,18.16,+,1.21,2.12E-01
positive regulation of biosynthetic process (GO:0009891),334,79,65.23,+,1.21,5.18E-02
response to nitrogen compound (GO:1901698),161,38,31.44,+,1.21,1.40E-01
protein K63-linked ubiquitination (GO:0070534),17,4,3.32,+,1.2,4.24E-01
peroxisomal transport (GO:0043574),17,4,3.32,+,1.2,4.24E-01
cellular response to oxidative stress (GO:0034599),17,4,3.32,+,1.2,4.24E-01
histone ubiquitination (GO:0016574),17,4,3.32,+,1.2,4.24E-01
actin cytoskeleton reorganization (GO:0031532),17,4,3.32,+,1.2,4.24E-01
regulation of sodium ion transport (GO:0002028),17,4,3.32,+,1.2,4.24E-01
meiotic chromosome separation (GO:0051307),17,4,3.32,+,1.2,4.24E-01
regulation of cell division (GO:0051302),17,4,3.32,+,1.2,4.24E-01
regulation of DNA repair (GO:0006282),17,4,3.32,+,1.2,4.24E-01
homeostatic process (GO:0042592),336,79,65.62,+,1.2,5.74E-02
positive regulation of macromolecule biosynthetic process (GO:0010557),324,76,63.28,+,1.2,6.36E-02
positive regulation of cell differentiation (GO:0045597),64,15,12.5,+,1.2,2.75E-01
neurotransmitter secretion (GO:0007269),47,11,9.18,+,1.2,3.15E-01
RNA catabolic process (GO:0006401),94,22,18.36,+,1.2,2.26E-01
protein localization to organelle (GO:0033365),329,77,64.25,+,1.2,6.46E-02
signal release from synapse (GO:0099643),47,11,9.18,+,1.2,3.15E-01
protein dephosphorylation (GO:0006470),77,18,15.04,+,1.2,2.54E-01
positive regulation of catabolic process (GO:0009896),77,18,15.04,+,1.2,2.54E-01
cellular nitrogen compound metabolic process (GO:0034641),3004,702,586.66,+,1.2,1.96E-07
positive regulation of neuron projection development (GO:0010976),30,7,5.86,+,1.19,3.71E-01
protein targeting to mitochondrion (GO:0006626),30,7,5.86,+,1.19,3.71E-01
protein targeting (GO:0006605),120,28,23.44,+,1.19,1.97E-01
organelle localization (GO:0051640),253,59,49.41,+,1.19,9.88E-02
positive regulation of cellular biosynthetic process (GO:0031328),331,77,64.64,+,1.19,7.12E-02
carbohydrate biosynthetic process (GO:0016051),43,10,8.4,+,1.19,3.34E-01
fatty acid derivative metabolic process (GO:1901568),43,10,8.4,+,1.19,3.34E-01
cellular metabolic process (GO:0044237),5083,1180,992.68,+,1.19,3.05E-12
proteolysis (GO:0006508),669,155,130.65,+,1.19,1.87E-02
regulation of cell motility (GO:2000145),108,25,21.09,+,1.19,2.23E-01
secretion (GO:0046903),173,40,33.79,+,1.18,1.61E-01
positive regulation of Wnt signaling pathway (GO:0030177),26,6,5.08,+,1.18,3.98E-01
TORC1 signaling (GO:0038202),13,3,2.54,+,1.18,4.66E-01
cardiac muscle contraction (GO:0060048),13,3,2.54,+,1.18,4.66E-01
aromatic amino acid family catabolic process (GO:0009074),13,3,2.54,+,1.18,4.66E-01
peptidyl-lysine methylation (GO:0018022),26,6,5.08,+,1.18,3.98E-01
telomere maintenance via telomere lengthening (GO:0010833),13,3,2.54,+,1.18,4.66E-01
resolution of meiotic recombination intermediates (GO:0000712),13,3,2.54,+,1.18,4.66E-01
histone H2A ubiquitination (GO:0033522),13,3,2.54,+,1.18,4.66E-01
TOR signaling (GO:0031929),39,9,7.62,+,1.18,3.54E-01
regulation of protein catabolic process (GO:0042176),65,15,12.69,+,1.18,2.94E-01
establishment of vesicle localization (GO:0051650),156,36,30.47,+,1.18,1.78E-01
vesicle localization (GO:0051648),156,36,30.47,+,1.18,1.78E-01
nucleosome organization (GO:0034728),39,9,7.62,+,1.18,3.54E-01
primary metabolic process (GO:0044238),4945,1139,965.73,+,1.18,6.96E-11
protein polyubiquitination (GO:0000209),113,26,22.07,+,1.18,2.27E-01
vesicle fusion to plasma membrane (GO:0099500),109,25,21.29,+,1.17,2.37E-01
exocytic process (GO:0140029),109,25,21.29,+,1.17,2.37E-01
exocytosis (GO:0006887),109,25,21.29,+,1.17,2.37E-01
ribosomal small subunit biogenesis (GO:0042274),48,11,9.37,+,1.17,3.39E-01
response to starvation (GO:0042594),48,11,9.37,+,1.17,3.39E-01
protein-containing complex subunit organization (GO:0043933),450,103,87.88,+,1.17,5.99E-02
organic substance metabolic process (GO:0071704),5243,1200,1023.92,+,1.17,7.00E-11
metabolic process (GO:0008152),5481,1253,1070.4,+,1.17,2.43E-11
mitotic cell cycle (GO:0000278),245,56,47.85,+,1.17,1.34E-01
mitotic cell cycle process (GO:1903047),245,56,47.85,+,1.17,1.34E-01
mitotic nuclear division (GO:0140014),245,56,47.85,+,1.17,1.34E-01
transport along microtubule (GO:0010970),140,32,27.34,+,1.17,2.09E-01
microtubule-based transport (GO:0099111),140,32,27.34,+,1.17,2.09E-01
chemical homeostasis (GO:0048878),267,61,52.14,+,1.17,1.23E-01
organic cyclic compound metabolic process (GO:1901360),2819,644,550.53,+,1.17,1.19E-05
positive regulation of kinase activity (GO:0033674),127,29,24.8,+,1.17,2.24E-01
nitrogen compound metabolic process (GO:0006807),4682,1068,914.36,+,1.17,3.54E-09
regulation of MAP kinase activity (GO:0043405),57,13,11.13,+,1.17,3.26E-01
membrane fusion (GO:0061025),158,36,30.86,+,1.17,1.98E-01
cytoskeleton-dependent intracellular transport (GO:0030705),167,38,32.61,+,1.17,1.93E-01
heterocycle metabolic process (GO:0046483),2747,625,536.47,+,1.17,2.60E-05
sodium ion transmembrane transport (GO:0035725),66,15,12.89,+,1.16,3.13E-01
calcium ion transport into cytosol (GO:0060402),22,5,4.3,+,1.16,4.29E-01
mitochondrial ATP synthesis coupled electron transport (GO:0042775),22,5,4.3,+,1.16,4.29E-01
ATP synthesis coupled electron transport (GO:0042773),22,5,4.3,+,1.16,4.29E-01
cellular response to abiotic stimulus (GO:0071214),22,5,4.3,+,1.16,4.29E-01
cellular response to environmental stimulus (GO:0104004),22,5,4.3,+,1.16,4.29E-01
regulation of BMP signaling pathway (GO:0030510),22,5,4.3,+,1.16,4.29E-01
vesicle organization (GO:0016050),326,74,63.67,+,1.16,1.09E-01
organelle fusion (GO:0048284),150,34,29.29,+,1.16,2.14E-01
organelle organization (GO:0006996),1673,379,326.73,+,1.16,1.60E-03
cellular aromatic compound metabolic process (GO:0006725),2768,627,540.57,+,1.16,4.07E-05
stress-activated protein kinase signaling cascade (GO:0031098),53,12,10.35,+,1.16,3.44E-01
spindle organization (GO:0007051),53,12,10.35,+,1.16,3.44E-01
protein localization to cell junction (GO:1902414),31,7,6.05,+,1.16,4.02E-01
G1/S transition of mitotic cell cycle (GO:0000082),31,7,6.05,+,1.16,4.02E-01
DNA conformation change (GO:0071103),62,14,12.11,+,1.16,3.30E-01
negative regulation of translation (GO:0017148),31,7,6.05,+,1.16,4.02E-01
establishment of organelle localization (GO:0051656),204,46,39.84,+,1.15,1.82E-01
cellular protein metabolic process (GO:0044267),1776,400,346.84,+,1.15,1.74E-03
intraciliary transport (GO:0042073),111,25,21.68,+,1.15,2.64E-01
positive regulation of protein serine/threonine kinase activity (GO:0071902),40,9,7.81,+,1.15,3.81E-01
regulation of hydrolase activity (GO:0051336),280,63,54.68,+,1.15,1.44E-01
biosynthetic process (GO:0009058),2597,584,507.18,+,1.15,1.61E-04
organic substance biosynthetic process (GO:1901576),2592,582,506.2,+,1.15,1.91E-04
regulation of cell death (GO:0010941),147,33,28.71,+,1.15,2.34E-01
nucleobase-containing compound metabolic process (GO:0006139),2701,606,527.49,+,1.15,1.48E-04
negative regulation of cellular process (GO:0048523),901,202,175.96,+,1.15,2.60E-02
cellular component biogenesis (GO:0044085),893,200,174.4,+,1.15,2.75E-02
positive regulation of molecular function (GO:0044093),393,88,76.75,+,1.15,1.09E-01
cellular biosynthetic process (GO:0044249),2556,571,499.17,+,1.14,3.53E-04
regulation of locomotion (GO:0040012),112,25,21.87,+,1.14,2.78E-01
negative regulation of metabolic process (GO:0009892),583,130,113.86,+,1.14,7.03E-02
protein metabolic process (GO:0019538),2007,447,391.95,+,1.14,2.03E-03
negative regulation of biological process (GO:0048519),1024,228,199.98,+,1.14,2.42E-02
cyclic nucleotide metabolic process (GO:0009187),18,4,3.52,+,1.14,4.67E-01
positive regulation of angiogenesis (GO:0045766),9,2,1.76,+,1.14,5.24E-01
epithelium development (GO:0060429),54,12,10.55,+,1.14,3.67E-01
dopamine receptor signaling pathway (GO:0007212),9,2,1.76,+,1.14,5.24E-01
"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",9,2,1.76,+,1.14,5.24E-01
regulation of chromosome separation (GO:1905818),18,4,3.52,+,1.14,4.67E-01
regulation of chemotaxis (GO:0050920),36,8,7.03,+,1.14,4.06E-01
positive chemotaxis (GO:0050918),9,2,1.76,+,1.14,5.24E-01
sprouting angiogenesis (GO:0002040),9,2,1.76,+,1.14,5.24E-01
autophagosome maturation (GO:0097352),9,2,1.76,+,1.14,5.24E-01
protein mannosylation (GO:0035268),9,2,1.76,+,1.14,5.24E-01
protein prenylation (GO:0018342),9,2,1.76,+,1.14,5.24E-01
positive regulation of translational initiation (GO:0045948),9,2,1.76,+,1.14,5.24E-01
positive regulation of ion transmembrane transport (GO:0034767),9,2,1.76,+,1.14,5.24E-01
response to virus (GO:0009615),36,8,7.03,+,1.14,4.06E-01
nucleosome assembly (GO:0006334),18,4,3.52,+,1.14,4.67E-01
cellular response to chemical stress (GO:0062197),18,4,3.52,+,1.14,4.67E-01
osteoclast differentiation (GO:0030316),9,2,1.76,+,1.14,5.24E-01
production of miRNAs involved in gene silencing by miRNA (GO:0035196),9,2,1.76,+,1.14,5.24E-01
amino sugar catabolic process (GO:0046348),9,2,1.76,+,1.14,5.24E-01
cell cycle checkpoint (GO:0000075),45,10,8.79,+,1.14,3.85E-01
stem cell differentiation (GO:0048863),27,6,5.27,+,1.14,4.32E-01
smooth muscle contraction (GO:0006939),9,2,1.76,+,1.14,5.24E-01
mannosylation (GO:0097502),9,2,1.76,+,1.14,5.24E-01
aerobic electron transport chain (GO:0019646),9,2,1.76,+,1.14,5.24E-01
lysosome organization (GO:0007040),9,2,1.76,+,1.14,5.24E-01
"positive regulation of DNA-templated transcription, elongation (GO:0032786)",9,2,1.76,+,1.14,5.24E-01
positive regulation of ion transmembrane transporter activity (GO:0032414),9,2,1.76,+,1.14,5.24E-01
positive regulation of transporter activity (GO:0032411),9,2,1.76,+,1.14,5.24E-01
cellular zinc ion homeostasis (GO:0006882),18,4,3.52,+,1.14,4.67E-01
cellular iron ion homeostasis (GO:0006879),9,2,1.76,+,1.14,5.24E-01
positive regulation of cellular metabolic process (GO:0031325),725,161,141.59,+,1.14,5.45E-02
regulation of programmed cell death (GO:0043067),131,29,25.58,+,1.13,2.74E-01
regulation of cellular component movement (GO:0051270),113,25,22.07,+,1.13,2.93E-01
regulation of peptidase activity (GO:0052547),104,23,20.31,+,1.13,3.03E-01
negative regulation of gene expression (GO:0010629),398,88,77.73,+,1.13,1.32E-01
purine ribonucleotide biosynthetic process (GO:0009152),77,17,15.04,+,1.13,3.39E-01
mRNA catabolic process (GO:0006402),77,17,15.04,+,1.13,3.39E-01
vesicle fusion (GO:0006906),136,30,26.56,+,1.13,2.76E-01
positive regulation of gene expression (GO:0010628),390,86,76.16,+,1.13,1.40E-01
regulation of protein localization (GO:0032880),59,13,11.52,+,1.13,3.69E-01
cellular component organization or biogenesis (GO:0071840),2374,523,463.63,+,1.13,1.93E-03
cellular component disassembly (GO:0022411),109,24,21.29,+,1.13,3.06E-01
regulation of endopeptidase activity (GO:0052548),100,22,19.53,+,1.13,3.17E-01
negative regulation of biosynthetic process (GO:0009890),332,73,64.84,+,1.13,1.68E-01
negative regulation of cellular biosynthetic process (GO:0031327),332,73,64.84,+,1.13,1.68E-01
neuron projection morphogenesis (GO:0048812),173,38,33.79,+,1.12,2.55E-01
mitochondrial transmembrane transport (GO:1990542),41,9,8.01,+,1.12,4.08E-01
cell cycle (GO:0007049),392,86,76.56,+,1.12,1.51E-01
protein transport along microtubule (GO:0098840),114,25,22.26,+,1.12,3.08E-01
microtubule-based protein transport (GO:0099118),114,25,22.26,+,1.12,3.08E-01
regulation of cellular response to stress (GO:0080135),73,16,14.26,+,1.12,3.56E-01
organelle membrane fusion (GO:0090174),137,30,26.76,+,1.12,2.89E-01
response to wounding (GO:0009611),32,7,6.25,+,1.12,4.34E-01
chromatin organization involved in negative regulation of transcription (GO:0097549),32,7,6.25,+,1.12,4.34E-01
cilium organization (GO:0044782),119,26,23.24,+,1.12,3.10E-01
cell projection morphogenesis (GO:0048858),174,38,33.98,+,1.12,2.66E-01
plasma membrane bounded cell projection morphogenesis (GO:0120039),174,38,33.98,+,1.12,2.66E-01
transport (GO:0006810),1713,374,334.54,+,1.12,1.36E-02
negative regulation of macromolecule metabolic process (GO:0010605),555,121,108.39,+,1.12,1.20E-01
macromolecule modification (GO:0043412),1335,291,260.72,+,1.12,2.91E-02
membrane organization (GO:0061024),445,97,86.91,+,1.12,1.49E-01
protein modification by small protein conjugation (GO:0032446),271,59,52.92,+,1.11,2.17E-01
negative regulation of nitrogen compound metabolic process (GO:0051172),478,104,93.35,+,1.11,1.44E-01
signal release (GO:0023061),69,15,13.48,+,1.11,3.74E-01
Rho protein signal transduction (GO:0007266),46,10,8.98,+,1.11,4.10E-01
cellular component assembly involved in morphogenesis (GO:0010927),23,5,4.49,+,1.11,4.66E-01
organic hydroxy compound transport (GO:0015850),46,10,8.98,+,1.11,4.10E-01
negative regulation of cellular metabolic process (GO:0031324),502,109,98.04,+,1.11,1.42E-01
protein acylation (GO:0043543),83,18,16.21,+,1.11,3.60E-01
establishment of localization (GO:0051234),1741,377,340.01,+,1.11,1.98E-02
Ras protein signal transduction (GO:0007265),74,16,14.45,+,1.11,3.76E-01
regulation of membrane lipid distribution (GO:0097035),37,8,7.23,+,1.11,4.35E-01
regulation of cell development (GO:0060284),111,24,21.68,+,1.11,3.36E-01
positive regulation of nitrogen compound metabolic process (GO:0051173),666,144,130.07,+,1.11,1.16E-01
negative regulation of response to stimulus (GO:0048585),236,51,46.09,+,1.11,2.52E-01
cellular component morphogenesis (GO:0032989),199,43,38.86,+,1.11,2.73E-01
negative regulation of RNA metabolic process (GO:0051253),287,62,56.05,+,1.11,2.28E-01
cell part morphogenesis (GO:0032990),176,38,34.37,+,1.11,2.89E-01
macromolecule metabolic process (GO:0043170),4396,949,858.51,+,1.11,2.37E-04
localization (GO:0051179),2154,465,420.66,+,1.11,1.22E-02
nuclear division (GO:0000280),292,63,57.03,+,1.1,2.29E-01
regulation of neurogenesis (GO:0050767),102,22,19.92,+,1.1,3.49E-01
negative regulation of protein metabolic process (GO:0051248),181,39,35.35,+,1.1,2.90E-01
protein ubiquitination (GO:0016567),246,53,48.04,+,1.1,2.54E-01
nucleic acid metabolic process (GO:0090304),2479,534,484.13,+,1.1,8.46E-03
cellular component organization (GO:0016043),2257,486,440.78,+,1.1,1.22E-02
negative regulation of nucleic acid-templated transcription (GO:1903507),274,59,53.51,+,1.1,2.42E-01
"negative regulation of transcription, DNA-templated (GO:0045892)",274,59,53.51,+,1.1,2.42E-01
negative regulation of RNA biosynthetic process (GO:1902679),274,59,53.51,+,1.1,2.42E-01
positive regulation of metabolic process (GO:0009893),786,169,153.5,+,1.1,1.09E-01
negative regulation of nucleobase-containing compound metabolic process (GO:0045934),298,64,58.2,+,1.1,2.38E-01
regulation of catalytic activity (GO:0050790),629,135,122.84,+,1.1,1.42E-01
ribonucleoside triphosphate metabolic process (GO:0009199),42,9,8.2,+,1.1,4.36E-01
negative regulation of intracellular signal transduction (GO:1902532),84,18,16.4,+,1.1,3.79E-01
monovalent inorganic cation homeostasis (GO:0055067),42,9,8.2,+,1.1,4.36E-01
ribonucleoside triphosphate biosynthetic process (GO:0009201),42,9,8.2,+,1.1,4.36E-01
hormone secretion (GO:0046879),14,3,2.73,+,1.1,5.15E-01
regulation of blood vessel diameter (GO:0097746),14,3,2.73,+,1.1,5.15E-01
"chemical synaptic transmission, postsynaptic (GO:0099565)",14,3,2.73,+,1.1,5.15E-01
tissue homeostasis (GO:0001894),14,3,2.73,+,1.1,5.15E-01
regulation of neurotransmitter levels (GO:0001505),56,12,10.94,+,1.1,4.13E-01
non-recombinational repair (GO:0000726),14,3,2.73,+,1.1,5.15E-01
hormone transport (GO:0009914),14,3,2.73,+,1.1,5.15E-01
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),322,69,62.88,+,1.1,2.34E-01
cellular transition metal ion homeostasis (GO:0046916),28,6,5.47,+,1.1,4.66E-01
synaptic vesicle transport (GO:0048489),14,3,2.73,+,1.1,5.15E-01
synaptic vesicle endocytosis (GO:0048488),28,6,5.47,+,1.1,4.66E-01
regulation of G1/S transition of mitotic cell cycle (GO:2000045),14,3,2.73,+,1.1,5.15E-01
neurotransmitter transport (GO:0006836),56,12,10.94,+,1.1,4.13E-01
cellular nitrogen compound biosynthetic process (GO:0044271),2208,473,431.21,+,1.1,1.78E-02
vesicle-mediated transport (GO:0016192),640,137,124.99,+,1.1,1.47E-01
organelle fission (GO:0048285),313,67,61.13,+,1.1,2.41E-01
organelle assembly (GO:0070925),276,59,53.9,+,1.09,2.60E-01
negative regulation of macromolecule biosynthetic process (GO:0010558),323,69,63.08,+,1.09,2.42E-01
apoptotic process (GO:0006915),192,41,37.5,+,1.09,3.04E-01
regulation of proteolysis (GO:0030162),150,32,29.29,+,1.09,3.32E-01
plasma membrane bounded cell projection assembly (GO:0120031),136,29,26.56,+,1.09,3.43E-01
MAPK cascade (GO:0000165),141,30,27.54,+,1.09,3.44E-01
positive regulation of macromolecule metabolic process (GO:0010604),701,149,136.9,+,1.09,1.56E-01
RNA metabolic process (GO:0016070),2259,480,441.17,+,1.09,2.66E-02
peptidyl-amino acid modification (GO:0018193),353,75,68.94,+,1.09,2.46E-01
protein localization to cilium (GO:0061512),113,24,22.07,+,1.09,3.68E-01
cellular macromolecule metabolic process (GO:0044260),3730,792,728.44,+,1.09,4.66E-03
cell cycle process (GO:0022402),358,76,69.92,+,1.09,2.47E-01
regulation of Rho protein signal transduction (GO:0035023),33,7,6.44,+,1.09,4.65E-01
hormone-mediated signaling pathway (GO:0009755),33,7,6.44,+,1.09,4.65E-01
protein methylation (GO:0006479),33,7,6.44,+,1.09,4.65E-01
maturation of SSU-rRNA (GO:0030490),33,7,6.44,+,1.09,4.65E-01
protein alkylation (GO:0008213),33,7,6.44,+,1.09,4.65E-01
cell cycle G1/S phase transition (GO:0044843),33,7,6.44,+,1.09,4.65E-01
defense response to virus (GO:0051607),33,7,6.44,+,1.09,4.65E-01
programmed cell death (GO:0012501),198,42,38.67,+,1.09,3.16E-01
cellular protein modification process (GO:0006464),1257,266,245.48,+,1.08,9.38E-02
protein modification process (GO:0036211),1257,266,245.48,+,1.08,9.38E-02
cell death (GO:0008219),213,45,41.6,+,1.08,3.18E-01
cell projection assembly (GO:0030031),142,30,27.73,+,1.08,3.58E-01
regulation of apoptotic process (GO:0042981),128,27,25,+,1.08,3.70E-01
signal transduction by protein phosphorylation (GO:0023014),147,31,28.71,+,1.08,3.58E-01
plasma membrane bounded cell projection organization (GO:0120036),356,75,69.52,+,1.08,2.69E-01
regulation of angiogenesis (GO:0045765),19,4,3.71,+,1.08,5.08E-01
phospholipid catabolic process (GO:0009395),19,4,3.71,+,1.08,5.08E-01
chromatin organization involved in regulation of transcription (GO:0034401),38,8,7.42,+,1.08,4.64E-01
regulation of vasculature development (GO:1901342),19,4,3.71,+,1.08,5.08E-01
glycosylation (GO:0070085),95,20,18.55,+,1.08,3.99E-01
G2/M transition of mitotic cell cycle (GO:0000086),19,4,3.71,+,1.08,5.08E-01
protein modification by small protein conjugation or removal (GO:0070647),342,72,66.79,+,1.08,2.76E-01
actomyosin structure organization (GO:0031032),38,8,7.42,+,1.08,4.64E-01
histone H4 acetylation (GO:0043967),19,4,3.71,+,1.08,5.08E-01
neuron development (GO:0048666),228,48,44.53,+,1.08,3.20E-01
cell projection organization (GO:0030030),361,76,70.5,+,1.08,2.70E-01
regulation of cellular protein metabolic process (GO:0032268),556,117,108.58,+,1.08,2.18E-01
actin filament organization (GO:0007015),176,37,34.37,+,1.08,3.49E-01
negative regulation of peptidase activity (GO:0010466),81,17,15.82,+,1.07,4.16E-01
cellular component assembly (GO:0022607),772,162,150.77,+,1.07,1.85E-01
head development (GO:0060322),43,9,8.4,+,1.07,4.63E-01
brain development (GO:0007420),43,9,8.4,+,1.07,4.63E-01
regulation of cell differentiation (GO:0045595),153,32,29.88,+,1.07,3.73E-01
divalent metal ion transport (GO:0070838),115,24,22.46,+,1.07,4.00E-01
divalent inorganic cation transport (GO:0072511),115,24,22.46,+,1.07,4.00E-01
negative regulation of transcription by RNA polymerase II (GO:0000122),187,39,36.52,+,1.07,3.62E-01
supramolecular fiber organization (GO:0097435),264,55,51.56,+,1.07,3.33E-01
positive regulation of protein catabolic process (GO:0045732),48,10,9.37,+,1.07,4.62E-01
negative regulation of mitotic cell cycle (GO:0045930),48,10,9.37,+,1.07,4.62E-01
proton transmembrane transport (GO:1902600),48,10,9.37,+,1.07,4.62E-01
"vesicle targeting, trans-Golgi to periciliary membrane compartment (GO:0097712)",101,21,19.72,+,1.06,4.16E-01
cilium assembly (GO:0060271),101,21,19.72,+,1.06,4.16E-01
ciliary transition zone assembly (GO:1905349),101,21,19.72,+,1.06,4.16E-01
intraciliary transport involved in cilium assembly (GO:0035735),101,21,19.72,+,1.06,4.16E-01
axoneme assembly (GO:0035082),101,21,19.72,+,1.06,4.16E-01
gene expression (GO:0010467),2607,542,509.13,+,1.06,6.14E-02
negative regulation of endopeptidase activity (GO:0010951),77,16,15.04,+,1.06,4.36E-01
response to endoplasmic reticulum stress (GO:0034976),77,16,15.04,+,1.06,4.36E-01
response to stress (GO:0006950),828,172,161.7,+,1.06,2.14E-01
cellular process (GO:0009987),8999,1869,1757.45,+,1.06,9.17E-05
protein glycosylation (GO:0006486),82,17,16.01,+,1.06,4.35E-01
macromolecule glycosylation (GO:0043413),82,17,16.01,+,1.06,4.35E-01
"vesicle targeting, to, from or within Golgi (GO:0048199)",111,23,21.68,+,1.06,4.16E-01
glycoprotein metabolic process (GO:0009100),140,29,27.34,+,1.06,4.00E-01
organic cyclic compound biosynthetic process (GO:1901362),1989,412,388.44,+,1.06,1.08E-01
oxidative phosphorylation (GO:0006119),29,6,5.66,+,1.06,4.99E-01
negative regulation of cellular response to growth factor stimulus (GO:0090288),29,6,5.66,+,1.06,4.99E-01
cell morphogenesis (GO:0000902),232,48,45.31,+,1.06,3.63E-01
macromolecule biosynthetic process (GO:0009059),2210,457,431.6,+,1.06,1.01E-01
vesicle budding from membrane (GO:0006900),179,37,34.96,+,1.06,3.87E-01
regulation of molecular function (GO:0065009),779,161,152.13,+,1.06,2.42E-01
response to endogenous stimulus (GO:0009719),242,50,47.26,+,1.06,3.64E-01
cellular macromolecule biosynthetic process (GO:0034645),2203,455,430.23,+,1.06,1.07E-01
negative regulation of signal transduction (GO:0009968),184,38,35.93,+,1.06,3.87E-01
regulation of protein metabolic process (GO:0051246),596,123,116.39,+,1.06,2.79E-01
cellular chemical homeostasis (GO:0055082),194,40,37.89,+,1.06,3.87E-01
icosanoid metabolic process (GO:0006690),34,7,6.64,+,1.05,4.95E-01
spindle assembly (GO:0051225),34,7,6.64,+,1.05,4.95E-01
neuron projection development (GO:0031175),209,43,40.82,+,1.05,3.86E-01
negative regulation of cellular protein metabolic process (GO:0032269),175,36,34.18,+,1.05,4.00E-01
biological_process (GO:0008150),9754,2004,1904.89,+,1.05,4.24E-04
heterocycle biosynthetic process (GO:0018130),1962,403,383.17,+,1.05,1.48E-01
regulation of nervous system development (GO:0051960),112,23,21.87,+,1.05,4.33E-01
vesicle targeting (GO:0006903),112,23,21.87,+,1.05,4.33E-01
glycoprotein biosynthetic process (GO:0009101),117,24,22.85,+,1.05,4.32E-01
regulation of anatomical structure size (GO:0090066),117,24,22.85,+,1.05,4.32E-01
ATP biosynthetic process (GO:0006754),39,8,7.62,+,1.05,4.92E-01
negative regulation of hydrolase activity (GO:0051346),93,19,18.16,+,1.05,4.53E-01
regulation of cellular component size (GO:0032535),103,21,20.12,+,1.04,4.51E-01
aromatic compound biosynthetic process (GO:0019438),1963,400,383.36,+,1.04,1.91E-01
cellular response to endogenous stimulus (GO:0071495),226,46,44.14,+,1.04,4.09E-01
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),207,42,40.43,+,1.04,4.23E-01
nucleobase-containing compound biosynthetic process (GO:0034654),1938,393,378.48,+,1.04,2.22E-01
protein localization to cell periphery (GO:1990778),84,17,16.4,+,1.04,4.74E-01
tissue development (GO:0009888),149,30,29.1,+,1.03,4.58E-01
endocytosis (GO:0006897),154,31,30.08,+,1.03,4.57E-01
regulation of biological quality (GO:0065008),850,171,166,+,1.03,3.56E-01
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),30,6,5.86,+,1.02,5.32E-01
oligodendrocyte differentiation (GO:0048709),5,1,0.98,+,1.02,6.23E-01
positive regulation of ion transport (GO:0043270),10,2,1.95,+,1.02,5.81E-01
positive regulation of hormone secretion (GO:0046887),5,1,0.98,+,1.02,6.23E-01
positive regulation of peptide secretion (GO:0002793),5,1,0.98,+,1.02,6.23E-01
regulation of bone remodeling (GO:0046850),5,1,0.98,+,1.02,6.23E-01
"vacuole fusion, non-autophagic (GO:0042144)",5,1,0.98,+,1.02,6.23E-01
negative regulation of cell communication (GO:0010648),190,38,37.11,+,1.02,4.63E-01
negative regulation of signaling (GO:0023057),190,38,37.11,+,1.02,4.63E-01
negative regulation of macroautophagy (GO:0016242),5,1,0.98,+,1.02,6.23E-01
negative regulation of blood coagulation (GO:0030195),5,1,0.98,+,1.02,6.23E-01
positive regulation of epithelial cell proliferation (GO:0050679),10,2,1.95,+,1.02,5.81E-01
epithelial cell proliferation (GO:0050673),15,3,2.93,+,1.02,5.61E-01
endothelial cell proliferation (GO:0001935),10,2,1.95,+,1.02,5.81E-01
platelet activation (GO:0030168),10,2,1.95,+,1.02,5.81E-01
positive regulation of innate immune response (GO:0045089),10,2,1.95,+,1.02,5.81E-01
protein activation cascade (GO:0072376),10,2,1.95,+,1.02,5.81E-01
C4-dicarboxylate transport (GO:0015740),5,1,0.98,+,1.02,6.23E-01
positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),5,1,0.98,+,1.02,6.23E-01
protein localization to plasma membrane (GO:0072659),65,13,12.69,+,1.02,5.03E-01
"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",15,3,2.93,+,1.02,5.61E-01
aromatic amino acid family metabolic process (GO:0009072),15,3,2.93,+,1.02,5.61E-01
regulation of small GTPase mediated signal transduction (GO:0051056),50,10,9.76,+,1.02,5.12E-01
wound healing (GO:0042060),30,6,5.86,+,1.02,5.32E-01
kinetochore assembly (GO:0051382),5,1,0.98,+,1.02,6.23E-01
actin filament bundle assembly (GO:0051017),35,7,6.84,+,1.02,5.26E-01
regulation of sister chromatid segregation (GO:0033045),20,4,3.91,+,1.02,5.48E-01
"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",25,5,4.88,+,1.02,5.39E-01
maturation of 5.8S rRNA (GO:0000460),20,4,3.91,+,1.02,5.48E-01
non-canonical Wnt signaling pathway (GO:0035567),20,4,3.91,+,1.02,5.48E-01
"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",5,1,0.98,+,1.02,6.23E-01
regulation of tissue remodeling (GO:0034103),5,1,0.98,+,1.02,6.23E-01
nucleus localization (GO:0051647),5,1,0.98,+,1.02,6.23E-01
positive regulation of exocytosis (GO:0045921),10,2,1.95,+,1.02,5.81E-01
cell cycle G2/M phase transition (GO:0044839),20,4,3.91,+,1.02,5.48E-01
"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",5,1,0.98,+,1.02,6.23E-01
regulation of gene silencing (GO:0060968),15,3,2.93,+,1.02,5.61E-01
mitotic G2/M transition checkpoint (GO:0044818),10,2,1.95,+,1.02,5.81E-01
negative regulation of protein modification process (GO:0031400),60,12,11.72,+,1.02,5.06E-01
"positive regulation of DNA-templated transcription, initiation (GO:2000144)",5,1,0.98,+,1.02,6.23E-01
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),5,1,0.98,+,1.02,6.23E-01
positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),5,1,0.98,+,1.02,6.23E-01
regulation of DNA recombination (GO:0000018),15,3,2.93,+,1.02,5.61E-01
synaptic vesicle exocytosis (GO:0016079),35,7,6.84,+,1.02,5.26E-01
nuclear migration (GO:0007097),5,1,0.98,+,1.02,6.23E-01
metaphase/anaphase transition of mitotic cell cycle (GO:0007091),15,3,2.93,+,1.02,5.61E-01
ribosomal large subunit biogenesis (GO:0042273),55,11,10.74,+,1.02,5.09E-01
regulation of metaphase/anaphase transition of cell cycle (GO:1902099),15,3,2.93,+,1.02,5.61E-01
mitotic spindle organization (GO:0007052),35,7,6.84,+,1.02,5.26E-01
cell-substrate junction assembly (GO:0007044),5,1,0.98,+,1.02,6.23E-01
mitochondrial calcium ion homeostasis (GO:0051560),5,1,0.98,+,1.02,6.23E-01
regulation of response to biotic stimulus (GO:0002831),15,3,2.93,+,1.02,5.61E-01
establishment of planar polarity (GO:0001736),5,1,0.98,+,1.02,6.23E-01
positive regulation of protein kinase B signaling (GO:0051897),5,1,0.98,+,1.02,6.23E-01
myelination (GO:0042552),15,3,2.93,+,1.02,5.61E-01
plasma membrane organization (GO:0007009),30,6,5.86,+,1.02,5.32E-01
negative regulation of protein ubiquitination (GO:0031397),5,1,0.98,+,1.02,6.23E-01
microtubule organizing center organization (GO:0031023),40,8,7.81,+,1.02,5.21E-01
cGMP-mediated signaling (GO:0019934),10,2,1.95,+,1.02,5.81E-01
regulation of NIK/NF-kappaB signaling (GO:1901222),5,1,0.98,+,1.02,6.23E-01
myofibril assembly (GO:0030239),20,4,3.91,+,1.02,5.48E-01
receptor localization to synapse (GO:0097120),25,5,4.88,+,1.02,5.39E-01
cortical actin cytoskeleton organization (GO:0030866),15,3,2.93,+,1.02,5.61E-01
regulation of bone resorption (GO:0045124),5,1,0.98,+,1.02,6.23E-01
regulation of chromatin silencing (GO:0031935),10,2,1.95,+,1.02,5.81E-01
protein maturation (GO:0051604),85,17,16.6,+,1.02,4.93E-01
negative regulation of proteolysis (GO:0045861),85,17,16.6,+,1.02,4.93E-01
regulation of cellular metabolic process (GO:0031323),2486,497,485.5,+,1.02,2.94E-01
membrane invagination (GO:0010324),156,31,30.47,+,1.02,4.86E-01
microtubule cytoskeleton organization (GO:0000226),308,61,60.15,+,1.01,4.74E-01
small GTPase mediated signal transduction (GO:0007264),86,17,16.8,+,1.01,5.13E-01
calcium ion transport (GO:0006816),86,17,16.8,+,1.01,5.13E-01
cellular homeostasis (GO:0019725),218,43,42.57,+,1.01,4.95E-01
regulation of response to stress (GO:0080134),117,23,22.85,+,1.01,5.15E-01
regulation of metabolic process (GO:0019222),2718,534,530.81,+,1.01,4.47E-01
organic anion transport (GO:0015711),168,33,32.81,+,1.01,5.10E-01
phosphorylation (GO:0016310),672,132,131.24,+,1.01,4.85E-01
regulation of primary metabolic process (GO:0080090),2408,473,470.27,+,1.01,4.54E-01
cytoskeleton organization (GO:0007010),586,115,114.44,+,1,4.92E-01
positive regulation of cellular process (GO:0048522),1162,228,226.93,+,1,4.80E-01
regulation of phosphorus metabolic process (GO:0051174),398,78,77.73,+,1,5.03E-01
regulation of phosphate metabolic process (GO:0019220),398,78,77.73,+,1,5.03E-01
regulation of actin filament-based process (GO:0032970),97,19,18.94,+,1,5.26E-01
regulation of actin cytoskeleton organization (GO:0032956),97,19,18.94,+,1,5.26E-01
positive regulation of MAPK cascade (GO:0043410),97,19,18.94,+,1,5.26E-01
regulation of mitotic cell cycle (GO:0007346),92,18,17.97,+,1,5.28E-01
cellular ion homeostasis (GO:0006873),184,36,35.93,+,1,5.18E-01
regulation of Ras protein signal transduction (GO:0046578),46,9,8.98,+,1,5.42E-01
regulation of MAPK cascade (GO:0043408),128,25,25,+,1,5.27E-01
purine nucleoside triphosphate biosynthetic process (GO:0009145),41,8,8.01,-,1,5.92E-01
purine ribonucleoside triphosphate biosynthetic process (GO:0009206),41,8,8.01,-,1,5.92E-01
purine ribonucleoside triphosphate metabolic process (GO:0009205),41,8,8.01,-,1,5.92E-01
unsaturated fatty acid metabolic process (GO:0033559),41,8,8.01,-,1,5.92E-01
cell morphogenesis involved in neuron differentiation (GO:0048667),154,30,30.08,-,1,5.43E-01
regulation of nitrogen compound metabolic process (GO:0051171),2380,463,464.8,-,1,4.77E-01
chromosome separation (GO:0051304),36,7,7.03,-,1,5.94E-01
microtubule bundle formation (GO:0001578),108,21,21.09,-,1,5.50E-01
regulation of protein modification process (GO:0031399),356,69,69.52,-,0.99,5.07E-01
regulation of TOR signaling (GO:0032006),31,6,6.05,-,0.99,5.98E-01
protein deubiquitination (GO:0016579),62,12,12.11,-,0.99,5.64E-01
cellular response to transforming growth factor beta stimulus (GO:0071560),31,6,6.05,-,0.99,5.98E-01
response to transforming growth factor beta (GO:0071559),31,6,6.05,-,0.99,5.98E-01
negative regulation of cell population proliferation (GO:0008285),31,6,6.05,-,0.99,5.98E-01
transforming growth factor beta receptor signaling pathway (GO:0007179),31,6,6.05,-,0.99,5.98E-01
cellular cation homeostasis (GO:0030003),181,35,35.35,-,0.99,5.21E-01
regulation of cellular component organization (GO:0051128),378,73,73.82,-,0.99,4.92E-01
calcium ion transmembrane transport (GO:0070588),57,11,11.13,-,0.99,5.64E-01
axon development (GO:0061564),140,27,27.34,-,0.99,5.25E-01
cellular response to oxygen-containing compound (GO:1901701),140,27,27.34,-,0.99,5.25E-01
sodium ion transport (GO:0006814),83,16,16.21,-,0.99,5.45E-01
regulation of developmental process (GO:0050793),244,47,47.65,-,0.99,5.01E-01
regulation of biosynthetic process (GO:0009889),1811,348,353.68,-,0.98,3.88E-01
actin cytoskeleton organization (GO:0030036),255,49,49.8,-,0.98,4.92E-01
regulation of phosphorylation (GO:0042325),375,72,73.24,-,0.98,4.73E-01
regulation of macromolecule metabolic process (GO:0060255),2564,492,500.73,-,0.98,3.47E-01
actin filament polymerization (GO:0030041),73,14,14.26,-,0.98,5.43E-01
protein modification by small protein removal (GO:0070646),73,14,14.26,-,0.98,5.43E-01
regulation of localization (GO:0032879),412,79,80.46,-,0.98,4.64E-01
activation of adenylate cyclase activity (GO:0007190),94,18,18.36,-,0.98,5.29E-01
adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),94,18,18.36,-,0.98,5.29E-01
cellular response to external stimulus (GO:0071496),47,9,9.18,-,0.98,5.64E-01
blood vessel morphogenesis (GO:0048514),47,9,9.18,-,0.98,5.64E-01
RNA biosynthetic process (GO:0032774),1726,330,337.08,-,0.98,3.56E-01
regulation of macromolecule biosynthetic process (GO:0010556),1792,342,349.97,-,0.98,3.39E-01
positive regulation of cellular protein metabolic process (GO:0032270),320,61,62.49,-,0.98,4.58E-01
regulation of cellular biosynthetic process (GO:0031326),1805,344,352.5,-,0.98,3.29E-01
purine nucleoside triphosphate metabolic process (GO:0009144),42,8,8.2,-,0.98,5.64E-01
peptidyl-threonine phosphorylation (GO:0018107),21,4,4.1,-,0.98,6.09E-01
epidermal growth factor receptor signaling pathway (GO:0007173),21,4,4.1,-,0.98,6.09E-01
angiogenesis (GO:0001525),42,8,8.2,-,0.98,5.64E-01
negative regulation of MAPK cascade (GO:0043409),21,4,4.1,-,0.98,6.09E-01
calcium-mediated signaling (GO:0019722),21,4,4.1,-,0.98,6.09E-01
regulation of cellular response to growth factor stimulus (GO:0090287),42,8,8.2,-,0.98,5.64E-01
negative regulation of apoptotic signaling pathway (GO:2001234),21,4,4.1,-,0.98,6.09E-01
striated muscle contraction (GO:0006941),21,4,4.1,-,0.98,6.09E-01
cellular response to starvation (GO:0009267),42,8,8.2,-,0.98,5.64E-01
Golgi to plasma membrane transport (GO:0006893),21,4,4.1,-,0.98,6.09E-01
regulation of system process (GO:0044057),42,8,8.2,-,0.98,5.64E-01
regulation of cellular macromolecule biosynthetic process (GO:2000112),1786,340,348.79,-,0.97,3.22E-01
cation transport (GO:0006812),415,79,81.05,-,0.97,4.38E-01
nucleic acid-templated transcription (GO:0097659),1719,327,335.71,-,0.97,3.21E-01
"transcription, DNA-templated (GO:0006351)",1719,327,335.71,-,0.97,3.21E-01
regulation of RNA metabolic process (GO:0051252),1793,341,350.16,-,0.97,3.15E-01
regulation of nucleobase-containing compound metabolic process (GO:0019219),1831,348,357.58,-,0.97,3.08E-01
protein localization to membrane (GO:0072657),158,30,30.86,-,0.97,4.86E-01
actin polymerization or depolymerization (GO:0008154),79,15,15.43,-,0.97,5.24E-01
regulation of response to external stimulus (GO:0032101),79,15,15.43,-,0.97,5.24E-01
apoptotic signaling pathway (GO:0097190),79,15,15.43,-,0.97,5.24E-01
negative regulation of phosphorus metabolic process (GO:0010563),58,11,11.33,-,0.97,5.40E-01
negative regulation of phosphate metabolic process (GO:0045936),58,11,11.33,-,0.97,5.40E-01
actin filament-based process (GO:0030029),264,50,51.56,-,0.97,4.50E-01
actin filament bundle organization (GO:0061572),37,7,7.23,-,0.97,5.65E-01
transition metal ion homeostasis (GO:0055076),37,7,7.23,-,0.97,5.65E-01
microtubule-based process (GO:0007017),397,75,77.53,-,0.97,4.15E-01
regulation of multicellular organismal development (GO:2000026),196,37,38.28,-,0.97,4.60E-01
vasculature development (GO:0001944),53,10,10.35,-,0.97,5.39E-01
regulation of cell cycle phase transition (GO:1901987),53,10,10.35,-,0.97,5.39E-01
regulation of canonical Wnt signaling pathway (GO:0060828),53,10,10.35,-,0.97,5.39E-01
axonogenesis (GO:0007409),138,26,26.95,-,0.96,4.78E-01
microtubule-based movement (GO:0007018),197,37,38.47,-,0.96,4.48E-01
regulation of mitotic sister chromatid separation (GO:0010965),16,3,3.12,-,0.96,6.19E-01
phosphatidylinositol 3-kinase signaling (GO:0014065),16,3,3.12,-,0.96,6.19E-01
negative regulation of cell cycle process (GO:0010948),32,6,6.25,-,0.96,5.66E-01
regulation of cell cycle G1/S phase transition (GO:1902806),16,3,3.12,-,0.96,6.19E-01
iron ion homeostasis (GO:0055072),16,3,3.12,-,0.96,6.19E-01
regulation of synapse organization (GO:0050807),16,3,3.12,-,0.96,6.19E-01
regulation of extrinsic apoptotic signaling pathway (GO:2001236),16,3,3.12,-,0.96,6.19E-01
regulation of cysteine-type endopeptidase activity (GO:2000116),32,6,6.25,-,0.96,5.66E-01
spliceosomal snRNP assembly (GO:0000387),16,3,3.12,-,0.96,6.19E-01
regulation of cytokinesis (GO:0032465),16,3,3.12,-,0.96,6.19E-01
protein sumoylation (GO:0016925),16,3,3.12,-,0.96,6.19E-01
regulation of mitotic cell cycle phase transition (GO:1901990),48,9,9.37,-,0.96,5.38E-01
regulation of intracellular signal transduction (GO:1902531),411,77,80.27,-,0.96,3.84E-01
regulation of gene expression (GO:0010468),2045,383,399.38,-,0.96,2.00E-01
"regulation of transcription, DNA-templated (GO:0006355)",1672,313,326.53,-,0.96,2.26E-01
regulation of nucleic acid-templated transcription (GO:1903506),1672,313,326.53,-,0.96,2.26E-01
regulation of RNA biosynthetic process (GO:2001141),1672,313,326.53,-,0.96,2.26E-01
positive regulation of biological process (GO:0048518),1310,245,255.83,-,0.96,2.53E-01
peptidyl-serine phosphorylation (GO:0018105),107,20,20.9,-,0.96,4.80E-01
positive regulation of lymphocyte mediated immunity (GO:0002708),27,5,5.27,-,0.95,5.68E-01
regulation of chromatin organization (GO:1902275),27,5,5.27,-,0.95,5.68E-01
regulation of response to DNA damage stimulus (GO:2001020),27,5,5.27,-,0.95,5.68E-01
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),27,5,5.27,-,0.95,5.68E-01
negative regulation of cell cycle phase transition (GO:1901988),27,5,5.27,-,0.95,5.68E-01
regulation of mRNA catabolic process (GO:0061013),27,5,5.27,-,0.95,5.68E-01
cellular response to organic cyclic compound (GO:0071407),27,5,5.27,-,0.95,5.68E-01
protein localization to synapse (GO:0035418),27,5,5.27,-,0.95,5.68E-01
meiotic cell cycle process (GO:1903046),81,15,15.82,-,0.95,4.85E-01
meiotic nuclear division (GO:0140013),81,15,15.82,-,0.95,4.85E-01
meiotic cell cycle (GO:0051321),81,15,15.82,-,0.95,4.85E-01
transcription by RNA polymerase II (GO:0006366),1410,261,275.36,-,0.95,1.93E-01
anion transport (GO:0006820),222,41,43.36,-,0.95,3.97E-01
synaptic vesicle cycle (GO:0099504),65,12,12.69,-,0.95,4.97E-01
vesicle-mediated transport in synapse (GO:0099003),65,12,12.69,-,0.95,4.97E-01
response to oxygen-containing compound (GO:1901700),168,31,32.81,-,0.94,4.20E-01
inorganic ion homeostasis (GO:0098771),206,38,40.23,-,0.94,4.01E-01
axon guidance (GO:0007411),103,19,20.12,-,0.94,4.60E-01
chromosome segregation (GO:0007059),103,19,20.12,-,0.94,4.60E-01
neuron projection guidance (GO:0097485),103,19,20.12,-,0.94,4.60E-01
regulation of cytoskeleton organization (GO:0051493),141,26,27.54,-,0.94,4.33E-01
cAMP-mediated signaling (GO:0019933),141,26,27.54,-,0.94,4.33E-01
ion homeostasis (GO:0050801),217,40,42.38,-,0.94,3.95E-01
ATP synthesis coupled proton transport (GO:0015986),38,7,7.42,-,0.94,5.36E-01
"energy coupled proton transport, down electrochemical gradient (GO:0015985)",38,7,7.42,-,0.94,5.36E-01
negative regulation of protein phosphorylation (GO:0001933),49,9,9.57,-,0.94,5.13E-01
inositol phosphate-mediated signaling (GO:0048016),49,9,9.57,-,0.94,5.13E-01
negative regulation of phosphorylation (GO:0042326),49,9,9.57,-,0.94,5.13E-01
positive regulation of developmental process (GO:0051094),109,20,21.29,-,0.94,4.46E-01
cell morphogenesis involved in differentiation (GO:0000904),169,31,33,-,0.94,4.07E-01
Unclassified (UNCLASSIFIED),8306,1523,1622.11,-,0.94,4.24E-04
positive regulation of programmed cell death (GO:0043068),60,11,11.72,-,0.94,4.94E-01
enzyme linked receptor protein signaling pathway (GO:0007167),311,57,60.74,-,0.94,3.44E-01
positive regulation of protein metabolic process (GO:0051247),344,63,67.18,-,0.94,3.31E-01
cellular metal ion homeostasis (GO:0006875),159,29,31.05,-,0.93,4.00E-01
biological regulation (GO:0065007),5239,955,1023.14,-,0.93,5.80E-03
regulation of transcription by RNA polymerase II (GO:0006357),1379,251,269.31,-,0.93,1.29E-01
inositol lipid-mediated signaling (GO:0048017),33,6,6.44,-,0.93,5.35E-01
phosphatidylinositol-mediated signaling (GO:0048015),33,6,6.44,-,0.93,5.35E-01
negative regulation of transport (GO:0051051),33,6,6.44,-,0.93,5.35E-01
response to unfolded protein (GO:0006986),33,6,6.44,-,0.93,5.35E-01
cellular response to unfolded protein (GO:0034620),33,6,6.44,-,0.93,5.35E-01
histone deacetylation (GO:0016575),22,4,4.3,-,0.93,5.71E-01
NADP metabolic process (GO:0006739),11,2,2.15,-,0.93,6.37E-01
icosanoid biosynthetic process (GO:0046456),11,2,2.15,-,0.93,6.37E-01
positive regulation of leukocyte chemotaxis (GO:0002690),11,2,2.15,-,0.93,6.37E-01
regulation of chromosome segregation (GO:0051983),22,4,4.3,-,0.93,5.71E-01
striated muscle cell development (GO:0055002),22,4,4.3,-,0.93,5.71E-01
muscle structure development (GO:0061061),44,8,8.59,-,0.93,5.10E-01
centrosome duplication (GO:0051298),22,4,4.3,-,0.93,5.71E-01
purine nucleoside metabolic process (GO:0042278),11,2,2.15,-,0.93,6.37E-01
peptidyl-serine modification (GO:0018209),110,20,21.48,-,0.93,4.29E-01
regulation of inflammatory response (GO:0050727),22,4,4.3,-,0.93,5.71E-01
ribonucleoprotein complex assembly (GO:0022618),99,18,19.33,-,0.93,4.39E-01
regulation of protein phosphorylation (GO:0001932),314,57,61.32,-,0.93,3.17E-01
movement of cell or subcellular component (GO:0006928),551,100,107.61,-,0.93,2.46E-01
cell migration (GO:0016477),248,45,48.43,-,0.93,3.43E-01
cation homeostasis (GO:0055080),204,37,39.84,-,0.93,3.63E-01
regulation of cytosolic calcium ion concentration (GO:0051480),83,15,16.21,-,0.93,4.46E-01
intracellular signal transduction (GO:0035556),754,136,147.25,-,0.92,1.83E-01
positive regulation of cell death (GO:0010942),61,11,11.91,-,0.92,4.71E-01
localization of cell (GO:0051674),283,51,55.27,-,0.92,3.10E-01
cell motility (GO:0048870),283,51,55.27,-,0.92,3.10E-01
regulation of organelle organization (GO:0033043),250,45,48.82,-,0.92,3.22E-01
blood vessel development (GO:0001568),50,9,9.76,-,0.92,4.88E-01
phospholipid transport (GO:0015914),39,7,7.62,-,0.92,5.08E-01
ion transport (GO:0006811),625,112,122.06,-,0.92,1.90E-01
positive regulation of cytosolic calcium ion concentration (GO:0007204),67,12,13.08,-,0.92,4.54E-01
regulation of cellular component biogenesis (GO:0044087),151,27,29.49,-,0.92,3.66E-01
proteoglycan biosynthetic process (GO:0030166),28,5,5.47,-,0.91,5.34E-01
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),28,5,5.47,-,0.91,5.34E-01
response to oxidative stress (GO:0006979),28,5,5.47,-,0.91,5.34E-01
positive regulation of adaptive immune response (GO:0002821),28,5,5.47,-,0.91,5.34E-01
positive regulation of NF-kappaB transcription factor activity (GO:0051092),73,13,14.26,-,0.91,4.37E-01
central nervous system development (GO:0007417),73,13,14.26,-,0.91,4.37E-01
regulation of cellular process (GO:0050794),4600,818,898.35,-,0.91,9.22E-04
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),45,8,8.79,-,0.91,4.84E-01
cellular response to nutrient levels (GO:0031669),45,8,8.79,-,0.91,4.84E-01
cellular response to extracellular stimulus (GO:0031668),45,8,8.79,-,0.91,4.84E-01
negative regulation of molecular function (GO:0044092),180,32,35.15,-,0.91,3.35E-01
anion transmembrane transport (GO:0098656),96,17,18.75,-,0.91,4.00E-01
regulation of biological process (GO:0050789),4810,850,939.36,-,0.9,3.16E-04
protein phosphorylation (GO:0006468),521,92,101.75,-,0.9,1.77E-01
vesicle-mediated transport to the plasma membrane (GO:0098876),34,6,6.64,-,0.9,5.05E-01
lipid translocation (GO:0034204),34,6,6.64,-,0.9,5.05E-01
regulation of epidermal growth factor receptor signaling pathway (GO:0042058),17,3,3.32,-,0.9,5.76E-01
ribonucleoprotein complex subunit organization (GO:0071826),102,18,19.92,-,0.9,3.88E-01
mitotic sister chromatid separation (GO:0051306),17,3,3.32,-,0.9,5.76E-01
negative regulation of MAP kinase activity (GO:0043407),17,3,3.32,-,0.9,5.76E-01
positive regulation of secretion by cell (GO:1903532),17,3,3.32,-,0.9,5.76E-01
regulation of stress-activated MAPK cascade (GO:0032872),34,6,6.64,-,0.9,5.05E-01
regulation of stress-activated protein kinase signaling cascade (GO:0070302),34,6,6.64,-,0.9,5.05E-01
centrosome cycle (GO:0007098),34,6,6.64,-,0.9,5.05E-01
mitotic cell cycle checkpoint (GO:0007093),34,6,6.64,-,0.9,5.05E-01
regulation of defense response (GO:0031347),34,6,6.64,-,0.9,5.05E-01
regulation of G2/M transition of mitotic cell cycle (GO:0010389),17,3,3.32,-,0.9,5.76E-01
response to organic substance (GO:0010033),533,94,104.09,-,0.9,1.70E-01
neuron differentiation (GO:0030182),308,54,60.15,-,0.9,2.34E-01
cellular response to organic substance (GO:0071310),445,78,86.91,-,0.9,1.81E-01
negative regulation of cellular component organization (GO:0051129),97,17,18.94,-,0.9,3.83E-01
regulation of cAMP-mediated signaling (GO:0043949),137,24,26.76,-,0.9,3.40E-01
phagocytosis (GO:0006909),40,7,7.81,-,0.9,4.79E-01
positive regulation of protein modification process (GO:0031401),246,43,48.04,-,0.9,2.59E-01
tube development (GO:0035295),63,11,12.3,-,0.89,4.27E-01
cell development (GO:0048468),361,63,70.5,-,0.89,2.01E-01
positive regulation of intracellular signal transduction (GO:1902533),172,30,33.59,-,0.89,3.03E-01
negative regulation of catalytic activity (GO:0043086),155,27,30.27,-,0.89,3.14E-01
regulation of actin filament length (GO:0030832),69,12,13.48,-,0.89,4.12E-01
regulation of actin polymerization or depolymerization (GO:0008064),69,12,13.48,-,0.89,4.12E-01
regulation of DNA-binding transcription factor activity (GO:0051090),92,16,17.97,-,0.89,3.78E-01
regulation of transport (GO:0051049),253,44,49.41,-,0.89,2.45E-01
reciprocal meiotic recombination (GO:0007131),23,4,4.49,-,0.89,5.34E-01
homologous recombination (GO:0035825),23,4,4.49,-,0.89,5.34E-01
regulation of microtubule polymerization or depolymerization (GO:0031110),23,4,4.49,-,0.89,5.34E-01
muscle cell development (GO:0055001),23,4,4.49,-,0.89,5.34E-01
ERBB signaling pathway (GO:0038127),23,4,4.49,-,0.89,5.34E-01
metal ion transport (GO:0030001),305,53,59.56,-,0.89,2.16E-01
generation of neurons (GO:0048699),334,58,65.23,-,0.89,2.02E-01
locomotion (GO:0040011),363,63,70.89,-,0.89,1.89E-01
regulation of cell cycle process (GO:0010564),98,17,19.14,-,0.89,3.66E-01
regulation of lymphocyte mediated immunity (GO:0002706),29,5,5.66,-,0.88,5.01E-01
protein deacylation (GO:0035601),29,5,5.66,-,0.88,5.01E-01
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),58,10,11.33,-,0.88,4.21E-01
macromolecule deacylation (GO:0098732),29,5,5.66,-,0.88,5.01E-01
tube morphogenesis (GO:0035239),58,10,11.33,-,0.88,4.21E-01
cellular response to chemical stimulus (GO:0070887),586,101,114.44,-,0.88,1.08E-01
metal ion homeostasis (GO:0055065),180,31,35.15,-,0.88,2.74E-01
regulation of nuclear division (GO:0051783),35,6,6.84,-,0.88,4.74E-01
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),35,6,6.84,-,0.88,4.74E-01
inorganic cation transmembrane transport (GO:0098662),280,48,54.68,-,0.88,2.01E-01
positive regulation of phosphorus metabolic process (GO:0010562),286,49,55.85,-,0.88,1.97E-01
positive regulation of phosphate metabolic process (GO:0045937),286,49,55.85,-,0.88,1.97E-01
cation transmembrane transport (GO:0098655),310,53,60.54,-,0.88,1.81E-01
neurogenesis (GO:0022008),351,60,68.55,-,0.88,1.63E-01
positive regulation of phosphorylation (GO:0042327),281,48,54.88,-,0.87,1.94E-01
cellular divalent inorganic cation homeostasis (GO:0072503),135,23,26.36,-,0.87,2.95E-01
regulation of transmembrane transporter activity (GO:0022898),47,8,9.18,-,0.87,4.32E-01
regulation of ion transmembrane transporter activity (GO:0032412),47,8,9.18,-,0.87,4.32E-01
regulation of transporter activity (GO:0032409),47,8,9.18,-,0.87,4.32E-01
transmembrane transport (GO:0055085),500,85,97.65,-,0.87,1.04E-01
regulation of cation transmembrane transport (GO:1904062),53,9,10.35,-,0.87,4.15E-01
positive regulation of apoptotic process (GO:0043065),59,10,11.52,-,0.87,3.99E-01
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),130,22,25.39,-,0.87,2.90E-01
regulation of actin filament organization (GO:0110053),77,13,15.04,-,0.86,3.59E-01
response to chemical (GO:0042221),825,139,161.12,-,0.86,3.83E-02
positive regulation of cellular component organization (GO:0051130),131,22,25.58,-,0.86,2.77E-01
regulation of signal transduction (GO:0009966),698,117,136.31,-,0.86,4.76E-02
inorganic ion transmembrane transport (GO:0098660),311,52,60.74,-,0.86,1.42E-01
cellular response to stimulus (GO:0051716),2435,406,475.54,-,0.85,2.58E-04
positive regulation of DNA-binding transcription factor activity (GO:0051091),84,14,16.4,-,0.85,3.30E-01
regulation of hormone levels (GO:0010817),42,7,8.2,-,0.85,4.25E-01
extrinsic apoptotic signaling pathway (GO:0097191),42,7,8.2,-,0.85,4.25E-01
mitochondrial fission (GO:0000266),18,3,3.52,-,0.85,5.33E-01
calcium ion import (GO:0070509),18,3,3.52,-,0.85,5.33E-01
positive regulation of cell cycle process (GO:0090068),30,5,5.86,-,0.85,4.68E-01
regulation of Wnt signaling pathway (GO:0030111),66,11,12.89,-,0.85,3.64E-01
phospholipid translocation (GO:0045332),30,5,5.86,-,0.85,4.68E-01
regulation of mitotic sister chromatid segregation (GO:0033047),18,3,3.52,-,0.85,5.33E-01
muscle cell differentiation (GO:0042692),30,5,5.86,-,0.85,4.68E-01
protein processing (GO:0016485),60,10,11.72,-,0.85,3.77E-01
regulation of cell cycle G2/M phase transition (GO:1902749),18,3,3.52,-,0.85,5.33E-01
multicellular organismal homeostasis (GO:0048871),18,3,3.52,-,0.85,5.33E-01
regulation of adaptive immune response (GO:0002819),30,5,5.86,-,0.85,4.68E-01
establishment of protein localization to membrane (GO:0090150),72,12,14.06,-,0.85,3.52E-01
nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),12,2,2.34,-,0.85,5.85E-01
T cell mediated immunity (GO:0002456),24,4,4.69,-,0.85,4.97E-01
bone resorption (GO:0045453),6,1,1.17,-,0.85,6.73E-01
regulation of stress fiber assembly (GO:0051492),6,1,1.17,-,0.85,6.73E-01
bone remodeling (GO:0046849),6,1,1.17,-,0.85,6.73E-01
antigen processing and presentation (GO:0019882),24,4,4.69,-,0.85,4.97E-01
"synaptic transmission, cholinergic (GO:0007271)",6,1,1.17,-,0.85,6.73E-01
replication fork processing (GO:0031297),6,1,1.17,-,0.85,6.73E-01
positive regulation of TOR signaling (GO:0032008),12,2,2.34,-,0.85,5.85E-01
negative regulation of phosphatase activity (GO:0010923),6,1,1.17,-,0.85,6.73E-01
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),6,1,1.17,-,0.85,6.73E-01
chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),12,2,2.34,-,0.85,5.85E-01
"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",6,1,1.17,-,0.85,6.73E-01
alanine transport (GO:0032328),6,1,1.17,-,0.85,6.73E-01
regulation of innate immune response (GO:0045088),12,2,2.34,-,0.85,5.85E-01
activin receptor signaling pathway (GO:0032924),12,2,2.34,-,0.85,5.85E-01
morphogenesis of an epithelium (GO:0002009),24,4,4.69,-,0.85,4.97E-01
kinetochore organization (GO:0051383),6,1,1.17,-,0.85,6.73E-01
regulation of mitochondrion organization (GO:0010821),12,2,2.34,-,0.85,5.85E-01
mitochondrial transcription (GO:0006390),6,1,1.17,-,0.85,6.73E-01
postreplication repair (GO:0006301),12,2,2.34,-,0.85,5.85E-01
negative regulation of coagulation (GO:0050819),6,1,1.17,-,0.85,6.73E-01
regulation of synapse structure or activity (GO:0050803),24,4,4.69,-,0.85,4.97E-01
positive regulation of cation channel activity (GO:2001259),6,1,1.17,-,0.85,6.73E-01
"regulation of DNA-templated transcription, initiation (GO:2000142)",6,1,1.17,-,0.85,6.73E-01
ribosomal subunit export from nucleus (GO:0000054),12,2,2.34,-,0.85,5.85E-01
protein localization to Golgi apparatus (GO:0034067),12,2,2.34,-,0.85,5.85E-01
regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),6,1,1.17,-,0.85,6.73E-01
transposition (GO:0032196),6,1,1.17,-,0.85,6.73E-01
nucleotide-sugar metabolic process (GO:0009225),12,2,2.34,-,0.85,5.85E-01
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),6,1,1.17,-,0.85,6.73E-01
regulation of ossification (GO:0030278),6,1,1.17,-,0.85,6.73E-01
nervous system development (GO:0007399),457,76,89.25,-,0.85,8.33E-02
regulation of multicellular organismal process (GO:0051239),325,54,63.47,-,0.85,1.26E-01
divalent inorganic cation homeostasis (GO:0072507),139,23,27.15,-,0.85,2.46E-01
ion transmembrane transport (GO:0034220),411,68,80.27,-,0.85,8.95E-02
regulation of adenylate cyclase activity (GO:0045761),133,22,25.97,-,0.85,2.52E-01
canonical Wnt signaling pathway (GO:0060070),97,16,18.94,-,0.84,2.96E-01
anatomical structure morphogenesis (GO:0009653),467,77,91.2,-,0.84,7.02E-02
anatomical structure formation involved in morphogenesis (GO:0048646),91,15,17.77,-,0.84,3.04E-01
regulation of secretion by cell (GO:1903530),79,13,15.43,-,0.84,3.23E-01
regulation of actin filament polymerization (GO:0030833),67,11,13.08,-,0.84,3.44E-01
sister chromatid segregation (GO:0000819),67,11,13.08,-,0.84,3.44E-01
cyclic-nucleotide-mediated signaling (GO:0019935),177,29,34.57,-,0.84,1.95E-01
regulation of response to stimulus (GO:0048583),873,143,170.49,-,0.84,1.52E-02
response to stimulus (GO:0050896),2843,463,555.22,-,0.83,7.20E-06
cell surface receptor signaling pathway involved in cell-cell signaling (GO:1905114),129,21,25.19,-,0.83,2.35E-01
taxis (GO:0042330),172,28,33.59,-,0.83,1.90E-01
sensory organ development (GO:0007423),43,7,8.4,-,0.83,3.99E-01
chemotaxis (GO:0006935),172,28,33.59,-,0.83,1.90E-01
cellular calcium ion homeostasis (GO:0006874),117,19,22.85,-,0.83,2.47E-01
positive regulation of ERK1 and ERK2 cascade (GO:0070374),37,6,7.23,-,0.83,4.16E-01
regulation of cyclase activity (GO:0031279),136,22,26.56,-,0.83,2.18E-01
regulation of lyase activity (GO:0051339),136,22,26.56,-,0.83,2.18E-01
regulation of ion transport (GO:0043269),99,16,19.33,-,0.83,2.66E-01
positive regulation of protein phosphorylation (GO:0001934),229,37,44.72,-,0.83,1.37E-01
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),62,10,12.11,-,0.83,3.36E-01
positive regulation of leukocyte mediated immunity (GO:0002705),31,5,6.05,-,0.83,4.37E-01
regulation of apoptotic signaling pathway (GO:2001233),31,5,6.05,-,0.83,4.37E-01
calcium ion homeostasis (GO:0055074),118,19,23.04,-,0.82,2.34E-01
regulation of chromosome organization (GO:0033044),56,9,10.94,-,0.82,3.47E-01
regulation of exocytosis (GO:0017157),56,9,10.94,-,0.82,3.47E-01
regulation of cell communication (GO:0010646),780,125,152.33,-,0.82,1.14E-02
regulation of signaling (GO:0023051),780,125,152.33,-,0.82,1.14E-02
positive regulation of translation (GO:0045727),25,4,4.88,-,0.82,4.61E-01
protein deacetylation (GO:0006476),25,4,4.88,-,0.82,4.61E-01
regulation of transmembrane transport (GO:0034762),75,12,14.65,-,0.82,2.97E-01
negative regulation of chromosome organization (GO:2001251),25,4,4.88,-,0.82,4.61E-01
nuclear chromosome segregation (GO:0098813),88,14,17.19,-,0.81,2.66E-01
blood circulation (GO:0008015),44,7,8.59,-,0.81,3.73E-01
regulation of DNA metabolic process (GO:0051052),44,7,8.59,-,0.81,3.73E-01
cell-cell junction organization (GO:0045216),63,10,12.3,-,0.81,3.16E-01
cell population proliferation (GO:0008283),202,32,39.45,-,0.81,1.31E-01
regulation of vesicle-mediated transport (GO:0060627),101,16,19.72,-,0.81,2.39E-01
stress-activated MAPK cascade (GO:0051403),38,6,7.42,-,0.81,3.89E-01
Notch signaling pathway (GO:0007219),38,6,7.42,-,0.81,3.89E-01
synapse assembly (GO:0007416),19,3,3.71,-,0.81,4.92E-01
muscle tissue development (GO:0060537),19,3,3.71,-,0.81,4.92E-01
positive regulation of Ras protein signal transduction (GO:0046579),19,3,3.71,-,0.81,4.92E-01
I-kappaB kinase/NF-kappaB signaling (GO:0007249),57,9,11.13,-,0.81,3.26E-01
synapse organization (GO:0050808),57,9,11.13,-,0.81,3.26E-01
mitotic sister chromatid segregation (GO:0000070),57,9,11.13,-,0.81,3.26E-01
regulation of supramolecular fiber organization (GO:1902903),89,14,17.38,-,0.81,2.51E-01
second-messenger-mediated signaling (GO:0019932),229,36,44.72,-,0.8,1.05E-01
cell differentiation (GO:0030154),751,118,146.67,-,0.8,7.31E-03
positive regulation of multicellular organismal process (GO:0051240),134,21,26.17,-,0.8,1.81E-01
Wnt signaling pathway (GO:0016055),115,18,22.46,-,0.8,2.04E-01
cellular developmental process (GO:0048869),754,118,147.25,-,0.8,6.40E-03
positive regulation of cell cycle (GO:0045787),32,5,6.25,-,0.8,4.06E-01
positive regulation of cellular component biogenesis (GO:0044089),64,10,12.5,-,0.8,2.97E-01
regulation of protein-containing complex assembly (GO:0043254),90,14,17.58,-,0.8,2.36E-01
positive regulation of cytoskeleton organization (GO:0051495),45,7,8.79,-,0.8,3.49E-01
organophosphate ester transport (GO:0015748),45,7,8.79,-,0.8,3.49E-01
regulation of cellular localization (GO:0060341),90,14,17.58,-,0.8,2.36E-01
circulatory system process (GO:0003013),45,7,8.79,-,0.8,3.49E-01
cell-cell signaling by wnt (GO:0198738),116,18,22.65,-,0.79,1.93E-01
regulation of cell population proliferation (GO:0042127),181,28,35.35,-,0.79,1.21E-01
regulation of hormone secretion (GO:0046883),13,2,2.54,-,0.79,5.34E-01
glucose 6-phosphate metabolic process (GO:0051156),13,2,2.54,-,0.79,5.34E-01
positive regulation of cellular amide metabolic process (GO:0034250),26,4,5.08,-,0.79,4.27E-01
chromosome localization (GO:0050000),13,2,2.54,-,0.79,5.34E-01
detection of mechanical stimulus (GO:0050982),13,2,2.54,-,0.79,5.34E-01
regulation of endocytosis (GO:0030100),26,4,5.08,-,0.79,4.27E-01
positive regulation of chemotaxis (GO:0050921),13,2,2.54,-,0.79,5.34E-01
regulation of G protein-coupled receptor signaling pathway (GO:0008277),13,2,2.54,-,0.79,5.34E-01
establishment of chromosome localization (GO:0051303),13,2,2.54,-,0.79,5.34E-01
response to steroid hormone (GO:0048545),13,2,2.54,-,0.79,5.34E-01
negative regulation of mitotic cell cycle phase transition (GO:1901991),26,4,5.08,-,0.79,4.27E-01
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),13,2,2.54,-,0.79,5.34E-01
oxidative demethylation (GO:0070989),13,2,2.54,-,0.79,5.34E-01
tumor necrosis factor-mediated signaling pathway (GO:0033209),13,2,2.54,-,0.79,5.34E-01
positive regulation of defense response (GO:0031349),13,2,2.54,-,0.79,5.34E-01
BMP signaling pathway (GO:0030509),52,8,10.16,-,0.79,3.15E-01
eye development (GO:0001654),39,6,7.62,-,0.79,3.62E-01
phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),39,6,7.62,-,0.79,3.62E-01
chromatin assembly or disassembly (GO:0006333),39,6,7.62,-,0.79,3.62E-01
visual system development (GO:0150063),39,6,7.62,-,0.79,3.62E-01
sensory system development (GO:0048880),39,6,7.62,-,0.79,3.62E-01
positive regulation of signal transduction (GO:0009967),293,45,57.22,-,0.79,5.51E-02
response to external stimulus (GO:0009605),508,78,99.21,-,0.79,1.50E-02
cell surface receptor signaling pathway (GO:0007166),835,128,163.07,-,0.78,2.10E-03
cellular response to cytokine stimulus (GO:0071345),144,22,28.12,-,0.78,1.42E-01
response to cytokine (GO:0034097),151,23,29.49,-,0.78,1.32E-01
muscle contraction (GO:0006936),46,7,8.98,-,0.78,3.26E-01
"alternative mRNA splicing, via spliceosome (GO:0000380)",46,7,8.98,-,0.78,3.26E-01
"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",158,24,30.86,-,0.78,1.23E-01
cell-cell adhesion (GO:0098609),158,24,30.86,-,0.78,1.23E-01
cell communication (GO:0007154),2155,327,420.86,-,0.78,2.66E-07
lymphocyte mediated immunity (GO:0002449),33,5,6.44,-,0.78,3.77E-01
defense response (GO:0006952),318,48,62.1,-,0.77,3.68E-02
cellular response to BMP stimulus (GO:0071773),53,8,10.35,-,0.77,2.94E-01
response to BMP (GO:0071772),53,8,10.35,-,0.77,2.94E-01
cell junction organization (GO:0034330),126,19,24.61,-,0.77,1.50E-01
signaling (GO:0023052),2145,323,418.9,-,0.77,1.37E-07
activation of phospholipase C activity (GO:0007202),40,6,7.81,-,0.77,3.37E-01
negative regulation of protein kinase activity (GO:0006469),40,6,7.81,-,0.77,3.37E-01
heart contraction (GO:0060047),20,3,3.91,-,0.77,4.52E-01
positive regulation of phospholipase C activity (GO:0010863),40,6,7.81,-,0.77,3.37E-01
negative regulation of kinase activity (GO:0033673),40,6,7.81,-,0.77,3.37E-01
regulation of phospholipase C activity (GO:1900274),40,6,7.81,-,0.77,3.37E-01
regulation of ERK1 and ERK2 cascade (GO:0070372),40,6,7.81,-,0.77,3.37E-01
ERK1 and ERK2 cascade (GO:0070371),40,6,7.81,-,0.77,3.37E-01
extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),20,3,3.91,-,0.77,4.52E-01
cytokine-mediated signaling pathway (GO:0019221),127,19,24.8,-,0.77,1.41E-01
signal transduction (GO:0007165),1998,298,390.2,-,0.76,1.67E-07
muscle system process (GO:0003012),47,7,9.18,-,0.76,3.03E-01
regulation of protein polymerization (GO:0032271),74,11,14.45,-,0.76,2.23E-01
positive regulation of actin filament polymerization (GO:0030838),27,4,5.27,-,0.76,3.94E-01
striated muscle cell differentiation (GO:0051146),27,4,5.27,-,0.76,3.94E-01
negative regulation of canonical Wnt signaling pathway (GO:0090090),27,4,5.27,-,0.76,3.94E-01
response to extracellular stimulus (GO:0009991),81,12,15.82,-,0.76,2.05E-01
protein transmembrane import into intracellular organelle (GO:0044743),27,4,5.27,-,0.76,3.94E-01
response to nutrient levels (GO:0031667),81,12,15.82,-,0.76,2.05E-01
receptor-mediated endocytosis (GO:0006898),61,9,11.91,-,0.76,2.50E-01
response to growth factor (GO:0070848),129,19,25.19,-,0.75,1.25E-01
cellular response to growth factor stimulus (GO:0071363),129,19,25.19,-,0.75,1.25E-01
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),34,5,6.64,-,0.75,3.49E-01
protein-containing complex disassembly (GO:0032984),68,10,13.28,-,0.75,2.28E-01
proteoglycan metabolic process (GO:0006029),34,5,6.64,-,0.75,3.49E-01
developmental process (GO:0032502),1228,180,239.82,-,0.75,1.83E-05
regulation of microtubule cytoskeleton organization (GO:0070507),41,6,8.01,-,0.75,3.12E-01
positive regulation of phospholipase activity (GO:0010518),41,6,8.01,-,0.75,3.12E-01
positive regulation of lipase activity (GO:0060193),41,6,8.01,-,0.75,3.12E-01
regulation of secretion (GO:0051046),103,15,20.12,-,0.75,1.50E-01
immune system development (GO:0002520),69,10,13.48,-,0.74,2.13E-01
monovalent inorganic cation transport (GO:0015672),221,32,43.16,-,0.74,4.64E-02
positive regulation of cell communication (GO:0010647),320,46,62.49,-,0.74,1.72E-02
positive regulation of signaling (GO:0023056),320,46,62.49,-,0.74,1.72E-02
negative regulation of transferase activity (GO:0051348),42,6,8.2,-,0.73,2.89E-01
heart process (GO:0003015),21,3,4.1,-,0.73,4.14E-01
"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",42,6,8.2,-,0.73,2.89E-01
sperm-egg recognition (GO:0035036),14,2,2.73,-,0.73,4.85E-01
axo-dendritic transport (GO:0008088),14,2,2.73,-,0.73,4.85E-01
neuromuscular synaptic transmission (GO:0007274),7,1,1.37,-,0.73,6.03E-01
tyrosine phosphorylation of STAT protein (GO:0007260),7,1,1.37,-,0.73,6.03E-01
receptor signaling pathway via JAK-STAT (GO:0007259),56,8,10.94,-,0.73,2.37E-01
protein O-linked glycosylation (GO:0006493),14,2,2.73,-,0.73,4.85E-01
protein localization to kinetochore (GO:0034501),7,1,1.37,-,0.73,6.03E-01
regulated exocytosis (GO:0045055),56,8,10.94,-,0.73,2.37E-01
receptor signaling pathway via STAT (GO:0097696),56,8,10.94,-,0.73,2.37E-01
cell-matrix adhesion (GO:0007160),28,4,5.47,-,0.73,3.62E-01
regulation of mitotic metaphase/anaphase transition (GO:0030071),14,2,2.73,-,0.73,4.85E-01
transcription elongation from RNA polymerase II promoter (GO:0006368),14,2,2.73,-,0.73,4.85E-01
cell-cell recognition (GO:0009988),14,2,2.73,-,0.73,4.85E-01
regulation of potassium ion transmembrane transport (GO:1901379),14,2,2.73,-,0.73,4.85E-01
response to mechanical stimulus (GO:0009612),14,2,2.73,-,0.73,4.85E-01
mRNA stabilization (GO:0048255),7,1,1.37,-,0.73,6.03E-01
regulation of systemic arterial blood pressure (GO:0003073),14,2,2.73,-,0.73,4.85E-01
positive regulation of calcium ion transport (GO:0051928),7,1,1.37,-,0.73,6.03E-01
cardiac muscle cell development (GO:0055013),7,1,1.37,-,0.73,6.03E-01
protein targeting to lysosome (GO:0006622),7,1,1.37,-,0.73,6.03E-01
regulation of JNK cascade (GO:0046328),28,4,5.47,-,0.73,3.62E-01
negative regulation of DNA replication (GO:0008156),7,1,1.37,-,0.73,6.03E-01
mismatch repair (GO:0006298),14,2,2.73,-,0.73,4.85E-01
RNA-dependent DNA biosynthetic process (GO:0006278),14,2,2.73,-,0.73,4.85E-01
positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),7,1,1.37,-,0.73,6.03E-01
positive regulation of response to external stimulus (GO:0032103),28,4,5.47,-,0.73,3.62E-01
poly(A)+ mRNA export from nucleus (GO:0016973),14,2,2.73,-,0.73,4.85E-01
heparan sulfate proteoglycan metabolic process (GO:0030201),14,2,2.73,-,0.73,4.85E-01
regulation of B cell proliferation (GO:0030888),7,1,1.37,-,0.73,6.03E-01
deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),7,1,1.37,-,0.73,6.03E-01
circulatory system development (GO:0072359),106,15,20.7,-,0.72,1.23E-01
multicellular organism development (GO:0007275),893,126,174.4,-,0.72,4.98E-05
regulation of ion transmembrane transport (GO:0034765),71,10,13.87,-,0.72,1.84E-01
hemopoiesis (GO:0030097),64,9,12.5,-,0.72,2.01E-01
hematopoietic or lymphoid organ development (GO:0048534),64,9,12.5,-,0.72,2.01E-01
anatomical structure development (GO:0048856),1095,153,213.85,-,0.72,4.08E-06
cell-cell signaling (GO:0007267),408,57,79.68,-,0.72,4.35E-03
defense response to Gram-positive bacterium (GO:0050830),43,6,8.4,-,0.71,2.67E-01
negative regulation of Wnt signaling pathway (GO:0030178),36,5,7.03,-,0.71,2.97E-01
intrinsic apoptotic signaling pathway (GO:0097193),36,5,7.03,-,0.71,2.97E-01
system development (GO:0048731),794,110,155.06,-,0.71,6.20E-05
animal organ morphogenesis (GO:0009887),116,16,22.65,-,0.71,9.23E-02
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),95,13,18.55,-,0.7,1.16E-01
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),22,3,4.3,-,0.7,3.78E-01
regulation of reproductive process (GO:2000241),22,3,4.3,-,0.7,3.78E-01
regulation of phospholipase activity (GO:0010517),44,6,8.59,-,0.7,2.46E-01
protein targeting to membrane (GO:0006612),44,6,8.59,-,0.7,2.46E-01
fertilization (GO:0009566),22,3,4.3,-,0.7,3.78E-01
positive regulation of response to stimulus (GO:0048584),413,56,80.66,-,0.69,2.15E-03
cell adhesion (GO:0007155),310,42,60.54,-,0.69,7.18E-03
regulation of leukocyte mediated immunity (GO:0002703),37,5,7.23,-,0.69,2.73E-01
biological adhesion (GO:0022610),311,42,60.74,-,0.69,6.72E-03
regulation of potassium ion transport (GO:0043266),15,2,2.93,-,0.68,4.39E-01
hippo signaling (GO:0035329),15,2,2.93,-,0.68,4.39E-01
chondroitin sulfate proteoglycan metabolic process (GO:0050654),15,2,2.93,-,0.68,4.39E-01
cell-substrate adhesion (GO:0031589),45,6,8.79,-,0.68,2.26E-01
positive regulation of leukocyte migration (GO:0002687),15,2,2.93,-,0.68,4.39E-01
response to toxic substance (GO:0009636),15,2,2.93,-,0.68,4.39E-01
regulation of mitotic nuclear division (GO:0007088),30,4,5.86,-,0.68,3.04E-01
cytoplasmic translational initiation (GO:0002183),15,2,2.93,-,0.68,4.39E-01
protein monoubiquitination (GO:0006513),15,2,2.93,-,0.68,4.39E-01
regulation of lipase activity (GO:0060191),45,6,8.79,-,0.68,2.26E-01
inorganic anion transport (GO:0015698),53,7,10.35,-,0.68,1.90E-01
cell-cell junction assembly (GO:0007043),53,7,10.35,-,0.68,1.90E-01
M phase (GO:0000279),38,5,7.42,-,0.67,2.50E-01
positive regulation of organelle organization (GO:0010638),76,10,14.84,-,0.67,1.26E-01
meiosis I cell cycle phase (GO:0098764),38,5,7.42,-,0.67,2.50E-01
meiotic cell cycle phase (GO:0098762),38,5,7.42,-,0.67,2.50E-01
telophase (GO:0051326),38,5,7.42,-,0.67,2.50E-01
meiotic telophase I (GO:0007134),38,5,7.42,-,0.67,2.50E-01
biological phase (GO:0044848),38,5,7.42,-,0.67,2.50E-01
meiosis I (GO:0007127),38,5,7.42,-,0.67,2.50E-01
cell cycle phase (GO:0022403),38,5,7.42,-,0.67,2.50E-01
positive regulation of protein-containing complex assembly (GO:0031334),38,5,7.42,-,0.67,2.50E-01
response to organic cyclic compound (GO:0014070),46,6,8.98,-,0.67,2.08E-01
toll-like receptor signaling pathway (GO:0002224),23,3,4.49,-,0.67,3.44E-01
defense response to other organism (GO:0098542),208,27,40.62,-,0.66,1.49E-02
cell recognition (GO:0008037),31,4,6.05,-,0.66,2.78E-01
protein transmembrane transport (GO:0071806),31,4,6.05,-,0.66,2.78E-01
protein localization to endoplasmic reticulum (GO:0070972),31,4,6.05,-,0.66,2.78E-01
intracellular protein transmembrane transport (GO:0065002),31,4,6.05,-,0.66,2.78E-01
meiotic chromosome segregation (GO:0045132),31,4,6.05,-,0.66,2.78E-01
negative regulation of organelle organization (GO:0010639),70,9,13.67,-,0.66,1.25E-01
chemical synaptic transmission (GO:0007268),249,32,48.63,-,0.66,7.09E-03
anterograde trans-synaptic signaling (GO:0098916),249,32,48.63,-,0.66,7.09E-03
interspecies interaction between organisms (GO:0044419),266,34,51.95,-,0.65,5.05E-03
trans-synaptic signaling (GO:0099537),251,32,49.02,-,0.65,6.11E-03
cell junction assembly (GO:0034329),79,10,15.43,-,0.65,9.86E-02
positive regulation of immune effector process (GO:0002699),40,5,7.81,-,0.64,2.09E-01
positive regulation of transport (GO:0051050),72,9,14.06,-,0.64,1.06E-01
inorganic anion transmembrane transport (GO:0098661),40,5,7.81,-,0.64,2.09E-01
negative regulation of blood pressure (GO:0045776),8,1,1.56,-,0.64,5.37E-01
positive regulation of DNA repair (GO:0045739),8,1,1.56,-,0.64,5.37E-01
JNK cascade (GO:0007254),32,4,6.25,-,0.64,2.53E-01
tRNA wobble uridine modification (GO:0002098),8,1,1.56,-,0.64,5.37E-01
chondrocyte differentiation (GO:0002062),8,1,1.56,-,0.64,5.37E-01
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),8,1,1.56,-,0.64,5.37E-01
immunoglobulin production (GO:0002377),8,1,1.56,-,0.64,5.37E-01
positive regulation of cell cycle G1/S phase transition (GO:1902808),8,1,1.56,-,0.64,5.37E-01
regulation of mRNA stability (GO:0043488),24,3,4.69,-,0.64,3.12E-01
positive regulation of cell population proliferation (GO:0008284),112,14,21.87,-,0.64,4.98E-02
microtubule anchoring (GO:0034453),8,1,1.56,-,0.64,5.37E-01
sperm capacitation (GO:0048240),8,1,1.56,-,0.64,5.37E-01
cardiac muscle cell differentiation (GO:0055007),8,1,1.56,-,0.64,5.37E-01
protein K48-linked deubiquitination (GO:0071108),8,1,1.56,-,0.64,5.37E-01
immune effector process (GO:0002252),96,12,18.75,-,0.64,6.69E-02
cellular response to hypoxia (GO:0071456),8,1,1.56,-,0.64,5.37E-01
pattern recognition receptor signaling pathway (GO:0002221),24,3,4.69,-,0.64,3.12E-01
protein N-linked glycosylation via asparagine (GO:0018279),8,1,1.56,-,0.64,5.37E-01
mitotic chromosome condensation (GO:0007076),8,1,1.56,-,0.64,5.37E-01
regulation of DNA replication (GO:0006275),16,2,3.12,-,0.64,3.96E-01
bone mineralization (GO:0030282),8,1,1.56,-,0.64,5.37E-01
NIK/NF-kappaB signaling (GO:0038061),8,1,1.56,-,0.64,5.37E-01
leukocyte chemotaxis (GO:0030595),48,6,9.37,-,0.64,1.74E-01
cardiocyte differentiation (GO:0035051),8,1,1.56,-,0.64,5.37E-01
glial cell differentiation (GO:0010001),8,1,1.56,-,0.64,5.37E-01
animal organ development (GO:0048513),393,49,76.75,-,0.64,4.17E-04
innate immune response (GO:0045087),137,17,26.76,-,0.64,2.98E-02
synaptic signaling (GO:0099536),266,33,51.95,-,0.64,3.14E-03
response to external biotic stimulus (GO:0043207),253,31,49.41,-,0.63,3.24E-03
response to other organism (GO:0051707),253,31,49.41,-,0.63,3.24E-03
peptidyl-tyrosine modification (GO:0018212),49,6,9.57,-,0.63,1.59E-01
cellular protein complex disassembly (GO:0043624),49,6,9.57,-,0.63,1.59E-01
response to biotic stimulus (GO:0009607),254,31,49.6,-,0.62,2.99E-03
leukocyte mediated immunity (GO:0002443),41,5,8.01,-,0.62,1.90E-01
inflammatory response (GO:0006954),123,15,24.02,-,0.62,3.37E-02
chromatin assembly (GO:0031497),33,4,6.44,-,0.62,2.30E-01
regulation of cation channel activity (GO:2001257),33,4,6.44,-,0.62,2.30E-01
multicellular organismal process (GO:0032501),1489,179,290.79,-,0.62,1.64E-13
regulation of RNA stability (GO:0043487),25,3,4.88,-,0.61,2.82E-01
regulation of microtubule-based process (GO:0032886),50,6,9.76,-,0.61,1.45E-01
positive regulation of stress-activated MAPK cascade (GO:0032874),25,3,4.88,-,0.61,2.82E-01
positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),25,3,4.88,-,0.61,2.82E-01
myeloid leukocyte migration (GO:0097529),50,6,9.76,-,0.61,1.45E-01
response to lipid (GO:0033993),67,8,13.08,-,0.61,9.55E-02
regulation of immune effector process (GO:0002697),42,5,8.2,-,0.61,1.73E-01
meiosis I cell cycle process (GO:0061982),42,5,8.2,-,0.61,1.73E-01
membrane fission (GO:0090148),42,5,8.2,-,0.61,1.73E-01
leukocyte migration (GO:0050900),59,7,11.52,-,0.61,1.12E-01
positive regulation of protein polymerization (GO:0032273),34,4,6.64,-,0.6,2.08E-01
centriole replication (GO:0007099),17,2,3.32,-,0.6,3.55E-01
regulation of neurotransmitter secretion (GO:0046928),17,2,3.32,-,0.6,3.55E-01
immune system process (GO:0002376),477,56,93.15,-,0.6,1.82E-05
regulation of cell adhesion (GO:0030155),60,7,11.72,-,0.6,1.02E-01
cell chemotaxis (GO:0060326),60,7,11.72,-,0.6,1.02E-01
positive regulation of supramolecular fiber organization (GO:1902905),43,5,8.4,-,0.6,1.57E-01
DNA packaging (GO:0006323),43,5,8.4,-,0.6,1.57E-01
endoplasmic reticulum unfolded protein response (GO:0030968),26,3,5.08,-,0.59,2.54E-01
calcium-ion regulated exocytosis (GO:0017156),26,3,5.08,-,0.59,2.54E-01
cellular response to lipid (GO:0071396),52,6,10.16,-,0.59,1.20E-01
reproductive process (GO:0022414),191,22,37.3,-,0.59,4.65E-03
reproduction (GO:0000003),191,22,37.3,-,0.59,4.65E-03
tissue morphogenesis (GO:0048729),35,4,6.84,-,0.59,1.88E-01
pattern specification process (GO:0007389),70,8,13.67,-,0.59,7.24E-02
granulocyte migration (GO:0097530),44,5,8.59,-,0.58,1.42E-01
cell fate commitment (GO:0045165),53,6,10.35,-,0.58,1.09E-01
sperm motility (GO:0097722),9,1,1.76,-,0.57,4.76E-01
regulation of production of molecular mediator of immune response (GO:0002700),9,1,1.76,-,0.57,4.76E-01
hemostasis (GO:0007599),18,2,3.52,-,0.57,3.18E-01
blood coagulation (GO:0007596),18,2,3.52,-,0.57,3.18E-01
mitotic spindle assembly (GO:0090307),18,2,3.52,-,0.57,3.18E-01
negative regulation of DNA metabolic process (GO:0051053),18,2,3.52,-,0.57,3.18E-01
regulation of leukocyte migration (GO:0002685),18,2,3.52,-,0.57,3.18E-01
"synaptic transmission, glutamatergic (GO:0035249)",36,4,7.03,-,0.57,1.70E-01
negative regulation of cell adhesion (GO:0007162),27,3,5.27,-,0.57,2.29E-01
UDP-N-acetylglucosamine metabolic process (GO:0006047),9,1,1.76,-,0.57,4.76E-01
flagellated sperm motility (GO:0030317),9,1,1.76,-,0.57,4.76E-01
skeletal muscle contraction (GO:0003009),9,1,1.76,-,0.57,4.76E-01
microtubule depolymerization (GO:0007019),18,2,3.52,-,0.57,3.18E-01
mitochondrial RNA metabolic process (GO:0000959),9,1,1.76,-,0.57,4.76E-01
zymogen activation (GO:0031638),9,1,1.76,-,0.57,4.76E-01
tissue remodeling (GO:0048771),9,1,1.76,-,0.57,4.76E-01
glutamate receptor signaling pathway (GO:0007215),28,3,5.47,-,0.55,2.05E-01
regulation of neurotransmitter receptor activity (GO:0099601),19,2,3.71,-,0.54,2.83E-01
neutrophil migration (GO:1990266),38,4,7.42,-,0.54,1.38E-01
regulation of blood pressure (GO:0008217),19,2,3.71,-,0.54,2.83E-01
coagulation (GO:0050817),19,2,3.71,-,0.54,2.83E-01
negative regulation of cAMP-mediated signaling (GO:0043951),19,2,3.71,-,0.54,2.83E-01
regulation of membrane potential (GO:0042391),114,12,22.26,-,0.54,1.30E-02
embryo development (GO:0009790),86,9,16.8,-,0.54,2.88E-02
action potential (GO:0001508),29,3,5.66,-,0.53,1.84E-01
gland development (GO:0048732),29,3,5.66,-,0.53,1.84E-01
response to bacterium (GO:0009617),128,13,25,-,0.52,6.33E-03
regulation of trans-synaptic signaling (GO:0099177),79,8,15.43,-,0.52,2.96E-02
modulation of chemical synaptic transmission (GO:0050804),79,8,15.43,-,0.52,2.96E-02
immune response (GO:0006955),336,34,65.62,-,0.52,1.12E-05
granulocyte chemotaxis (GO:0071621),40,4,7.81,-,0.51,1.11E-01
protein K63-linked deubiquitination (GO:0070536),10,1,1.95,-,0.51,4.19E-01
regulation of response to wounding (GO:1903034),10,1,1.95,-,0.51,4.19E-01
iron-sulfur cluster assembly (GO:0016226),10,1,1.95,-,0.51,4.19E-01
biomineral tissue development (GO:0031214),10,1,1.95,-,0.51,4.19E-01
biomineralization (GO:0110148),10,1,1.95,-,0.51,4.19E-01
plasma membrane fusion (GO:0045026),10,1,1.95,-,0.51,4.19E-01
retina development in camera-type eye (GO:0060041),10,1,1.95,-,0.51,4.19E-01
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),10,1,1.95,-,0.51,4.19E-01
positive regulation of secretion (GO:0051047),40,4,7.81,-,0.51,1.11E-01
connective tissue development (GO:0061448),10,1,1.95,-,0.51,4.19E-01
positive regulation of mitotic cell cycle (GO:0045931),20,2,3.91,-,0.51,2.52E-01
negative regulation of DNA recombination (GO:0045910),10,1,1.95,-,0.51,4.19E-01
negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100),10,1,1.95,-,0.51,4.19E-01
"regulation of synaptic transmission, glutamatergic (GO:0051966)",20,2,3.91,-,0.51,2.52E-01
regulation of coagulation (GO:0050818),10,1,1.95,-,0.51,4.19E-01
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),10,1,1.95,-,0.51,4.19E-01
positive regulation of apoptotic signaling pathway (GO:2001235),10,1,1.95,-,0.51,4.19E-01
regulation of wound healing (GO:0061041),10,1,1.95,-,0.51,4.19E-01
protein depolymerization (GO:0051261),40,4,7.81,-,0.51,1.11E-01
telomere-telomerase complex assembly (GO:1905324),10,1,1.95,-,0.51,4.19E-01
cartilage development (GO:0051216),10,1,1.95,-,0.51,4.19E-01
Arp2/3 complex-mediated actin nucleation (GO:0034314),20,2,3.91,-,0.51,2.52E-01
telomere maintenance via telomerase (GO:0007004),10,1,1.95,-,0.51,4.19E-01
binding of sperm to zona pellucida (GO:0007339),10,1,1.95,-,0.51,4.19E-01
single fertilization (GO:0007338),20,2,3.91,-,0.51,2.52E-01
cellular response to steroid hormone stimulus (GO:0071383),10,1,1.95,-,0.51,4.19E-01
positive regulation of cell adhesion (GO:0045785),31,3,6.05,-,0.5,1.46E-01
defense response to bacterium (GO:0042742),93,9,18.16,-,0.5,1.39E-02
cell division (GO:0051301),42,4,8.2,-,0.49,8.84E-02
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),21,2,4.1,-,0.49,2.23E-01
receptor internalization (GO:0031623),21,2,4.1,-,0.49,2.23E-01
detection of stimulus (GO:0051606),74,7,14.45,-,0.48,2.44E-02
potassium ion transmembrane transport (GO:0071805),106,10,20.7,-,0.48,7.25E-03
potassium ion transport (GO:0006813),107,10,20.9,-,0.48,6.50E-03
T cell receptor signaling pathway (GO:0050852),33,3,6.44,-,0.47,1.15E-01
negative regulation of T cell proliferation (GO:0042130),11,1,2.15,-,0.47,3.67E-01
telomere capping (GO:0016233),11,1,2.15,-,0.47,3.67E-01
negative regulation of chromosome separation (GO:1905819),11,1,2.15,-,0.47,3.67E-01
signal transduction by p53 class mediator (GO:0072331),11,1,2.15,-,0.47,3.67E-01
reproductive structure development (GO:0048608),22,2,4.3,-,0.47,1.98E-01
gliogenesis (GO:0042063),11,1,2.15,-,0.47,3.67E-01
reproductive system development (GO:0061458),22,2,4.3,-,0.47,1.98E-01
negative regulation of chromosome segregation (GO:0051985),11,1,2.15,-,0.47,3.67E-01
cytoplasmic mRNA processing body assembly (GO:0033962),11,1,2.15,-,0.47,3.67E-01
adaptive immune response (GO:0002250),55,5,10.74,-,0.47,4.35E-02
positive regulation of JNK cascade (GO:0046330),22,2,4.3,-,0.47,1.98E-01
Golgi to plasma membrane protein transport (GO:0043001),11,1,2.15,-,0.47,3.67E-01
positive regulation of mitotic nuclear division (GO:0045840),11,1,2.15,-,0.47,3.67E-01
sensory perception of sound (GO:0007605),11,1,2.15,-,0.47,3.67E-01
regulation of cell junction assembly (GO:1901888),11,1,2.15,-,0.47,3.67E-01
detection of chemical stimulus (GO:0009593),45,4,8.79,-,0.46,6.23E-02
cytokinesis (GO:0000910),34,3,6.64,-,0.45,1.02E-01
regulation of body fluid levels (GO:0050878),46,4,8.98,-,0.45,5.53E-02
positive regulation of immune response (GO:0050778),104,9,20.31,-,0.44,4.09E-03
extracellular matrix organization (GO:0030198),116,10,22.65,-,0.44,2.37E-03
regulation of immune response (GO:0050776),116,10,22.65,-,0.44,2.37E-03
cellular response to tumor necrosis factor (GO:0071356),35,3,6.84,-,0.44,9.06E-02
extracellular structure organization (GO:0043062),117,10,22.85,-,0.44,2.11E-03
peptidyl-tyrosine phosphorylation (GO:0018108),47,4,9.18,-,0.44,4.90E-02
heart development (GO:0007507),59,5,11.52,-,0.43,2.72E-02
G protein-coupled receptor signaling pathway (GO:0007186),573,48,111.9,-,0.43,4.26E-12
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),36,3,7.03,-,0.43,8.00E-02
response to tumor necrosis factor (GO:0034612),36,3,7.03,-,0.43,8.00E-02
spermatid development (GO:0007286),24,2,4.69,-,0.43,1.53E-01
mesoderm development (GO:0007498),12,1,2.34,-,0.43,3.21E-01
cellular response to light stimulus (GO:0071482),12,1,2.34,-,0.43,3.21E-01
spermatid differentiation (GO:0048515),24,2,4.69,-,0.43,1.53E-01
determination of heart left/right asymmetry (GO:0061371),12,1,2.34,-,0.43,3.21E-01
carbohydrate derivative transport (GO:1901264),12,1,2.34,-,0.43,3.21E-01
axonemal dynein complex assembly (GO:0070286),12,1,2.34,-,0.43,3.21E-01
mammary gland development (GO:0030879),24,2,4.69,-,0.43,1.53E-01
cardiac muscle tissue development (GO:0048738),12,1,2.34,-,0.43,3.21E-01
cellular response to lipopolysaccharide (GO:0071222),37,3,7.23,-,0.42,7.05E-02
response to metal ion (GO:0010038),37,3,7.23,-,0.42,7.05E-02
regulation of lymphocyte proliferation (GO:0050670),25,2,4.88,-,0.41,1.35E-01
regulation of mononuclear cell proliferation (GO:0032944),25,2,4.88,-,0.41,1.35E-01
amino sugar metabolic process (GO:0006040),25,2,4.88,-,0.41,1.35E-01
regulation of leukocyte proliferation (GO:0070663),25,2,4.88,-,0.41,1.35E-01
regulation of immune system process (GO:0002682),202,16,39.45,-,0.41,1.83E-05
spermatogenesis (GO:0007283),38,3,7.42,-,0.4,6.21E-02
positive regulation of leukocyte activation (GO:0002696),38,3,7.42,-,0.4,6.21E-02
positive regulation of cell activation (GO:0050867),38,3,7.42,-,0.4,6.21E-02
immune response-regulating cell surface receptor signaling pathway (GO:0002768),64,5,12.5,-,0.4,1.47E-02
immune response-regulating signaling pathway (GO:0002764),64,5,12.5,-,0.4,1.47E-02
regulation of heart contraction (GO:0008016),13,1,2.54,-,0.39,2.79E-01
protein localization to lysosome (GO:0061462),13,1,2.54,-,0.39,2.79E-01
positive regulation of synaptic transmission (GO:0050806),26,2,5.08,-,0.39,1.18E-01
regulation of peptidyl-tyrosine phosphorylation (GO:0050730),26,2,5.08,-,0.39,1.18E-01
positive regulation of immune system process (GO:0002684),144,11,28.12,-,0.39,2.03E-04
antimicrobial humoral response (GO:0019730),53,4,10.35,-,0.39,2.31E-02
male gamete generation (GO:0048232),40,3,7.81,-,0.38,4.79E-02
negative regulation of actin filament polymerization (GO:0030837),27,2,5.27,-,0.38,1.03E-01
response to interleukin-1 (GO:0070555),27,2,5.27,-,0.38,1.03E-01
lymphocyte migration (GO:0072676),27,2,5.27,-,0.38,1.03E-01
cellular response to biotic stimulus (GO:0071216),41,3,8.01,-,0.37,4.20E-02
response to lipopolysaccharide (GO:0032496),41,3,8.01,-,0.37,4.20E-02
system process (GO:0003008),434,31,84.76,-,0.37,1.15E-11
production of molecular mediator of immune response (GO:0002440),14,1,2.73,-,0.37,2.42E-01
regulation of AMPA receptor activity (GO:2000311),14,1,2.73,-,0.37,2.42E-01
peptidyl-tyrosine dephosphorylation (GO:0035335),14,1,2.73,-,0.37,2.42E-01
negative regulation of nuclear division (GO:0051784),14,1,2.73,-,0.37,2.42E-01
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),14,1,2.73,-,0.37,2.42E-01
protein palmitoylation (GO:0018345),28,2,5.47,-,0.37,9.02E-02
substrate adhesion-dependent cell spreading (GO:0034446),14,1,2.73,-,0.37,2.42E-01
cell adhesion mediated by integrin (GO:0033627),14,1,2.73,-,0.37,2.42E-01
regulation of intrinsic apoptotic signaling pathway (GO:2001242),14,1,2.73,-,0.37,2.42E-01
camera-type eye development (GO:0043010),28,2,5.47,-,0.37,9.02E-02
cell activation (GO:0001775),98,7,19.14,-,0.37,1.35E-03
T cell differentiation (GO:0030217),14,1,2.73,-,0.37,2.42E-01
regulation of leukocyte activation (GO:0002694),57,4,11.13,-,0.36,1.37E-02
anterior/posterior pattern specification (GO:0009952),43,3,8.4,-,0.36,3.22E-02
regulation of cell activation (GO:0050865),58,4,11.33,-,0.35,1.20E-02
positive regulation of lymphocyte activation (GO:0051251),29,2,5.66,-,0.35,7.86E-02
regulation of lymphocyte activation (GO:0051249),44,3,8.59,-,0.35,2.81E-02
immune response-activating cell surface receptor signaling pathway (GO:0002429),60,4,11.72,-,0.34,9.17E-03
immune response-activating signal transduction (GO:0002757),60,4,11.72,-,0.34,9.17E-03
specification of symmetry (GO:0009799),15,1,2.93,-,0.34,2.10E-01
smoothened signaling pathway (GO:0007224),15,1,2.93,-,0.34,2.10E-01
protein import into mitochondrial matrix (GO:0030150),15,1,2.93,-,0.34,2.10E-01
positive regulation of response to DNA damage stimulus (GO:2001022),15,1,2.93,-,0.34,2.10E-01
protein K48-linked ubiquitination (GO:0070936),15,1,2.93,-,0.34,2.10E-01
determination of left/right symmetry (GO:0007368),15,1,2.93,-,0.34,2.10E-01
sexual reproduction (GO:0019953),75,5,14.65,-,0.34,3.51E-03
determination of bilateral symmetry (GO:0009855),15,1,2.93,-,0.34,2.10E-01
response to inorganic substance (GO:0010035),45,3,8.79,-,0.34,2.45E-02
response to molecule of bacterial origin (GO:0002237),46,3,8.98,-,0.33,2.14E-02
fibroblast growth factor receptor signaling pathway (GO:0008543),31,2,6.05,-,0.33,5.94E-02
regulation of signaling receptor activity (GO:0010469),31,2,6.05,-,0.33,5.94E-02
leukocyte differentiation (GO:0002521),47,3,9.18,-,0.33,1.86E-02
ionotropic glutamate receptor signaling pathway (GO:0035235),16,1,3.12,-,0.32,1.81E-01
ossification (GO:0001503),16,1,3.12,-,0.32,1.81E-01
regulation of Notch signaling pathway (GO:0008593),16,1,3.12,-,0.32,1.81E-01
antibacterial humoral response (GO:0019731),32,2,6.25,-,0.32,5.16E-02
chloride transmembrane transport (GO:1902476),32,2,6.25,-,0.32,5.16E-02
antigen receptor-mediated signaling pathway (GO:0050851),48,3,9.37,-,0.32,1.62E-02
cilium movement involved in cell motility (GO:0060294),16,1,3.12,-,0.32,1.81E-01
chromosome condensation (GO:0030261),16,1,3.12,-,0.32,1.81E-01
regulation of hemopoiesis (GO:1903706),16,1,3.12,-,0.32,1.81E-01
striated muscle tissue development (GO:0014706),16,1,3.12,-,0.32,1.81E-01
cytokine production (GO:0001816),81,5,15.82,-,0.32,1.55E-03
regulation of receptor signaling pathway via JAK-STAT (GO:0046425),49,3,9.57,-,0.31,1.40E-02
regulation of receptor signaling pathway via STAT (GO:1904892),49,3,9.57,-,0.31,1.40E-02
B cell activation (GO:0042113),33,2,6.44,-,0.31,4.47E-02
negative regulation of immune system process (GO:0002683),33,2,6.44,-,0.31,4.47E-02
multi-organism process (GO:0051704),99,6,19.33,-,0.31,4.00E-04
multi-organism reproductive process (GO:0044703),99,6,19.33,-,0.31,4.00E-04
negative regulation of leukocyte cell-cell adhesion (GO:1903038),17,1,3.32,-,0.3,1.56E-01
lens development in camera-type eye (GO:0002088),17,1,3.32,-,0.3,1.56E-01
positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),34,2,6.64,-,0.3,3.87E-02
negative regulation of T cell activation (GO:0050868),17,1,3.32,-,0.3,1.56E-01
multicellular organism reproduction (GO:0032504),68,4,13.28,-,0.3,3.02E-03
positive regulation of receptor signaling pathway via STAT (GO:1904894),34,2,6.64,-,0.3,3.87E-02
activation of immune response (GO:0002253),69,4,13.48,-,0.3,2.62E-03
cellular process involved in reproduction in multicellular organism (GO:0022412),53,3,10.35,-,0.29,7.92E-03
nervous system process (GO:0050877),357,20,69.72,-,0.29,1.55E-12
leukocyte activation (GO:0045321),90,5,17.58,-,0.28,4.33E-04
male gonad development (GO:0008584),18,1,3.52,-,0.28,1.34E-01
negative regulation of cell-cell adhesion (GO:0022408),18,1,3.52,-,0.28,1.34E-01
male sex differentiation (GO:0046661),18,1,3.52,-,0.28,1.34E-01
developmental process involved in reproduction (GO:0003006),73,4,14.26,-,0.28,1.47E-03
germ cell development (GO:0007281),37,2,7.23,-,0.28,2.49E-02
regulation of cytokine production (GO:0001817),74,4,14.45,-,0.28,1.27E-03
lymphocyte activation (GO:0046649),74,4,14.45,-,0.28,1.27E-03
chloride transport (GO:0006821),37,2,7.23,-,0.28,2.49E-02
protein targeting to ER (GO:0045047),19,1,3.71,-,0.27,1.15E-01
actin filament depolymerization (GO:0030042),19,1,3.71,-,0.27,1.15E-01
establishment of protein localization to endoplasmic reticulum (GO:0072599),19,1,3.71,-,0.27,1.15E-01
humoral immune response (GO:0006959),76,4,14.84,-,0.27,9.48E-04
sister chromatid cohesion (GO:0007062),19,1,3.71,-,0.27,1.15E-01
gamete generation (GO:0007276),57,3,11.13,-,0.27,4.41E-03
embryonic organ development (GO:0048568),39,2,7.62,-,0.26,1.84E-02
regulation of T cell proliferation (GO:0042129),20,1,3.91,-,0.26,9.86E-02
T cell proliferation (GO:0042098),20,1,3.91,-,0.26,9.86E-02
cilium or flagellum-dependent cell motility (GO:0001539),20,1,3.91,-,0.26,9.86E-02
regulation of cell-cell adhesion (GO:0022407),40,2,7.81,-,0.26,1.58E-02
cilium-dependent cell motility (GO:0060285),20,1,3.91,-,0.26,9.86E-02
negative regulation of lymphocyte activation (GO:0051250),20,1,3.91,-,0.26,9.86E-02
multicellular organismal reproductive process (GO:0048609),61,3,11.91,-,0.25,2.42E-03
mononuclear cell proliferation (GO:0032943),41,2,8.01,-,0.25,1.36E-02
lymphocyte proliferation (GO:0046651),41,2,8.01,-,0.25,1.36E-02
leukocyte proliferation (GO:0070661),41,2,8.01,-,0.25,1.36E-02
integrin-mediated signaling pathway (GO:0007229),21,1,4.1,-,0.24,8.43E-02
ribosomal large subunit assembly (GO:0000027),21,1,4.1,-,0.24,8.43E-02
B cell proliferation (GO:0042100),22,1,4.3,-,0.23,7.20E-02
embryo development ending in birth or egg hatching (GO:0009792),22,1,4.3,-,0.23,7.20E-02
negative regulation of leukocyte activation (GO:0002695),22,1,4.3,-,0.23,7.20E-02
negative regulation of cell activation (GO:0050866),22,1,4.3,-,0.23,7.20E-02
lymphocyte activation involved in immune response (GO:0002285),22,1,4.3,-,0.23,7.20E-02
chordate embryonic development (GO:0043009),22,1,4.3,-,0.23,7.20E-02
cell fate specification (GO:0001708),23,1,4.49,-,0.22,6.14E-02
positive regulation of cell-cell adhesion (GO:0022409),24,1,4.69,-,0.21,5.23E-02
regulation of synaptic plasticity (GO:0048167),25,1,4.88,-,0.2,4.45E-02
T cell activation (GO:0042110),56,2,10.94,-,0.18,1.26E-03
sex differentiation (GO:0007548),28,1,5.47,-,0.18,2.72E-02
positive regulation of cytokine production (GO:0001819),28,1,5.47,-,0.18,2.72E-02
sensory perception (GO:0007600),274,9,53.51,-,0.17,5.14E-14
leukocyte activation involved in immune response (GO:0002366),31,1,6.05,-,0.17,1.65E-02
cell activation involved in immune response (GO:0002263),31,1,6.05,-,0.17,1.65E-02
regulation of leukocyte cell-cell adhesion (GO:1903037),32,1,6.25,-,0.16,1.39E-02
defense response to Gram-negative bacterium (GO:0050829),32,1,6.25,-,0.16,1.39E-02
skeletal system development (GO:0001501),33,1,6.44,-,0.16,1.18E-02
cilium movement (GO:0003341),33,1,6.44,-,0.16,1.18E-02
lymphocyte differentiation (GO:0030098),34,1,6.64,-,0.15,9.94E-03
regulation of T cell activation (GO:0050863),34,1,6.64,-,0.15,9.94E-03
leukocyte cell-cell adhesion (GO:0007159),37,1,7.23,-,0.14,5.95E-03
neuropeptide signaling pathway (GO:0007218),39,1,7.62,-,0.13,4.22E-03
sensory perception of chemical stimulus (GO:0007606),237,6,46.28,-,0.13,9.81E-14
embryonic morphogenesis (GO:0048598),45,1,8.79,-,0.11,1.48E-03
mitotic cytokinesis (GO:0000281),14,0,2.73,-, < 0.01,6.49E-02
sensory perception of pain (GO:0019233),4,0,0.78,-, < 0.01,4.58E-01
positive regulation of blood pressure (GO:0045777),3,0,0.59,-, < 0.01,5.57E-01
regulation of chromatin assembly or disassembly (GO:0001672),5,0,0.98,-, < 0.01,3.77E-01
negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),4,0,0.78,-, < 0.01,4.58E-01
meiotic DNA double-strand break formation (GO:0042138),1,0,0.2,-, < 0.01,8.23E-01
V(D)J recombination (GO:0033151),1,0,0.2,-, < 0.01,8.23E-01
urogenital system development (GO:0001655),12,0,2.34,-, < 0.01,9.59E-02
negative regulation of Notch signaling pathway (GO:0045746),5,0,0.98,-, < 0.01,3.77E-01
positive regulation of leukocyte cell-cell adhesion (GO:1903039),21,0,4.1,-, < 0.01,1.65E-02
odontogenesis of dentin-containing tooth (GO:0042475),4,0,0.78,-, < 0.01,4.58E-01
cardiolipin biosynthetic process (GO:0032049),1,0,0.2,-, < 0.01,8.23E-01
positive regulation of T cell proliferation (GO:0042102),12,0,2.34,-, < 0.01,9.59E-02
regulation of cytokine production involved in immune response (GO:0002718),6,0,1.17,-, < 0.01,3.10E-01
RNA interference (GO:0016246),1,0,0.2,-, < 0.01,8.23E-01
negative regulation of cellular protein catabolic process (GO:1903363),4,0,0.78,-, < 0.01,4.58E-01
heterochromatin organization (GO:0070828),8,0,1.56,-, < 0.01,2.10E-01
post-embryonic development (GO:0009791),1,0,0.2,-, < 0.01,8.23E-01
collagen fibril organization (GO:0030199),7,0,1.37,-, < 0.01,2.55E-01
histone deubiquitination (GO:0016578),4,0,0.78,-, < 0.01,4.58E-01
B cell differentiation (GO:0030183),19,0,3.71,-, < 0.01,2.44E-02
response to estradiol (GO:0032355),4,0,0.78,-, < 0.01,4.58E-01
response to cold (GO:0009409),5,0,0.98,-, < 0.01,3.77E-01
heart looping (GO:0001947),11,0,2.15,-, < 0.01,1.17E-01
signal transduction in response to DNA damage (GO:0042770),8,0,1.56,-, < 0.01,2.10E-01
response to nutrient (GO:0007584),4,0,0.78,-, < 0.01,4.58E-01
G2 DNA damage checkpoint (GO:0031572),5,0,0.98,-, < 0.01,3.77E-01
nucleotide-sugar transmembrane transport (GO:0015780),2,0,0.39,-, < 0.01,6.77E-01
tumor necrosis factor production (GO:0032640),6,0,1.17,-, < 0.01,3.10E-01
attachment of spindle microtubules to kinetochore (GO:0008608),10,0,1.95,-, < 0.01,1.42E-01
skeletal muscle tissue development (GO:0007519),3,0,0.59,-, < 0.01,5.57E-01
muscle organ development (GO:0007517),5,0,0.98,-, < 0.01,3.77E-01
negative regulation of proteasomal protein catabolic process (GO:1901799),4,0,0.78,-, < 0.01,4.58E-01
mesoderm morphogenesis (GO:0048332),11,0,2.15,-, < 0.01,1.17E-01
chromosome organization involved in meiotic cell cycle (GO:0070192),15,0,2.93,-, < 0.01,5.34E-02
regulation of complement activation (GO:0030449),1,0,0.2,-, < 0.01,8.23E-01
citrate transport (GO:0015746),4,0,0.78,-, < 0.01,4.58E-01
positive regulation of wound healing (GO:0090303),4,0,0.78,-, < 0.01,4.58E-01
synaptic membrane adhesion (GO:0099560),3,0,0.59,-, < 0.01,5.57E-01
heterochromatin assembly (GO:0031507),7,0,1.37,-, < 0.01,2.55E-01
phosphatidylglycerol metabolic process (GO:0046471),2,0,0.39,-, < 0.01,6.77E-01
branched-chain amino acid biosynthetic process (GO:0009082),3,0,0.59,-, < 0.01,5.57E-01
type 2 immune response (GO:0042092),3,0,0.59,-, < 0.01,5.57E-01
"retrograde transport, endosome to plasma membrane (GO:1990126)",9,0,1.76,-, < 0.01,1.72E-01
regulation of cytokine biosynthetic process (GO:0042035),4,0,0.78,-, < 0.01,4.58E-01
bone development (GO:0060348),7,0,1.37,-, < 0.01,2.55E-01
regulation of protein localization to membrane (GO:1905475),12,0,2.34,-, < 0.01,9.59E-02
negative regulation of mitotic sister chromatid segregation (GO:0033048),10,0,1.95,-, < 0.01,1.42E-01
negative regulation of sister chromatid segregation (GO:0033046),10,0,1.95,-, < 0.01,1.42E-01
secondary metabolite biosynthetic process (GO:0044550),2,0,0.39,-, < 0.01,6.77E-01
regulation of telomere maintenance via telomere lengthening (GO:1904356),6,0,1.17,-, < 0.01,3.10E-01
regulation of chromatin assembly (GO:0010847),3,0,0.59,-, < 0.01,5.57E-01
attachment of mitotic spindle microtubules to kinetochore (GO:0051315),5,0,0.98,-, < 0.01,3.77E-01
metaphase plate congression (GO:0051310),11,0,2.15,-, < 0.01,1.17E-01
male meiotic nuclear division (GO:0007140),6,0,1.17,-, < 0.01,3.10E-01
syncytium formation by plasma membrane fusion (GO:0000768),3,0,0.59,-, < 0.01,5.57E-01
carotenoid biosynthetic process (GO:0016117),1,0,0.2,-, < 0.01,8.23E-01
endoderm development (GO:0007492),11,0,2.15,-, < 0.01,1.17E-01
steroid hormone mediated signaling pathway (GO:0043401),4,0,0.78,-, < 0.01,4.58E-01
negative regulation of mitotic sister chromatid separation (GO:2000816),10,0,1.95,-, < 0.01,1.42E-01
homologous chromosome pairing at meiosis (GO:0007129),6,0,1.17,-, < 0.01,3.10E-01
actomyosin contractile ring organization (GO:0044837),3,0,0.59,-, < 0.01,5.57E-01
glycosaminoglycan biosynthetic process (GO:0006024),11,0,2.15,-, < 0.01,1.17E-01
aminoglycan biosynthetic process (GO:0006023),18,0,3.52,-, < 0.01,2.97E-02
aminoglycan metabolic process (GO:0006022),29,0,5.66,-, < 0.01,3.45E-03
kidney development (GO:0001822),8,0,1.56,-, < 0.01,2.10E-01
DNA double-strand break processing (GO:0000729),3,0,0.59,-, < 0.01,5.57E-01
regulation of telomere maintenance via telomerase (GO:0032210),5,0,0.98,-, < 0.01,3.77E-01
regulation of telomere maintenance (GO:0032204),9,0,1.76,-, < 0.01,1.72E-01
copper ion homeostasis (GO:0055070),3,0,0.59,-, < 0.01,5.57E-01
positive regulation of T cell activation (GO:0050870),21,0,4.1,-, < 0.01,1.65E-02
septin ring organization (GO:0031106),3,0,0.59,-, < 0.01,5.57E-01
DNA replication-independent nucleosome organization (GO:0034724),7,0,1.37,-, < 0.01,2.55E-01
regulation of receptor-mediated endocytosis (GO:0048259),11,0,2.15,-, < 0.01,1.17E-01
peripheral nervous system development (GO:0007422),4,0,0.78,-, < 0.01,4.58E-01
B cell receptor signaling pathway (GO:0050853),18,0,3.52,-, < 0.01,2.97E-02
mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),3,0,0.59,-, < 0.01,5.57E-01
defense response to fungus (GO:0050832),1,0,0.2,-, < 0.01,8.23E-01
nucleotide transmembrane transport (GO:1901679),2,0,0.39,-, < 0.01,6.77E-01
cytokinetic process (GO:0032506),7,0,1.37,-, < 0.01,2.55E-01
phosphatidylglycerol biosynthetic process (GO:0006655),1,0,0.2,-, < 0.01,8.23E-01
embryonic organ morphogenesis (GO:0048562),28,0,5.47,-, < 0.01,4.20E-03
T cell activation involved in immune response (GO:0002286),19,0,3.71,-, < 0.01,2.44E-02
heart morphogenesis (GO:0003007),17,0,3.32,-, < 0.01,3.61E-02
posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),7,0,1.37,-, < 0.01,2.55E-01
response to osmotic stress (GO:0006970),4,0,0.78,-, < 0.01,4.58E-01
positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),4,0,0.78,-, < 0.01,4.58E-01
cellular response to osmotic stress (GO:0071470),1,0,0.2,-, < 0.01,8.23E-01
complement activation (GO:0006956),7,0,1.37,-, < 0.01,2.55E-01
syncytium formation (GO:0006949),3,0,0.59,-, < 0.01,5.57E-01
response to cadmium ion (GO:0046686),3,0,0.59,-, < 0.01,5.57E-01
long-chain fatty acid transport (GO:0015909),8,0,1.56,-, < 0.01,2.10E-01
positive regulation of T cell differentiation (GO:0045582),6,0,1.17,-, < 0.01,3.10E-01
activation of innate immune response (GO:0002218),4,0,0.78,-, < 0.01,4.58E-01
regulation of release of sequestered calcium ion into cytosol (GO:0051279),3,0,0.59,-, < 0.01,5.57E-01
central nervous system neuron differentiation (GO:0021953),6,0,1.17,-, < 0.01,3.10E-01
alpha-beta T cell differentiation (GO:0046632),6,0,1.17,-, < 0.01,3.10E-01
mitotic G2 DNA damage checkpoint (GO:0007095),5,0,0.98,-, < 0.01,3.77E-01
mitotic spindle assembly checkpoint (GO:0007094),9,0,1.76,-, < 0.01,1.72E-01
regulation of mitotic spindle organization (GO:0060236),4,0,0.78,-, < 0.01,4.58E-01
plasma lipoprotein particle clearance (GO:0034381),3,0,0.59,-, < 0.01,5.57E-01
cell-cell fusion (GO:0140253),3,0,0.59,-, < 0.01,5.57E-01
mitotic metaphase plate congression (GO:0007080),9,0,1.76,-, < 0.01,1.72E-01
neural tube development (GO:0021915),2,0,0.39,-, < 0.01,6.77E-01
mitotic sister chromatid cohesion (GO:0007064),8,0,1.56,-, < 0.01,2.10E-01
septin cytoskeleton organization (GO:0032185),3,0,0.59,-, < 0.01,5.57E-01
cytoskeleton-dependent cytokinesis (GO:0061640),19,0,3.71,-, < 0.01,2.44E-02
morphogenesis of a branching structure (GO:0001763),3,0,0.59,-, < 0.01,5.57E-01
negative regulation of mitotic metaphase/anaphase transition (GO:0045841),9,0,1.76,-, < 0.01,1.72E-01
ectoderm development (GO:0007398),11,0,2.15,-, < 0.01,1.17E-01
skeletal muscle organ development (GO:0060538),4,0,0.78,-, < 0.01,4.58E-01
negative regulation of mitotic nuclear division (GO:0045839),10,0,1.95,-, < 0.01,1.42E-01
iron import into cell (GO:0033212),1,0,0.2,-, < 0.01,8.23E-01
gastrulation (GO:0007369),11,0,2.15,-, < 0.01,1.17E-01
mesoderm formation (GO:0001707),11,0,2.15,-, < 0.01,1.17E-01
histone H4-K16 acetylation (GO:0043984),6,0,1.17,-, < 0.01,3.10E-01
endoderm formation (GO:0001706),11,0,2.15,-, < 0.01,1.17E-01
ectoderm formation (GO:0001705),11,0,2.15,-, < 0.01,1.17E-01
formation of primary germ layer (GO:0001704),11,0,2.15,-, < 0.01,1.17E-01
acrosome reaction (GO:0007340),4,0,0.78,-, < 0.01,4.58E-01
mitochondrial RNA processing (GO:0000963),3,0,0.59,-, < 0.01,5.57E-01
negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),4,0,0.78,-, < 0.01,4.58E-01
pyrimidine nucleotide-sugar transmembrane transport (GO:0090481),2,0,0.39,-, < 0.01,6.77E-01
tyrosine metabolic process (GO:0006570),5,0,0.98,-, < 0.01,3.77E-01
lysosome localization (GO:0032418),10,0,1.95,-, < 0.01,1.42E-01
positive regulation of inflammatory response (GO:0050729),3,0,0.59,-, < 0.01,5.57E-01
actomyosin contractile ring assembly (GO:0000915),3,0,0.59,-, < 0.01,5.57E-01
assembly of actomyosin apparatus involved in cytokinesis (GO:0000912),3,0,0.59,-, < 0.01,5.57E-01
positive regulation of protein secretion (GO:0050714),2,0,0.39,-, < 0.01,6.77E-01
regulation of multi-organism process (GO:0043900),5,0,0.98,-, < 0.01,3.77E-01
chondroitin sulfate metabolic process (GO:0030204),9,0,1.76,-, < 0.01,1.72E-01
glycosaminoglycan metabolic process (GO:0030203),16,0,3.12,-, < 0.01,4.39E-02
arginine catabolic process (GO:0006527),5,0,0.98,-, < 0.01,3.77E-01
cellular copper ion homeostasis (GO:0006878),1,0,0.2,-, < 0.01,8.23E-01
nucleotide transport (GO:0006862),2,0,0.39,-, < 0.01,6.77E-01
meiotic sister chromatid segregation (GO:0045144),7,0,1.37,-, < 0.01,2.55E-01
homologous chromosome segregation (GO:0045143),10,0,1.95,-, < 0.01,1.42E-01
leucine transport (GO:0015820),2,0,0.39,-, < 0.01,6.77E-01
intracellular steroid hormone receptor signaling pathway (GO:0030518),3,0,0.59,-, < 0.01,5.57E-01
inner dynein arm assembly (GO:0036159),4,0,0.78,-, < 0.01,4.58E-01
outer dynein arm assembly (GO:0036158),6,0,1.17,-, < 0.01,3.10E-01
actin-mediated cell contraction (GO:0070252),6,0,1.17,-, < 0.01,3.10E-01
branched-chain amino acid transport (GO:0015803),2,0,0.39,-, < 0.01,6.77E-01
embryonic heart tube development (GO:0035050),12,0,2.34,-, < 0.01,9.59E-02
